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Abstract	
Natural	Killer	cells	efficiently	recognize	and	kill	infected	or	malignant	cells	and	can	eliminate	several	
of	these	cells	one	after	the	other	in	a	process	called	serial	killing.	The	activation	of	NK	cells	and	how	
they	form	conjugates	with	target	cells	is	well	studied,	but	for	the	efficient	killing	of	multiple	cells,	NK	
cells	 also	 have	 to	 detach	 from	 the	 previous	 target	 cell.	 The	 process	 of	 detachment	 is	 still	 poorly	
understood;	 therefore	 analyzing	 the	 regulation	 of	 this	 process	 in	more	 detail	 is	 important	 for	 the	
investigation	of	NK	cell	biology.	I	used	flow	cytometry	based	assays	to	analyze	the	adhesion	and	the	
detachment	of	NK	cells	and	target	cells.	
The	 data	 show,	 that	 the	 detachment	was	 different	 between	 fresh,	 IL-2	 activated	 and	 cultured	NK	
cells	 while	 the	 formation	 of	 conjugates	 was	 almost	 unchanged.	 Interestingly,	 blocking	 NK	 cell	
cytotoxicity	 inhibited	detachment.	 Reducing	 target	 cell	 death	by	 increasing	 their	 resistance	against	
NK	cells	also	reduced	the	detachment	of	NK	cells	and	increased	the	production	of	the	cytokines	IFN-γ	
and	TNF-α.	 Induction	of	NK	cell	 independent	 target	 cell	 death	had	 the	opposite	effect.	 The	 loss	of	
ligands	 for	 activating	 NK	 cell	 receptors	 and	 the	majority	 of	 adhesion	molecules	 on	 the	 target	 cell	
membrane	during	cell	death	could	be	responsible	for	the	NK	cell	detachment.	Additionally,	NK	cells	
seem	 to	 sense	 soluble	 factors	 released	by	dying	 cells,	 like	apoptotic	bodies,	which	accelerated	 the	
detachment.	
This	demonstrates,	that	the	detachment	of	NK	cells	is	a	highly	regulated	process,	which	depends	on	
the	activation	status	of	the	NK	cell,	ongoing	receptor-ligand	interactions	and	changes	in	the	protein	
profile	 of	 the	 cell	 membrane	 after	 death	 of	 the	 target	 cell.	 Regulation	 of	 detachment	 is	 not	 only	
necessary	 for	 the	efficiency	of	 serial	 killing	but	also	 influences	other	NK	cell	 effector	 functions	 like	
cytokine	production.	
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Zusammenfassung	
Natürliche	 Killerzellen	 (NK	 Zellen)	 erkennen	 sehr	 effizient	 kanzerogene	 oder	 virus-infizierte	 Zellen	
und	 können	mehrere	 dieser	 Zellen	 nacheinander	 töten.	Während	 die	 Aktivierung	 und	 der	 Aufbau	
eines	 Konjugats	mit	 der	 Zielzelle	 besonders	 gut	 erforscht	 und	 verstanden	 sind,	 ist	 der	 Prozess	 des	
Ablösens	von	der	Zielzelle	noch	wenig	untersucht.	Dabei	ist	das	Ablösen	der	NK	Zelle	nach	dem	Tod	
der	Zielzelle	essenziell	um	mehrere	Zielzellen	 schnell	und	effektiv	nacheinander	 zu	 töten.	 In	dieser	
Arbeit	 wurde	 die	 Regulation	 des	 Ablösens	 von	 NK	 Zellen	 detailliert	 untersucht.	 Mittels	
Durchflusszytometrie	analysierte	ich	die	Bildung	und	auch	den	Zerfall	von	Konjugaten	der	NK	Zellen	
mit	den	Zielzellen.	
Wir	konnten	zeigen,	dass	sich	frische,	IL-2	aktivierte	und	kultivierte	NK	Zellen	unterschiedlich	schnell	
von	 ihren	 Zielzellen	 ablösen.	 Dabei	 gibt	 es	 nur	 kleine	 Unterschiede	 in	 der	 Bildung	 der	 Konjugate	
zwischen	den	unterschiedlich	aktivierten	NK	Zellen.	Wurde	die	Zytotoxizität	der	NK	Zellen	 inhibiert,	
dann	reduzierte	das	den	Zerfall	von	Konjugaten	deutlich.	Denselben	Effekt	konnten	wir	beobachten	
wenn	 die	 Resistenz	 der	 Zielzellen	 gegen	NK	 Zellen	 erhöht	wurde.	 Das	 langsamere	 Ablösen	 der	NK	
Zellen	führte	in	beiden	Fällen	zu	einer	Überproduktion	der	proinflammatorischen	Zytokine	TNF-α	und	
IFN-γ.	Den	gegenteiligen	Effekt,	nämlich	eine	Beschleunigung	des	Zerfalls	der	Konjugate,	konnten	wir	
zeigen,	 wenn	 in	 den	 Zielzellen	 unabhängig	 von	 den	 NK	 Zellen	 Apoptose	 induziert	 wurde.	 Die	
Zielzellen	verlieren	nach	dem	durch	NK	Zellen	induzierten	Tod	viele	Adhäsionsproteine	sowie	einige	
ihrer	 aktivierenden	 Liganden.	 Dies	 könnte	 zum	 Ablösen	 der	 NK	 Zelle	 von	 der	 Zielzelle	 führen.	
Außerdem	scheinen	NK	Zellen	 lösliche	Faktoren	wahrzunehmen,	die	von	den	sterbenden	Zielzellen	
abgegeben	werden	und	den	Zerfall	der	Konjugate	beschleunigen.	
Ich	konnte	zeigen,	dass	das	Ablösen	von	NK	Zellen	ein	stark	regulierter	Prozess	ist.	Er	ist	abhängig	von	
der	Voraktivierung	der	NK	Zelle,	anhaltenden	Rezeptor-Liganden	 Interaktionen	und	Veränderungen	
in	der	Proteinzusammensetzung	der	Zielzellmembran	nach	dem	Tod	der	Zielzelle.	Die	Regulation	des	
Ablösens	 der	 NK	 Zelle	 von	 der	 Zielzelle	 ist	 nicht	 nur	 für	 effizientes	 Serial	 Killing	 nötig,	 sondern	
beeinflusst	auch	andere	Effektorfunktionen	wie	die	Zytokinproduktion.	
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1 Introduction	
1.1 A	short	introduction	into	NK	cell	biology	
During	hematopoiesis	 the	common	 lymphoid	progenitor	 (CLP)	develops	 into	one	of	 three	different	
lymphocytes:	T,	B	or	Natural	Killer	(NK)	cells.	T	and	B	lymphocytes	are	classified	as	members	of	the	
adaptive	 immune	system	due	to	their	ability	to	express	a	wide	range	of	different	receptors,	gained	
through	somatic	recombination	and	hypermutation	of	genes	(Boehm	and	Swann,	2014).	NK	cells	 in	
contrast	 are	 considered	 to	 be	 part	 of	 the	 innate	 immune	 system.	 Their	 receptors	 are	 germ	 line	
encoded	 and	 recognize	 specific	molecular	 patterns	 on	 the	outer	 cell	membrane	of	 other	 cells	 and	
need	no	prior	 sensitization.	However,	 in	 the	 last	10	years	 it	became	more	and	more	clear	 that	NK	
cells	have	additional	features	of	the	adaptive	immune	system	and	can	generate	long-lived	memory-
like	cells	after	contact	to	haptens,	cytokines	or	virus-induced	proteins	(Cooper	et	al.,	2009;	O'Leary	et	
al.,	2006;	Sun	et	al.,	2009).	NK	cells	are	mainly	present	in	the	blood	and	constitute	approximately	5-
15%	of	all	peripheral	blood	lymphocytes	(PBLs).	In	case	of	an	inflammation	NK	cells	can	migrate	into	
organs	and	detect	and	kill	diseased	cells	through	direct	cellular	contact	or	the	secretion	of	cytokines	
and	 attract	 other	 immune	 cells	 through	 the	 release	of	 chemokines.	 Additionally,	 all	 organs	 harbor	
tissue	resident	NK	cells,	which	can	have	distinctive	features	regarding	the	expression	of	receptors	or	
effector	proteins	(Lysakova-Devine	and	O'Farrelly,	2014).	NK	cells	are	a	heterogeneous	group	of	cells	
defined	by	the	expression	of	surface	proteins.	Commonly	NK	cells	are	defined	as	negative	for	the	T	
cell	 receptor	 complex	 CD3	 and	 positive	 for	 glycoprotein	 CD56	 as	 well	 as	 the	 natural	 cytotoxicity	
receptor	 NKp46	 (combined:	 CD3-CD56+NKp46+	 lymphocytes).	 Though,	 in	 the	 past	 decade	 many	
studies	 revealed	 that	 NK	 cells	 from	 different	 compartments	 of	 the	 body	 can	 have	 an	 individual	
protein	composition,	which	makes	the	classification	of	cells	complicated.	NK	cells	are	further	divided	
into	CD56bright	cells,	which	are	the	main	producer	of	cytokines	and	CD56dim	cells,	which	express	much	
more	perforin	and	are	more	cytotoxic	(Caligiuri,	2008;	Vivier	et	al.,	2008).	
NK	cells	express	two	opposing	types	of	receptors:	1)	Activating	receptors	that	bind	different	ligands	
on	 the	 cell	 surface,	 some	 of	 these	 are	 induced	 or	 upregulated	 by	 stressed	 and	 diseaseed	 cells.	 2)	
Inhibitory	 receptors,	 most	 of	 which	 bind	 to	 MHC	 class	 I	 molecules	 on	 healthy	 cells	 and	 send	 an	
inhibiting	signal	to	reduce	NK	cell	activation.	The	activating	and	inhibiting	signals	are	integrated	and	
the	 outcome	 decides	 whether	 the	 cytotoxicity	 of	 the	 NK	 cell	 is	 induced	 or	 not.	 The	 secretion	 of	
perforin	 and	 Granzymes	 into	 the	 immunological	 synapse	 between	 the	 NK	 and	 target	 cell	 mainly	
mediates	cytotoxicity.	Additionally,	NK	cells	can	kill	via	stimulating	death	receptors	on	the	target	cell	
with	 TNF-related	 apoptosis-inducing	 ligand	 (TRAIL)	 and	 Fas	 ligand	 (FasL)	 and	 the	 secretion	 of	
cytokines	like	Tumor	Necrosis	Factor	(TNF)-α	and	Interferon	(IFN)-γ	(Campbell	and	Hasegawa,	2013).	 	
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1.2 Activation	of	NK	cells	by	cytokines		
The	fight	against	diseased	cells,	pathogens	and	tumors	 involves	the	 interaction	of	a	broad	range	of	
different	 immune	 cells.	 They	 communicate	 via	 cytokines	 to	 control	 and	 synchronize	 the	 immune	
response.	The	cytokines	 Interleukin-2	for	short	time	pre-activation	and	Interleukin-2,	 Interleukin-15	
and	Interleukin-21	for	long	time	culture	of	the	NK	cells	were	used	in	this	study.	
Interleukin-2	(IL-2)	is	part	of	the	common	γ-chain	cytokine	family	and	a	main	activator	of	NK	cells.	It	
is	mostly	produced	by	activated	T	cells	and	activates	NK	cells,	but	also	CD4+/CD8+	T	cells	and	B	cells.	
IL-2	is	additionally	produced	by	dendritic	cells	(DCs)	at	an	early	time	point	of	an	infection	and	induces	
proliferation	of	NK	cells	and	 increases	cytotoxicity	as	well	as	 the	production	of	cytokines	 like	 IFN-γ	
(Granucci	 et	 al.,	 2001;	 London	 et	 al.,	 1986;	 Trinchieri	 et	 al.,	 1984;	 Young	 and	Ortaldo,	 1987).	 IL-2	
binds	to	the	IL-2	receptor,	which	consists	of	an	α-	and	β-subunit	and	the	common	cytokine	receptor	
γ-chain.	 CD56dim	 and	 CD56bright	 NK	 cells	 have	 different	 affinities	 for	 IL-2.	 While	 CD56dim	 NK	 cells	
express	 the	 intermediate-affinity	 receptor,	CD56bright	NK	cells	express	 the	high	affinity	 IL-2	 receptor	
and	can	therefore	already	be	affected	by	low-doses	of	IL-2	(Fehniger	et	al.,	2003).	After	IL-2	binds	to	
its	 receptor,	 JAK1/JAK3	 signaling	 proteins	 attached	 to	 the	 intracellular	 domains	 of	 the	 receptor	
initiate	activating	signals.	Different	signaling	pathways	including	PI3K,	STAT	and	MAPK	pathways	are	
activated	by	IL-2	(Boyman	and	Sprent,	2012).		
Interleukin-15	 (IL-15)	 stimulates	NK	 cell	 survival	 and	 can	enhance	 the	proliferation	 (Ferlazzo	et	 al.,	
2004;	Kennedy	et	al.,	2000).	In	an	inflammatory	environment	IL-15	is	produced	by	many	members	of	
the	 innate	 immune	 system	 like	 DCs,	 monocytes	 and	 macrophages	 but	 also	 by	 epithelial	 cells	
(Fehniger	and	Caligiuri,	2001).	IL-15	prolongs	the	survival	of	NK	cells	by	enhancing	the	expression	of	
anti-apoptotic	 protein	 Bcl-2,	 which	 counteracts	 cellular	 stress	 through	 inactivation	 of	 different	
caspases	 (Cory	et	al.,	2003;	Ranson	et	al.,	2003).	 IL-15	exists	as	a	 soluble	molecule	and	membrane	
bound	 on	 the	 surface	 of	 the	 expressing	 cell	 types.	 The	 stimulation	 via	 membrane	 bound	 IL-15	
dramatically	 increases	 the	 proliferation	 of	 NK	 cells.	 Therefore	 in	 the	 ex	 vivo	 culture	 of	 NK	 cells,	
irradiated	PBMCs	or	genetically	modified	K562,	which	express	membrane	bound	IL-15,	are	added	as	
feeder	cells	(Cho	and	Campana,	2009).	
Interleukin-21	(IL-21)	is,	 like	IL-2	and	IL-15,	part	of	the	IL-2	cytokine	family.	It	 is	mainly	produced	by	
activated	CD4+	T	cells	and	stimulates	the	expansion	of	NK	cells	and	proliferation	of	T	cells	and	B	cells	
(Parrish-Novak	et	al.,	2000).	Additionally,	IL-21	increases	the	production	of	perforin,	Granzyme	A	and	
B	 and	 thereby	 increases	 the	 cytotoxicity	 against	 target	 cells	 like	 K562	 (Skak	 et	 al.,	 2008).	 IL-21	
treatment	can	double	the	expansion	of	ex	vivo	cultivated	NK	cells	compared	to	cultivation	with	IL-2	
and	IL-15	alone	(Granzin	et	al.,	2016).	
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1.3 NK	cell	receptors	
1.3.1 Balance	of	receptor	signaling	
The	potential	 capacity	of	NK	cells	 to	bind	and	kill	autologous	cells	makes	 it	 indispensable	 to	highly	
regulate	 this	 cytotoxic	 process.	 If	 NK	 cells	 do	 not	 receive	 enough	 activating	 signals	 by	 stressed,	
malignant	or	infected	cells,	they	fail	to	detect	and	kill	them.	This	could	cause	a	disease	to	spread	and	
result	 in	 a	menace	 for	 the	whole	organism.	On	 the	other	hand	overactive	NK	 cells	 that	 cannot	be	
inhibited	by	healthy	cells	are	able	to	harm	the	body	as	well.	Under	these	circumstances	NK	cells	can	
damage	tissues	and	provoke	auto-immune	diseases.		
	
Figure	1.	Schematic	illustration	of	NK	cell	regulation.	NK	cells	are	regulated	by	germ-line	encoded	activating	or	inhibitory	
receptors.	After	 ligation	with	 its	 specific	 ligand,	 the	receptors	 induce	activating	or	 inhibiting	signals.	Depending	on	which	
signal	predominates	the	NK	cell	is	activated	and	kills	the	target	cell	or	this	is	inhibited.	The	absence	of	activating	ligands	or	
the	presence	of	many	inhibiting	ligands	leads	to	an	inhibition	of	the	NK	cell	and	prevents	the	target	cell	 lysis.	 In	contrast,	
the	overexpression	of	activating	ligands	or	the	loss	of	inhibiting	ligands	stimulate	the	NK	cell	and	induce	the	target	cell	lysis.	
The	activity	of	NK	cells	is	regulated	by	means	of	a	complex	system	of	activating	and	inhibiting	signals.	
The	signals	are	integrated	and	the	outcome	determines	if	the	NK	cell	attempts	to	lyse	the	target	cell	
or	not.	These	signals	are	 initiated	by	germ-line	encoded	receptors	on	 the	cell	 surface,	which	signal	
through	 their	 intracellular	 domains	 or	 adaptor	 proteins.	 They	 are	 discriminated	 in	 activating	 and	
inhibitory	receptors	even	though	there	are	overlaps.	Stressed	and	diseased	cells	 induce	or	 increase	
the	surface	expression	of	ligands	for	activating	receptors.	Healthy	cells	have	less	of	those	activating	
ligands	but	express	high	amounts	of	MHC	class	I	proteins,	which	are	recognized	by	inhibitory	NK	cell	
receptors	(Fogel	et	al.,	2013;	Long	et	al.,	2013;	Watzl,	2014).	As	depicted	in	Figure	1	the	abundance	
of	ligands	for	activating	and	inhibiting	receptors	is	essential	for	the	decision	about	NK	cell	activation.	
Target	cells	which	lack	ligands	for	activating	receptors	but	express	 inhibitory	MHC	class	I	molecules	
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do	 not	 activate	 the	NK	 cell	 and	 are	 left	 unaffected.	 This	 detection	 of	 healthy	 cells	 is	 entitled	 self-
recognition.	 The	presence	or	overexpression	of	 activating	 ligands	 can	 induce	NK	 cell	 cytotoxicity	 if	
the	activating	signal	overwhelms	the	inhibitory	signal.	In	accordance	with	the	missing-self	theory	the	
loss	or	down-regulation	of	MHC	class	I	by	malignant	or	virus	infected	cells	diminishes	the	inhibitory	
signal	and	induces	lysis	of	the	target	cell	(Raulet,	2006).		
1.3.2 Activating	NK	cell	receptors	
NK	cells	have	a	broad	range	of	germline	encoded	activating	receptors.	They	recognize	soluble	ligands,	
surface	proteins	on	potential	target	cells	and	cytokines.	These	receptors	are	associated	intracellularly	
with	adaptor	proteins	and	signal	upon	ligation	through	the	phosphorylation	of	downstream	signaling	
molecules,	 which	 initiates	 NK	 cell	 effector	 functions.	 NK	 cell	 receptors	 can	 be	 grouped	 by	 the	
activation-motif	 they	or	 their	 adaptors	utilize.	Natural	 cytotoxicity	 receptors	 (NCRs)	NKp30,	NKp44	
and	 NKp46	 and	 the	 Fc	 receptor	 FcγRIIIA	 (CD16)	 are	 coupled	 to	 immunoreceptor	 tyrosine-based	
activation	motif	(ITAM)-bearing	adaptor	proteins	FcεRIγ	chain,	CD3ζ	chain	or	DNAX-activating	protein	
of	12	kDa	 (DAP12).	 In	humans	 the	Natural	Killer	Group	2D	 (NKG2D)	 receptor	associates	exclusively	
with	 the	 YxxM	 tyrosine-based	 motif	 bearing	 DNAX-activating	 protein	 of	 10	 kDa	 (DAP10)	 adaptor	
protein	 and	 Signaling	 lymphocytic	 activating	 molecule	 (SLAM)	 family	 receptors	 2B4,	 NTB-A	 and	
CRACC	 contain	 immunoreceptor	 tyrosine-based	 switch	 motifs	 (ITSM)	 that	 can	 couple	 to	 SLAM-
associated	protein	(SAP)	or	EAT-2	(Long	et	al.,	2013;	Vivier	et	al.,	2011;	Watzl,	2014).	Phosphorylation	
of	these	adaptor	proteins	by	kinases	leads	to	binding/activation	of	downstream	signaling	molecules	
like	 AKT,	 ERK	 and	 others.	 The	 detailed	 functions	 of	 the	 receptors,	 which	 are	 investigated	 in	 this	
thesis,	are	described	in	the	following	chapters.	
1.3.2.1 Natural	Killer	Group	2D	(NKG2D)	receptor		
One	 of	 the	 best-characterized	 NK	 cell	 receptors	 is	 the	 Natural	 Killer	 Group	 2D	 (NKG2D)	 receptor.	
After	 it	 had	 been	 discovered,	 NKG2D	 could	 be	 identified	 as	 an	 activating	 receptor	 in	 NK	 cells	
(Houchins	et	al.,	1991;	Wu	et	al.,	1999),	which	is	encoded	by	the	KLRK1	gene	and	consists	of	just	two	
alleles	 (Glienke	et	al.,	1998).	Besides	all	NK	cells	NKG2D	 is	expressed	by	CD8+	T	cells,	NKT	and	γδ	T	
cells	 and	 binds	 to	 ligands	 from	 two	 families	 related	 to	 MHC	 class	 I	 molecules.	 One	 ligand	 family	
consists	 of	MHC	 class	 I	 polypeptide-related	 sequence	 A	 and	 B	 (MICA	 and	MICB)	 and	 one	 of	 UL16	
binding	proteins	1-6	(ULBP1-6).	All	ligands	are	stress-induced	and	usually	absent	on	healthy	cells.	The	
surface	 expression	 is	 only	 induced	 after	 infections	 with	 pathogens,	 transformation	 or	 another	
damage	 of	 the	 cell	 (Lopez-Larrea	 et	 al.,	 2008).	 In	 humans	 the	 NKG2D	 homodimer	 associates	
intracellularly	with	 four	chains	of	 the	transmembrane	adaptor	protein	DAP10	(Garrity	et	al.,	2005).	
This	 hexameric	 NKG2D:DAP10	 structure	 initiates	 signal	 transduction	 through	 the	 YxxM	 tyrosine-
based	 motif	 in	 the	 cytoplasmic	 tails	 of	 the	 DAP10	 proteins,	 which	 can	 bind	 and	 activate	 further	
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signaling	 molecules.	 The	 following	 phosphorylation	 cascades	 are	 necessary	 for	 NK	 cell	 effector	
functions.	 DAP10	 can	 bind	 the	 p85α	 subunit	 of	 phosphatidylinositol-3	 kinase	 (PI3K)	 after	
phosphorylation	 (Wu	et	 al.,	 1999),	which	 then	 can	phosphorylate	 and	 activate	 extracellular	 signal-
regulated	 kinase	 (ERK)	 and	 ERK	 activator	Mitogen-activated	 protein	 kinase	 kinase	 (MEK)	 (Upshaw	
and	 Leibson,	 2006).	 Both	molecules	 are	 crucial	 for	 NK	 cell	 cytotoxicity.	 But	 this	 signaling	 pathway	
alone	is	not	sufficient	to	trigger	NK	cell	cytotoxicity.	The	phosphorylation	of	VAV1	is	mediated	by	the	
adaptor	protein	Growth	factor	receptor-bound	protein	2	(Grb2)	binding	to	DAP10	and	is	needed	and	
crucial	for	the	reorganization	of	the	actin	cytoskeleton	and	polarization	of	the	microtubule-organizing	
center	(MTOC)	(Upshaw	et	al.,	2006).		
1.3.2.2 DNAX	Accessory	Molecule-1	(DNAM-1)	
The	 surface	 protein	 DNAX	 accessory	 molecule	 (DNAM-1,	 CD226)	 is	 an	 activating	 receptor,	 which	
binds	nectin	and	nectin-like	molecules.	Triggering	of	DNAM-1	by	its	ligands	Nectin-2	(CD112)	and	PVR	
(CD155)	 initiates	NK	cell	 cytotoxicity	and	 the	production	of	 IFN-γ	 (de	Andrade	et	al.,	 2014).	CD112	
and	 CD155	 are	 ubiquitously	 expressed	 but	 upregulated	 by	 solid	 tumors,	 lymphomas	 and	 virus-
infected	 cells	 (Lenac	Rovis	et	 al.,	 2016;	Qu	et	 al.,	 2015;	 Sanchez-Correa	et	 al.,	 2012).	After	 ligation	
DNAM-1	 is	 phosphorylated	 at	 its	 cytoplasmic	 tail	 via	 Src	 family	 kinases	 and	 associates	 with	 the	
adaptor	 protein	 Grb2.	 The	 signaling	 molecules	 VAV1,	 PI3K	 and	 Phospholipase	 C	 γ1	 (PLCγ1)	 are	
activated	and	phosphorylate	ERK,	AKT	and	induce	calcium	flux	(Zhang	et	al.,	2015).	These	pathways	
result	 in	the	reorganization	of	the	cytoskeleton	by	polymerization	of	actin,	granule	polarization	and	
the	production	of	IFN-γ.	In	the	past,	DNAM-1	and	adhesion	molecule	lymphocyte	function-associated	
antigen	1	(LFA-1)	were	considered	to	be	a	functional	unit,	which	promotes	adhesion	to	the	target	cell	
(Shibuya	et	al.,	1999).	But	this	association	is	less	clear,	since	it	was	discovered	recently,	that	LFA-1	is	
not	 critical	 for	DNAM-1	 signaling	 (Zhang	 et	 al.,	 2015).	 It	 is	 important	 to	 remark,	 that	 the	DNAM-1	
ligands	CD112	and	CD155	are	also	recognized	by	the	inhibitory	receptor	T	cell	immunoreceptor	with	
Ig	and	ITIM	domains	(TIGIT).	Triggering	of	this	receptor	leads	to	the	disruption	of	granule	polarization	
and	decreases	the	cytotoxicity	of	NK	cells	(Stanietsky	et	al.,	2013;	Stanietsky	et	al.,	2009).		
1.3.2.3 Natural	Cytotoxicity	Receptors	
Natural	cytotoxicity	receptors	(NCRs)	are	a	group	of	three	activating	NK	cell	receptors.	They	include	
NKp30,	 NKp44	 and	 NKp46,	 which	 all	 signal	 through	 ITAM	 bearing	 adaptor	 proteins.	 The	 first	
discovered	member	was	NKp46	the	expression	of	which	is	restricted	mostly	to	NK	cells	(Sivori	et	al.,	
1997;	Walzer	et	al.,	2007).	The	cellular	 ligand	for	NKp46	remained	elusive	for	a	 long	time.	Recently	
Vivier	and	colleagues	discovered	Properdin	(alias	Complement	factor	P;	CFP)	to	be	a	ligand;	a	protein	
that	is	involved	in	the	complement	system	and	opsonizes	diseased	and	apoptotic	cells	(Vivier,	2016;	
Xu	et	al.,	2008).	The	 receptor	NKp44	was	discovered	 shortly	after	NKp46	and	 is	only	expressed	on	
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activated	NK	cells	 (Vitale	et	al.,	 1998).	 Three	cellular	 ligands	 for	NKp44	are	known	up	 to	now:	The	
proliferating	cell	nuclear	antigen	(PCNA)	is	overexpressed	in	cancer	cells	and	inhibits	NK	cell	function	
through	activation	of	the	cytoplasmic	NKp44-ITIM	motif	(Rosental	et	al.,	2011).	The	NKp44-L	and	the	
recently	 discovered	 platelet	 derived	 growth	 factor	 D	 (PDGF-D)	 activate	 NK	 cells	 through	 ITAM-
signaling	 and	 are	mainly	 expressed	 on	 virus	 infected	 or	 transformed	 cells	 (Baychelier	 et	 al.,	 2013;	
Colonna,	2016).	 The	activating	 receptor	NKp30	 is	 expressed	on	all	NK	 cells	 and	binds	 to	B7H6	and	
BAT-3	on	stressed	and	infected	cells	(Brandt	et	al.,	2009;	Pende	et	al.,	1999;	Pogge	von	Strandmann	
et	 al.,	 2007).	 All	 three	 NCRs	 signal	 through	 ITAM	motifs	 but	 use	 different	 adaptor	 proteins.	 After	
ligation,	Src	family	kinases	phosphorylate	the	FcεRIγ	and	CD3ζ	chain	linked	to	NKp46	and	NKp30,	or	
DAP12	 linked	 to	NKp44.	The	 following	assembly	of	a	signaling	complex	 involves	 the	 recruitment	of	
the	kinases	ZAP70	and	SYK,	transmembrane	adaptors	like	LAT	and	NTAL	as	well	as	cytosolic	adaptor	
proteins	 like	 SLP76.	 Next,	 PI3K,	 PLC-γ1/2	 and	 VAV2/3	 can	 bind	 and	 are	 activated	 through	
phosphorylation	and	finally	start	the	cytotoxic	machinery	(Long	et	al.,	2013;	Vivier	et	al.,	2011;	Watzl,	
2014).		
1.3.2.4 NK-T-B-antigen	(NTB-A)	
The	co-activating	receptor	NTB-A	belongs	to	the	SLAM	family	receptors	and	is	expressed	by	all	NK,	T	
and	 B	 cells.	 It	 binds	 homophilic	 to	 NTB-A	 proteins	 on	 the	 surface	 of	 potential	 target	 cells	 and	
stimulates	cytotoxicity	and	the	production	of	pro-inflammatory	cytokines	(Bottino	et	al.,	2001;	Flaig	
et	al.,	2004).	A	recent	study	suggests	that	NTB-A	can	additionally	bind	to	viral	hemagglutinin	(HA)	and	
co-stimulate	 the	 anti-viral	 activity	 of	 NK	 cells	 (Duev-Cohen	 et	 al.,	 2016).	 Upon	 ligation,	 NTB-A	
associates	intracellularly	with	the	adaptor	proteins	SAP	and	EAT-2	(Bottino	et	al.,	2001;	Eissmann	and	
Watzl,	2006),	which	bind	and	activate	downstream	signaling	molecules	and	induce	the	production	of	
IFN-γ	and	TNF-α	and	boost	NK	cell	cytotoxicity	(Falco	et	al.,	2004).	
1.3.2.5 2B4-CD48	
2B4	is	another	co-activating	receptor	of	the	SLAM	receptor	family	and	expressed	on	CD8+	T	cells	and	
NK	cells	(Nakajima	et	al.,	1999;	Tangye	et	al.,	1999).	It	binds	to	CD48,	which	is	ubiquitously	expressed	
on	hematopoietic	cells	but	is	upregulated	on	diseased	cells	(McArdel	et	al.,	2016).	The	infection	with	
Epstein-Barr	 virus	 (EBV)	 as	 well	 as	 the	 transformation	 of	 cells	 increases	 the	 expression	 of	 CD48	
(Hosen	et	al.,	2012;	Thorley-Lawson	et	al.,	1982).	After	ligation	with	CD48,	2B4	is	phosphorylated	at	
its	 intracellular	 ITSM	domain	and	can	bind	the	adaptor	proteins	SAP	and	EAT-2	.	Dependent	on	the	
availability	of	adaptor	proteins	and	together	with	a	second	activating	signal,	triggering	of	2B4	induces	
the	 cytotoxicity	 and	 production	 of	 cytokines	 like	 IFN-γ	 (Johnson	 et	 al.,	 2000;	 Johnson	 et	 al.,	 2003;	
Messmer	 et	 al.,	 2006;	 Sivori	 et	 al.,	 2000).	 Recruitment	 of	 the	 Src-family	 kinase	 FynT	 starts	 a	
phosphorylation	 cascade,	 which	 activates	 LFA-1	 through	 inside-out	 signaling	 and	 increases	 the	
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adhesion	to	the	target	cell	(Hoffmann	et	al.,	2011).	As	mentioned	before,	CD48	is	also	expressed	on	
NK	cells	themselves	and	2B4	is	able	to	bind	it	 in	cis	on	the	same	cell.	This	cis-interaction	diminishes	
the	 binding	 to	 CD48	 in	 trans	 on	 the	 target	 cell	 and	 represents	 another	 mechanism	 of	 NK	 cell	
regulation	 (Claus	 et	 al.,	 2016b).	 Interestingly	 in	 absence	 of	 functional	 SAP,	 the	 phosphatases	 Src	
homology	 region	 2	 domain-containing	 phosphatase	 (SHP)-1/2	 and	 SH2-containing	 Inositol	 5ʹ-
Phosphatase	(SHIP-1),	can	bind	to	the	ITSM	domains	of	2B4.	This	leads	to	an	inhibiting	signal,	which	
counteracts	 ITAM-mediated	 activation	 of	 the	 NK	 cell	 and	weakens	 the	 immune	 response	 through	
dephosphorylation	 of	 activating	 signaling	 molecules	 like	 VAV1	 (Meazza	 et	 al.,	 2014;	 Stepp	 et	 al.,	
1999b;	Watzl	and	Claus,	2014).		
1.3.3 Inhibitory	Receptors	
Inhibitory	receptors	on	NK	cells	deliver	signals,	which	can	block	activating	signals	and	prevent	lysis	of	
the	target	cell.	Most	potent	inhibitory	receptors	are	receptors	of	the	KIR2DLx	or	KIR3DLx	family	and	
NKG2A/CD94,	which	 all	 bind	 to	MHC	 class	 I	 proteins	 on	 the	 target	 cell.	Other	 inhibitory	 receptors	
recognize	 non-MHC	 class	 I	 ligands	 like	 collagen	 (LAIR1),	 sialic	 acids	 (SIGLEC-3/7/9)	 or	 cadherins	
(KLRG1).	Their	cytoplasmic	tail	contains	one	or	two	immunoreceptor	tyrosine-based	inhibitory	motifs	
(ITIMs).	 After	 triggering	 of	 the	 receptor,	 Src	 family	 kinases	 phosphorylate	 these	 ITIMs	 and	 enable	
phosphatases	SHIP-1,	SHP-1	and	SHP-2	or	others	to	bind,	which	then	catalyze	the	dephosphorylation	
and	thereby	 inactivation	of	activating	signaling	molecules	 like	VAV1/2/3,	Pl3K,	AKT	or	SYK.	NK	cells	
express	an	individual	repertoire	of	inhibitory	receptors.	It	is	essential	that	NK	cells	that	lack	inhibitory	
receptors	for	self-MHC	class	I	and	therefore	are	deficient	in	one	mechanism	to	distinguish	between	
healthy	 and	 diseased	 cells	 have	 a	 reduced	 activity.	 A	 process	 called	 education	 determines	 the	
responsiveness	of	NK	cells	depending	on	their	 inhibitory	receptors	 (Brodin	et	al.,	2009;	Long	et	al.,	
2013;	Watzl	and	Long,	2010).		
1.3.3.1 The	inhibitory	receptor	CD300a	
The	 inhibitory	 receptor	CD300a	 is	part	of	 the	CD300	receptor	 family.	 It	 is	expressed	on	all	NK	cells	
and	 a	 majority	 of	 other	 hematopoietic	 cells.	 The	 receptor	 consists	 of	 an	 IgV-like	 domain	 and	 an	
intracellular	tail	with	four	ITIMs	(Bachelet	et	al.,	2005;	Cantoni	et	al.,	1999).	Phosphatidylserine	(PS)	
and	phosphatidylethanolamine	(PE)	were	 identified	as	 ligands	for	CD300a.	Both	are	not	present	on	
the	outer	side	of	the	membrane	of	healthy	cells	but	translocate	to	the	cell	surface	of	apoptotic	and	
dying	cells	and	act	as	an	eat-me	signal	 for	phagocytes	 (Nakahashi-Oda	et	al.,	2012;	Simhadri	et	al.,	
2012).	After	 ligation	 tyrosine	 residues	 in	 the	 ITIM	motifs	are	phosphorylated	by	Src	 family	 tyrosine	
kinases,	which	enable	phosphatases	SHP-1	and	SHP-2	to	bind	and	being	phosphorylated	(Cantoni	et	
al.,	 1999).	 Lankry	 et	 al.	 could	 show	 that	 CD300a	 on	 NK	 cells	 interacts	 with	 PS	 on	 the	 target	 cell.	
Blocking	of	this	interaction	with	milk	fat	globule-EGF	factor	8	protein	(MFG-E8)	increased	the	NK	cell	
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cytotoxicity.	MFG-E8	is	a	glycoprotein,	which	is	secreted	by	activated	macrophages	and	binds	PS	on	
apoptotic	cells.	This	enables	phagocytes	to	bind	MFG-E8	via	alpha(v)beta(3)	integrin	and	engulf	and	
eliminate	the	target	cell	(Hanayama	et	al.,	2002).	PS	was	also	found	to	be	overexpressed	on	several	
tumor	cell	 lines	and	this	was	proposed	to	be	a	mechanism	of	tumor	 immune	escape	(Lankry	et	al.,	
2013).		
1.3.4 NK	cell	secreted	cytokines	and	chemokines	
NK	cell-mediated	cellular	cytotoxicity	is	not	the	only	participation	of	NK	cells	to	the	human	immune	
response.	NK	 cells	 also	 secrete	 a	 broad	 range	 of	 cytokines	 and	 chemokines	 to	 interact	with	 other	
immune	cells	or	which	directly	attack	the	target	cell.	The	best-known	NK	cell	derived	cytokines	are	
Interferon-γ	(IFN-γ)	and	tumor	necrosis	factor-α	(TNF-α),	which	are	described	in	detail	in	this	chapter.	
Interleukins	 secreted	 by	 NK	 cells	 after	 activation	 are	 the	 eosinophil	 activating	 IL-5,	 the	 anti-
inflammatory	IL-10	and	the	B	cell	activating	IL-13	(Hoshino	et	al.,	1999;	Mehrotra	et	al.,	1998;	Warren	
et	al.,	1995).	NK	cells	also	produce	the	hematopoietic	growth	factor	and	immune	modulator	GM-CSF	
(Levitt	 et	 al.,	 1991).	 As	 part	 of	 the	 early	 immune	 response	 NK	 cells	 produce	 and	 secrete	 several	
chemokines,	 which	 guide	 other	 immune	 cells	 to	 the	 site	 of	 inflammation.	 The	 macrophage	
inflammatory	 protein	 (MIP)-1α/β,	 IL-8	 and	 CCL5	 (also	 RANTES)	 are	 released	 shortly	 after	 NK	 cell	
stimulation	 and	 attract	 other	 NK	 cells,	macrophages,	 neutrophils	 and	 T	 cells	 (Fauriat	 et	 al.,	 2010;	
Griffith	et	al.,	2014).		
NK	cells	secrete	IFN-γ	upon	stimulation	with	IL-12/18	or	direct	contact	to	target	cells	(Fauriat	et	al.,	
2010).	 Particularly	 the	 infection	 of	 target	 cells	 with	 viruses,	 bacteria	 or	 parasites	 stimulates	 the	
production	 of	 IFN-γ.	 It	 influences	 the	 immune	 response	 in	 two	 ways:	 It	 acts	 on	 the	 target	 cells	
directly	 and	 stimulates	 various	other	 immune	 cells.	On	 the	 target	 cell,	 binding	of	 IFN-γ	 to	 the	 two	
IFN-γ	receptor	subunits	activates	 janus	kinase	1/2	 (JAK1/2)	and	the	MAPK	pathway,	which	 leads	to	
the	 phosphorylation	 of	 the	 transcription	 factors	 signal	 transducer	 and	 activator	 of	 transcription	 1	
(STAT1)	 and	 STAT3	 (Kovarik	 et	 al.,	 1999).	 These	 enhance	 the	 expression	 of	 MHC	 class	 I	 proteins,	
which	 render	 the	 diseased	 cells	 more	 susceptible	 for	 T	 cell-mediated	 killing.	 The	 transcription	 of	
other	proteins	like	death	receptor	CD95	or	apoptosis	inducing	caspase-1	is	also	induced	by	STAT1	and	
STAT3	and	make	these	cells	more	susceptible	for	immune	surveillance	(Lin	et	al.,	2017;	Shankaran	et	
al.,	2001;	Shin	et	al.,	2001).	As	an	activator	for	immune	cells	IFN-γ	can	stimulate	the	proliferation	and	
survival	 of	 CD4+	 T	 cells	 (Reed	 et	 al.,	 2008)	 and	 contribute	 to	 the	 activation	 of	 cytotoxic	 CD8+	 T	
lymphocytes	 (CTLs)	 (Giovarelli	et	al.,	1988).	The	activation	of	macrophages	by	 IFN-γ	 is	essential	 for	
the	clearance	of	bacteria	(Nathan	et	al.,	1984).	
Within	 the	 first	 3	 h	 after	 target	 cell	 contact	 resting	NK	 cells	 secrete	 soluble	 sTNF-α	 (Fauriat	 et	 al.,	
2010)	and	also	express	membrane	bound	mTNF-α	on	their	surface	(Caron	et	al.,	1999).	The	ligation	of	
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TNF-α	with	 the	death	 receptors	TNF	receptor	1	or	2	can	 induce	different	cellular	 responses.	 In	 the	
absence	of	anti-apoptotic	protein	TNF	receptor-associated	factor	2	(TRAF2),	TNF-α	induces	apoptosis	
through	 caspase	 activation	 and	 thereby	 participates	 directly	 in	 killing	 of	 target	 cells	 (Micheau	 and	
Tschopp,	 2003).	 Immune	 cells	 express	 TRAF2	 and	 therefore	 TNF-α	 receptor	 1	 and	 2	 induce	
transcription	factor	NFκB	activation	and	stimulate	expression	of	anti-apoptotic	and	pro-inflammatory	
proteins	(Cabal-Hierro	and	Lazo,	2012).	
1.4 The	immunological	synapse	
Cytotoxic	lymphocytes	can	mediate	cellular	cytotoxicity	inducing	target	cell	apoptosis	via	delivery	of	
cytotoxic	 proteins	 or	 stimulation	 of	 death	 receptors.	 The	 NK	 cell	 needs	 physical	 contact	 with	 the	
target	cell.	This	specialized	contact	area	 is	called	 immunological	synapse	(IS)	and	serves	on	the	one	
hand	 as	 firm	 connection,	 which	 brings	 NK	 cell	 receptors	 and	 their	 ligands	 in	 close	 proximity	 and	
facilitates	 their	 interaction.	 On	 the	 other	 hand	 the	 IS	 functions	 as	 a	 sealed	 space	 into	which	 lytic	
granules	are	secreted.	The	process	of	NK	cell	killing	can	be	divided	into	3	main	steps:	The	formation	
of	the	IS,	the	mediation	of	cytotoxicity	and	the	termination	of	the	conjugate	(Mace	et	al.,	2014).		
1.4.1 Formation	of	the	immunological	synapse	
NK	cells	circulate	 in	 the	peripheral	blood	or	are	 resident	 in	 lymphoid	or	non-lymphoid	 tissues.	Like	
other	lymphocytes,	NK	cells	are	able	to	move	directed	and	migrate	in	and	through	different	tissues	to	
monitor	 tissue	 cells	 and	 detect	 diseased	 ones.	 NK	 cells	 are	 attracted	 to	 the	 areas	 of	 interest	 by	
cytokines	 like	 IL-15	 (Allavena	 et	 al.,	 1997).	 In	 the	 mouse,	 also	 NKG2D	 ligand	 Rae-1b	 seems	 to	
influence	NK	cell	motility	(Deguine	et	al.,	2010).	This	attraction	leads	to	a	first	approach	to	potential	
target	cells.	Binding	of	adhesion	molecules	like	LFA-1,	CD2	or	L-Selectin	(CD62L)	can	initiate	a	 loose	
adhesion	to	these	cells	without	 ligation	of	other	activating	receptors.	This	adhesion	arrests	the	cell	
and	allows	the	binding	of	additional	NK	cell	receptors	to	their	ligands.	Engagement	of	activating	NK	
cell	receptors	NKG2D,	DNAM-1	or	2B4	or	adhesion	molecule	CD2	results	in	inside-out	signaling.	This	
activates	 further	 LFA-1	 molecules	 and	 increases	 the	 binding	 to	 its	 ligands	 ICAM-1/2/3,	 which	
stabilizes	the	adhesion	to	the	target	cell	(Bryceson	et	al.,	2009).	Other	mechanisms	discussed	to	be	
involved	in	the	initial	adhesion	of	NK	cells	to	their	targets	are	NK	cell	nanotubes	that	can	connect	NK	
to	target	cells	over	 larger	distances.	They	contain	NKG2D,	the	adaptor	protein	DAP10	and	signaling	
molecule	 VAV1	 and	 could	 guide	 the	 NK	 cell	 movement	 towards	 the	 target	 cell	 (Chauveau	 et	 al.,	
2010).	In	resting	NK	cells,	triggering	of	LFA-1	alone	leads	to	the	convergence	of	lytic	granules	at	the	
MTOC	and	 their	 transport	 to	 the	 immunological	 synapse	but	not	 to	degranulation	 (Bryceson	et	al.,	
2005).	Degranulation	and	killing	of	 the	target	cell	need	the	signal	of	additional	activating	receptors	
(Bryceson	et	al.,	2009;	Hsu	et	al.,	2016)	or	 the	pre-activation	with	cytokines	 like	 IL-2	 (Barber	et	al.,	
2004).		
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LFA-1	 activation	 is	 an	 important	 trigger	 for	 the	 NK	 cell	 to	 start	 the	 formation	 of	 the	 IS.	 After	
activation,	 the	 adaptor	 protein	 Talin	 switches	 from	 its	 inactive	 to	 its	 active	 state	 and	binds	 to	 the	
intracellular	 tail	 of	 the	 ß2	 chain	 (CD18)	 of	 LFA-1	 (Martel	 et	 al.,	 2001).	 This	 binding	 leads	 to	
conformational	 rearrangements	 of	 the	 extracellular	 integrin	 domain,	which	 results	 in	 an	 increased	
affinity	to	the	LFA-1	ligands	ICAM-1/2/3	(Tadokoro	et	al.,	2003).	Additionally,	the	interaction	of	LFA-1	
and	Talin	also	is	important	for	outside-in	signaling	and	leads	to	the	activation	of	signaling	molecules,	
which	results	in	the	rearrangement	of	the	actin	cytoskeleton	–	a	key	event	in	the	formation	of	the	IS	
(Mace	et	al.,	2009).	The	binding	of	Talin	to	LFA-1	activates	two	signaling	pathways.	On	the	one	hand	
Talin	and	the	Arp2/3	complex	associate	with	the	protein	vinculin	and	cluster	at	the	intracellular	tail	of	
LFA-1.	 On	 the	 other	 hand	 Talin	 forms	 a	 complex	with	 type	 Iγ	 phosphatidylinositol	 4-phosphate	 5-
kinase	 (PtdIns(4)P	 5-kinase).	 This	 complex	 binds	 to	 LFA-1	 and	 synthesizes	 Phosphatidylinositol-4,5-
bisphosphate	(PtdIns(4,5)P2).	The	increased	concentration	of	PtdIns(4,5)P2	results	in	the	recruitment	
of	Wiskott–Aldrich	Syndrome	protein	(WASp),	which	activates	the	actin	nucleation	activity	of	Arp2/3.	
Both	pathways	together	promote	the	accumulation	and	reorganization	of	 the	actin	cytoskeleton	at	
the	 site	 of	 active	 LFA-1	 (Mace	 et	 al.,	 2009;	 Mace	 et	 al.,	 2010).	 The	 lytic	 granules	 are	 present	
continuously	and	the	activation	of	LFA-1	or	the	pre-activation	with	IL-2	results	in	the	convergence	of	
these	 lytic	granules	at	 the	MTOC	using	 the	motor	protein	dynein	 to	move	along	microtubules.	The	
convergence	 of	 lytic	 granules	 is	 important	 for	 the	 following	 directed	 degranulation	 towards	 the	
target	 cell,	 because	 this	 increases	 the	 killing	 efficiency	 and	 decreases	 bystander	 killing	 (Hsu	 et	 al.,	
2016).	 At	 this	 point,	 IS	 formation	 is	 susceptible	 to	 signals	 from	 inhibitory	 receptors	 that	 can	 stop	
target	 cell	 lysis.	 As	 described	 in	 part	 1.3.3,	 ligation	 of	 inhibitory	 receptors	 activates	 phosphatases	
SHP-1/2	 and	 SHIP-1,	 which	 then	 dephosphorylate	 signaling	 proteins	 important	 for	 activation.	
Important	 inhibitory	 steps	 are	 the	 dephosphorylation	 of	 VAV1	 by	 SHP-1,	 which	 blocks	 actin-
dependent	activation	signals	and	the	phosphorylation	of	CRK.	This	prevents	the	association	of	CRK	in	
activating	 signaling	 complexes	 and	 thereby	 diminishes	 the	 NK	 cell	 activation	 (Peterson	 and	 Long,	
2008;	Stebbins	et	al.,	2003).	
1.4.2 Maintenance	of	the	immunological	synapse	and	killing	of	the	target	cell	
Without	 inhibitory	 signals,	 the	NK	 cell	 initiates	 the	 target	 cell	 lysis.	 To	 this	 end	 the	 cytoskeleton	 is	
rearranged	and	the	content	of	the	 lytic	granules	 is	released	 into	the	 IS,	which	 induces	apoptosis	of	
the	target	cell.	
After	NK	cell	activation,	phosphorylated	signaling	molecules	 like	the	Guanine	exchange	factor	(GEF)	
VAV1	initiate	the	rearrangement	of	the	cytoskeleton.	The	Arp2/3	complex	is	recruited	to	the	IS	and	
polymerizes	 new	 F-actin	 filaments.	 It	 is	 activated	 by	 Wiskott-Aldrich-Syndrom-Protein	 family	
members	WASp	 and	WAVE2.	 The	 expression	 of	 these	 proteins	 can	 be	 enhanced	 by	 pre-activation	
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with	IL-2	(Mace	et	al.,	2010;	Orange	et	al.,	2002;	Orange	et	al.,	2011).	Small	GTPases	downstream	of	
VAV1	like	Rac1	and	Cdc42	as	well	as	other	GEFs	are	 involved	in	this	process	(Billadeau	et	al.,	1998;	
Carlin	et	al.,	2011;	Krzewski	et	al.,	2006).	The	polymerization	of	new	actin	filaments	is	indispensable	
for	the	stability	of	the	NK:Target	cell	contact	(Netter,	2014).	It	is	needed	to	create	a	tight	actin-mesh,	
which	stabilizes	the	IS	and	creates	a	dense	and	sealed	space	between	the	cells.	The	rearrangement	of	
the	cytoskeleton	also	enables	receptors	to	form	microclusters	(Abeyweera	et	al.,	2011;	Treanor	et	al.,	
2006).	Finally	the	presence	of	energy	in	form	of	ATP	is	needed	during	the	whole	time	of	conjugation	
to	maintain	IS	stability	(Netter,	2014).	
The	next	step	in	NK	cell	activation	is	the	opening	of	ion	channels	and	influx	of	calcium.	As	described	
in	chapter	1.3,	ligation	of	activating	NK	cell	receptors	leads	to	the	binding	and	activation	of	adaptor	
proteins	to	their	intracellular	domain.	Important	for	calcium	signaling	is	the	activation	of	PLCγ1.	This	
enzyme	 catalyzes	 the	 hydrolysis	 of	 membrane	 bound	 PtdIns(4,5)P2	 to	 inositol-1,4,5-trisphosphate	
(InsP3)	and	diacylglycerol	(DAG).	Thereupon	InsP3	binds	to	InsP3	calcium	channels	in	the	membrane	of	
the	endoplasmic	reticulum	(ER)	and	initiates	the	release	of	calcium	into	the	cytosol	(Patterson	et	al.,	
2005).	The	specialized	calcium	sensors	stromal	interaction	molecule	1/2	(STIM1/2)	in	the	membrane	
of	 the	ER	 recognize	 the	depletion	of	ER	calcium	stores	and	open	calcium-release-activated	calcium	
(CRAC)	channels	like	ORAI1	in	the	cell	membrane	(Maul-Pavicic	et	al.,	2011;	Shaw	and	Feske,	2012).	
The	 resulting	 influx	 of	 calcium	 activates	 calcium-dependent	 enzymes	 and	 regulatory	 proteins	 like	
calmodulin	 or	 calcineurin,	 which	 both	 stimulate	 the	 exocytosis	 of	 lytic	 granules	 (Figure	 2)	 (Pores-
Fernando	et	 al.,	 2009;	Rochette-Egly	 and	Tovey,	 1984).	Additionally	 calcium	activates	 transcription	
factors	 NFAT,	 CREB	 and	 NFκB	 and	 thereby	 enhances	 the	 expression	 of	 cytotoxic	 proteins	 (Feske,	
2007).		
To	 study	 calcium	 signals,	 cells	 can	 be	 treated	with	 different	 drugs,	which	 can	 initiate	 or	 block	 the	
release	of	calcium	 into	 the	cytosol.	This	 study	 focuses	on	 the	 ionophore	 Ionomycin	and	 the	SERCA	
pump	 inhibitor	 Thapsigargin.	 Ionomycin	 is	 a	 calcium	 salt	 produced	by	 the	bacterium	Streptomyces	
conglobatus.	 It	 forms	 pores	 into	 the	 cell	 membrane	 and	 thereby	 allows	 extracellular	 calcium	 to	
diffuse	 into	 the	 cytosol	 (Liu	 and	 Hermann,	 1978).	 Thapsigargin	 in	 contrast	 is	 an	 inhibitor	 for	 the	
sarco/endoplasmic	reticulum	Ca2+-ATPase.	This	prevents	the	transport	of	calcium	into	the	ER,	which	
also	results	in	an	increase	of	the	cytosolic	calcium	level	(Lytton	et	al.,	1991).	
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Figure	2.	Schematic	illustration	of	calcium	signaling.	Activation	of	NK	cell	receptors	leads	to	the	recruitment	of	the	kinases	
Lck	 and	 Zap70.	 Activation	 of	 adaptor	 protein	 LAT	 initiates	 recruitment	 and	 activation	 of	 SLP76,	 GADS	 and	 ITK,	 which	
phosphorylate	PLCγ.	Activated	PLCγ	catalyzes	the	hydrolysis	of	PtdIns(4,5)P2	to	InsP3	and	DAG.	InsP3	opens	Ca
2+	channels	in	
the	 ER	 membrane	 and	 releases	 calcium	 into	 the	 cytosol.	 Depleted	 calcium	 stores	 are	 recognized	 by	 STIM1/2	 calcium	
sensors,	which	then	open	CRAC	channels.	Extracellular	calcium	diffuses	into	the	cell	and	activates	downstream	signaling	via	
calmodulin	 and	 initiates	 granule	 exocytosis.	 The	 drugs	 Ionomycin	 and	 Thapsigargin	 can	 raise	 cytosolic	 calcium	 levels.	
Ionomycin	 forms	 calcium	 permeable	 pores	 into	 the	 cell	 membrane,	 Thapsigargin	 blocks	 the	 SERCA	 pump	 and	 inhibits	
calcium	transport	into	the	ER.	
Another	 family	 of	 second	messengers	 involved	 in	 NK	 cell	 cytotoxicity	 are	 reactive	 oxygen	 species	
(ROS),	which	include	superoxide	anions	(O2−),	hydrogen	peroxide	(H2O2)	and	hydroxyl	radicals	(OH·).	
They	 are	 produced	 by	 NADPH	 oxidase	 (NOX)	 in	 the	 cell	 membrane	 and	 superoxide	 dismutase	 2	
(SOD2)	 in	 the	 mitochondrial	 membrane	 (Schieber	 and	 Chandel,	 2014).	 Activation	 of	 NK	 cells	 by	
triggering	 of	 activating	 receptors	 leads	 to	 a	 rise	 of	 intracellular	 ROS,	 mainly	 produced	 by	
mitochondrial	 SOD2	enzyme.	 This	 initiates	 downstream	 signaling	 and	 activates	 transcription	 factor	
NFκB	 to	 enhance	 cytotoxicity	 of	 NK	 cells	 against	 target	 cells	 (Valle	 Blazquez	 et	 al.,	 1997).	 NFκB	 is	
known	to	be	sensitive	for	redox	signaling	and	activated	by	a	rise	of	the	ROS	concentration	in	the	cell.	
ROS	increases	the	DNA	binding	and	transactivation	of	NFκB,	which	leads	to	the	expression	of	genes	
involved	 in	 inflammation	 and	 cell	 survival	 (Meyer	 et	 al.,	 1993).	 Additionally,	 protein	 tyrosine	
phosphatases	(PTPs)	like	SHP-2	are	inactivated	by	ROS,	which	decreases	inhibitory	signaling	(Meng	et	
al.,	2002).	The	 impact	of	ROS	on	NK	cell	cytoskeleton	 is	not	 fully	understood.	ROS	was	reported	to	
directly	 regulate	 actin	 dynamics	 in	 activated	 neutrophils	 by	 reduction	 of	 F-actin	 polymerization,	
which	 impaired	 polarization,	 chemotaxis,	 adhesion,	 and	 phagocytosis	 (Sakai	 et	 al.,	 2012).	 On	 the	
other	hand,	treatment	of	cells	with	a	redox	scavenger	also	resulted	in	the	reduction	of	F-actin,	which	
caused	actin	assembly	inhibition	and	reduced	retrograde	actin	flow	(Munnamalai	and	Suter,	2009).	It	
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is	 most	 likely	 that	 the	 concentration	 and	 composition	 of	 ROS	 is	 very	 important	 for	 the	 observed	
effects	on	the	cell.	
The	following	key	aspect	of	NK	cell	cytotoxicity	is	the	reorganization	of	the	microtubule	cytoskeleton,	
the	polarization	of	the	MTOC	and	the	release	of	lytic	granules.	In	cytotoxic	T	cells	MTOC	movement	
and	 polarization	 is	 dependent	 on	 Dynein	 motor	 proteins	 (Yi	 et	 al.,	 2013).	 In	 contrast	 it	 could	 be	
shown	that	MTOC	polarization	in	NK	cells	works	differently	and	seems	to	be	based	on	the	interaction	
of	 motor	 protein	 Kinesin-1	 with	 the	 Arl8b	 ATPase.	 Additionally,	 together	 with	 the	 small	 GTPase	
Rab27a,	Kinesin-1	and	Arl8b	are	most	likely	responsible	for	the	movement	of	lytic	granules	from	the	
MTOC	to	the	membrane	at	the	IS	(Tuli	et	al.,	2013).	Moreover	the	Golgi	apparatus	is	polarized	to	the	
IS	most	 likely	 for	 rapid	 secretion	of	 lytic	 granules	 towards	 the	 IS	 (Kupfer	et	al.,	 1983).	 To	maintain	
calcium	and	redox	signals	and	probably	to	supply	ATP,	mitochondria	are	also	polarized	towards	the	IS	
after	 triggering	of	activating	receptors	 (Abarca-Rojano	et	al.,	2009).	After	polarization	of	 the	MTOC	
the	associated	lytic	granules	are	secreted	by	moving	from	the	MTOC	through	the	actin	mesh	at	the	IS	
and	attaching	to	the	cell	membrane.	The	movement	through	the	actin	network	is	dependent	on	the	
actin	 motor	 protein	 myosin	 IIA,	 which	 navigates	 the	 lytic	 granules	 through	 hypodense	 areas	
(Andzelm	et	al.,	2007;	Rak	et	al.,	2011).	The	small	GTPase	Rab27a	and	the	adaptor	protein	Munc13-4	
are	recruited	to	the	lytic	granules	directly	after	activation	of	the	NK	cell	(Wood	et	al.,	2009).	Rab27a	
is	 important	 for	 vesicle	 trafficking	 and	Munc13-4	 was	 shown	 to	 regulate	 membrane	 docking	 and	
fusion	 of	 lytic	 granules	with	 the	 cell	membrane	 (Menager	 et	 al.,	 2007;	 Stinchcombe	 et	 al.,	 2001).	
Other	proteins	involved	in	the	docking	of	lytic	granules	with	the	cell	membrane	are	SNARE	proteins	
like	VAMPs	and	syntaxin-11	(Krzewski	and	Coligan,	2012).		
The	fusion	of	lytic	granules	with	the	cell	membrane	finally	leads	to	the	secretion	of	cytotoxic	proteins	
into	 the	 IS	 and	 towards	 the	 target	 cell.	 The	main	 proteins	 involved	 in	NK	 cell-mediated	 killing	 are	
perforin	and	Granzymes	and	both	are	found	in	NK	cells	as	well	as	CTLs	(Dennert	and	Podack,	1983;	
Masson	 et	 al.,	 1986;	 Podack	 and	 Dennert,	 1983).	 The	 70	 kDa	 protein	 perforin	 consists	 of	 several	
domains	 including	a	 targeting	domain	 for	sublocalization	 into	 the	 lytic	granules	and	the	N-terminal	
MACPF	domain,	which	is	important	for	its	integration	into	the	target	cell	membrane	(Brennan	et	al.,	
2011;	Rochel	and	Cowan,	1996).	Additionally,	the	C-terminal	C2	domain	can	bind	to	membranes	in	a	
calcium	dependent	manner	(Voskoboinik	et	al.,	2005).	The	mechanism	how	perforin	works	in	NK	cells	
is	 not	 completely	 investigated.	 However,	 the	 big	 similarities	 between	 perforin	 and	 the	 bacterial	
cholesterol-dependent	 cytolysins	 (CDCs)	 suggest	 an	 identical	 process.	 CDCs	also	have	 a	membrane	
binding	and	a	membrane	attack	MACPF	domain.	They	 form	a	pre-pore,	 composed	of	multiple	CDC	
proteins,	which	binds	to	the	target	membrane.	The	transmembrane	β-hairpins	TMH1	and	TMH2	of	
the	MACPF	 domain	 from	 each	 protein	 insert	 into	 the	 target	 membrane	 and	 form	 a	 mature	 pore	
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(Voskoboinik	et	al.,	2015).	New	data	from	microscopy	experiments	confirm	that	perforin	works	in	a	
comparable	 way	 as	 CDCs	 (Leung	 et	 al.,	 2017).	 To	 prevent	 perforin	 from	 damaging	 the	 NK	 cell	
membrane	it	 is	only	active	at	pH	7	and	high	concentrations	of	calcium.	The	acidic	conditions	 inside	
the	lytic	granules	affect	its	conformational	state	and	thus	prevent	perforin	from	harming	membranes	
before	it	is	released	(Praper	et	al.,	2010).	After	degranulation	perforin	becomes	active	inside	the	IS.	
The	lysosomal	protein	CD107a	protects	the	NK	cell	surface	inside	the	IS	against	the	insertion	of	active	
perforin.	The	negatively	charged	residues	of	CD107a	probably	obstruct	 the	also	negatively	charged	
C2	domain	of	perforin	to	bind	to	the	NK	cell	membrane	(Cohnen	et	al.,	2013).	 It	 is	not	conclusively	
clarified	 how	 perforin	 enables	 the	Granzymes	 to	 enter	 the	 target	 cell,	 but	 combination	 of	 both	 is	
necessary	to	efficiently	induce	apoptosis.	Granzymes	most	likely	attach	to	the	target	cell	membrane.	
It	is	controversial	whether	Granzymes	enter	through	perforin	pores	in	the	plasma	membrane	or	if	the	
pores	 induce	 repair	 processes	 that	 then	 lead	 to	 the	 internalization	 of	 membrane	 together	 with	
Granzymes	 (Keefe	 et	 al.,	 2005;	 Metkar	 et	 al.,	 2002).	 Inside	 the	 cell,	 perforin	 would	 mediate	 the	
release	of	Granzymes	 from	the	endosome	 into	 the	cytosol,	where	 it	 induces	apoptosis	by	cleavage	
and	activation	of	caspases.		
Granzymes	 are	 a	 family	 of	 serine	 proteases	 that	 consists	 of	 the	 Granzymes	 A,	 B,	 H,	 M	 and	 K.	
Granzyme	B	is	the	family	member	that	has	been	studied	in	most	detail	and	possesses	the	strongest	
cytotoxic	activity.	It	can	cleave	and	activate	or	inactivate	many	different	substrates	in	the	target	cell.	
It	has	been	proposed	that	over	three	hundred	proteins	could	be	affected	by	Granzyme	B	(Rousalova	
and	 Krepela,	 2010).	 Granzyme	 B	 can	 directly	 cleave	 procaspase-3	 and	 procaspase-7	 and	 probably	
other	procaspases,	which	initiates	apoptosis	by	the	activation	of	the	caspase	cascade	(Darmon	et	al.,	
1995;	Gu	et	al.,	1996).	Additionally,	Granzyme	B	can	cleave	the	pro-apoptotic	Bcl-2	 family	member	
BH3	 interacting-domain	 death	 agonist	 (BID)	 (Waterhouse	 et	 al.,	 2005).	 BID	 starts	 the	
permeabilization	 of	 the	mitochondrial	membrane	 causing	 the	 release	 of	 cytochrome	 C,	which	 can	
activate	 different	 caspases	 and	 thereby	 induces	 apoptosis.	 The	 Serpin	 Proteinase	 Inhibitor	 9	
(SerpinB9)	 inhibits	 Granzyme	 B	 by	 binding	 to	 its	 catalytic	 region	 and	 prevents	 the	 cleavage	 of	 its	
substrate	(Bird	et	al.,	1998).	SerpinB9	can	be	overexpressed	in	different	types	of	tumors	like	lung	or	
prostate	cancer,	probably	to	prevent	NK/CTL-mediated	killing	(Ray	et	al.,	2012;	Soriano	et	al.,	2012).	
The	 activation	 of	 caspases	 leads	 to	 induction	 of	 apoptosis	 in	 the	 target	 cell,	 which	 has	 a	 large	
influence	on	 the	cell	morphology.	The	process	of	programmed	cell	death	 involves	shrinkage	of	 the	
cell	 and	 pyknosis	 (Kerr	 et	 al.,	 1972).	 Proteases	 cleave	 and	 degrade	 actin	 filaments	 and	 thereby	
destroy	 the	 intracellular	 stability	 (Mashima	et	al.,	 1997).	Additionally,	 caspases	 target	a	number	of	
cell	 adhesion	 and	 cytoskeletal	 proteins.	 Activated	 caspase-3	 and	 -7	 are	 known	 to	 cleave	 focal	
adhesion	kinase	(FAK)	by	this	means	disrupting	the	formation	of	focal	adhesion	complexes	(Wen	et	
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al.,	1997).	E-	and	P-cadherins	are	degraded	by	activated	caspases	and	VE-cadherin	is	probably	shed	
by	metalloproteinases	(Herren	et	al.,	1998;	Schmeiser	and	Grand,	1999).	These	effects	decrease	the	
cell-cell	and	cell-matrix	adhesion	of	apoptotic	cells.	
Another	 hallmark	 of	 apoptosis	 is	 membrane	 blebbing,	 which	 results	 in	 the	 release	 of	 apoptotic	
bodies.	 This	 heterogeneous	 group	 of	 50-4000	 nm	 big	 vesicles	 contains	 genetic	 material	 and	
organelles	(Akers	et	al.,	2013).	Apoptotic	bodies	are	recognized	and	engulfed	by	different	cells	of	the	
immune	system.	Especially	macrophages	and	dendritic	cells	detect	these	vesicles	by	“eat	me”	signals	
on	their	surface	and	eliminate	them	by	endocytosis	(Depraetere,	2000;	Erdosova	et	al.,	2002;	Kranich	
et	 al.,	 2008).	Nevertheless,	 apoptotic	 bodies	 can	 influence	 the	 activation	of	 other	 immune	 cells	 as	
well.	 The	 uptake	 of	 apoptotic	 bodies	 can	 suppress	 CTLs	 by	 the	 presentation	 of	membrane-bound	
immune	regulatory	TGF-ß1	on	the	vesicle	surface	(Xie	et	al.,	2009).	
1.4.3 Detachment	of	the	NK	cell	and	serial	killing	
Once	the	target	cell	has	been	killed,	 the	NK	cell	 terminates	 the	contact	and	detaches.	This	process	
seems	to	be	regulated,	as	NK	cells	clearly	detach	faster	if	the	target	cell	has	been	killed	successfully	
(Netter,	 2014;	 Vanherberghen	 et	 al.,	 2013).	 The	 process	 of	 NK	 cell	 detachment	 is	 not	 completely	
investigated.	At	the	beginning	of	the	IS	termination	the	NK	cell	is	in	a	state	of	relative	inactivity	(Mace	
et	al.,	2014).	Decreasing	the	activation	status	is	mainly	a	result	of	activator	down-regulation	(Claus	et	
al.,	2016b;	Roda-Navarro	and	Reyburn,	2009;	Sandusky	et	al.,	2006).	It	has	also	been	discussed,	if	the	
collapse	 of	 target	 cell	membrane	 integrity	 prevents	 the	 ongoing	 adhesion	 of	 the	 NK	 cell	 at	 a	 late	
point	of	apoptosis.	Patients	with	familial	hemophagocytic	lymphohistiocytosis	2	(FHL-2)	lack	perforin	
in	NK	cells	and	CTLs.	This	 reduces	 their	ability	 to	kill	 target	 cells	enormously	and	 leads	 to	a	 clearly	
decelerated	 detachment	 and	 a	 massive	 secretion	 of	 pro-inflammatory	 cytokines	 (Jenkins	 et	 al.,	
2015).		
It	 has	been	known	 for	 a	 long	 time	 that	 an	 important	effector	 function	of	 cytotoxic	 lymphocytes	 is	
serial	killing.	After	they	successfully	killed	a	target,	NK	cells	and	CTLs	can	kill	additional	cells	one	by	
one	and	thereby	effectively	reduce	the	number	of	diseased	cells	(Ullberg	and	Jondal,	1981;	Zagury,	
1975).	Most	studies	dealing	with	serial	killing	use	microscopic	approaches	to	track	single	NK	cells	and	
analyze	 their	 killing	 capability	 (Bhat	 and	Watzl,	 2007;	 Choi	 and	Mitchison,	 2013;	 Rothstein	 et	 al.,	
1978;	Vanherberghen	et	al.,	2016).	Using	this	technique	it	could	be	revealed	that	not	all	NK	cells	are	
serial	 killers.	 Many	 NK	 cells	 successfully	 form	 a	 conjugate	 with	 target	 cells	 but	 fail	 to	 induce	
apoptosis.	Other	NK	cells	kill	one	to	14	target	cells	in	a	row.	Some	end	up	exhausted,	not	able	to	kill	
another	target	and	few	NK	cells	are	active	over	the	whole	examination	time	(Bhat	and	Watzl,	2007;	
Choi	and	Mitchison,	2013;	Vanherberghen	et	al.,	2013).	To	prevent	exhaustion	NK	cells	are	able	 to	
recycle	lytic	granules	and	effector	proteins	and	synthesize	effector	molecules	de	novo	(Li	et	al.,	2011;	
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Liu	et	al.,	2011;	Liu	et	al.,	2005).	NK	cells	lacking	the	ability	to	efficiently	recycle	lytic	granules,	have	a	
reduced	ability	to	 lyse	multiple	targets	 (Capuano	et	al.,	2012).	Noticeably	the	time	period	between	
the	individual	killing	events	differs.	NK	cells	that	kill	multiple	targets	need	more	time	for	the	first	than	
for	 the	 following	 kills.	 It	 has	 been	 proposed	 that	 NK	 cells	 can	 keep	 activating	 stimuli	 from	 earlier	
targets	and	thereby	overcome	partial	inhibition	by	the	new	one.	This	kinetic	priming	accelerates	the	
killing	of	neighboring	diseased	cells	(Choi	and	Mitchison,	2013).		
Immunotherapy	 describes	 the	 use	 of	 autologous	 or	 allogeneic	 immune	 cells,	 stimulated	 with	
cytokines	 or	 by	 therapeutic	 antibodies	 and	 has	 become	 a	 serious	 alternative	 to	 conventional	
therapies	 against	 cancer	 or	 virus	 infections.	 Some	 of	 these	 interventions	 have	 influence	 on	 serial	
killing:	The	use	of	therapeutic	antibodies	against	B	lymphoblastoid	cells	can	increase	serial	killing	by	
NK	cells	(Bhat	and	Watzl,	2007).	Additionally,	NK	cells	can	be	genetically	modified	to	express	chimeric	
antigen	receptor	(CAR)–constructs.	The	transfection	of	NK	cells	with	a	ErbB2/HER2-specific	CAR	was	
shown	 to	 increase	 serial	 killing	 and	 decrease	 the	 tumor	 burden	 (Schonfeld	 et	 al.,	 2015).	
Understanding	 the	 regulation	 of	 NK	 cell	 detachment	 as	 a	 key	 factor	 for	 serial	 killing	 and	 NK	 cell	
effector	functions	could	help	to	increase	the	efficiency	of	NK	cell	immunotherapies.	
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2 Aim	of	the	thesis	
Serial	killing	is	a	key	feature	of	NK	cell	effector	functions	and	facilitates	the	elimination	of	successive	
target	 cells	 by	 one	 single	 effector	 cell.	 The	 aim	 of	 the	 thesis	 was	 the	 investigation	 of	 NK	 cell	
detachment	as	a	key	factor	for	serial	killing.		
It	is	known	how	cytokine	stimulation	and	ligation	of	individual	receptors	can	induce	activation	in	NK	
cells.	 Using	 a	 flow	 cytometry	 based	 approach	 to	 measure	 the	 decay	 of	 NK:target	 cell	 contacts,	 I	
wanted	 to	 link	 the	 dynamics	 of	 detachment	 directly	 to	 the	 type	 of	 NK	 cell	 activation.	 Ongoing	
signaling	by	activating	receptors	is	important	for	the	maintenance	of	the	IS.	I	analyzed	the	impact	of	
calcium	 and	 redox	 signaling	 on	NK	 cell	 effector	 functions	 by	 treatment	with	 interfering	 drugs	 and	
using	 a	 modified	 detachment	 assay	 I	 aimed	 to	 determine	 the	 calcium	 levels	 in	 NK	 cells	 during	
conjugation	with	a	susceptible	target	cell.	The	recogniton	of	target	cell	death	appears	to	be	the	main	
initiator	 of	 NK	 cell	 detachment	 and	 therefore	 I	 investigated	 how	 NK	 cells	 detect	 apoptotic	 target	
cells.	Finally	I	compared	the	protein	composition	of	the	target	cell	membrane	prior	to	and	after	NK	
cell-induced	apoptosis	to	detect	alterations	which	could	initiate	the	detachment.	
By	 investigation	of	 the	NK	cell	detachment	 the	aim	of	 this	 thesis	was	 to	gain	better	understanding	
how	the	termination	of	the	NK	cell	IS	is	regulated	and	how	NK	cells	successfully	recognize	the	target	
cell	death	as	early	as	possible.		
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3 Material	and	Methods	
3.1 Materials	
3.1.1 	 Primary	monoclonal	Antibodies	
Name	(Clone)	 Conjugate	 Source	
CD3	(HIT3a)	 PE	 BioLegend,	San	Diego,	California,	US	
CD56	(NCAM16.2)	 BV421	 BioLegend,	San	Diego,	California,	US	
Serpinb9	(7D8)	 /	 Abcam,	Cambridge,	UK	
CD107a	(H4A3)	 FITC,	APC	 BioLegend,	San	Diego,	California,	US	
CD48	(BJ40)	 PE	 BioLegend,	San	Diego,	California,	US	
ULBP1	(170818)	
/	 R&D	 Systems,	 McKinley,	 Minneapolis,	
USA	
ULBP2	(165903)	
/	 R&D	 Systems,	 McKinley,	 Minneapolis,	
USA	
B7H6	(875001)	
PE	 R&D	 Systems,	 McKinley,	 Minneapolis,	
USA	
NTB-A	(NT-7)	 PE	 BioLegend,	San	Diego,	California,	US	
perforin	(dG9)	 FITC	 BioLegend,	San	Diego,	California,	US	
CD15	(MEM-158)	 PE	 Immunotools,	Friesoythe,	Germany	
CD54	(H458)	 PE	 BD,	Franklin	Lakes,	New	Jersey,	USA	
CD58	(MEM-63)	 /	 Immunotools,	Friesoythe,	Germany	
CD59	(MEM-43)	 /	 Immunotools,	Friesoythe,	Germany	
CD102	(CBR-IC2/2)	 PE	 BioLegend,	San	Diego,	California,	US	
CD62-E	(hCD62E)	 /	 Immunotools,	Friesoythe,	Germany	
Nectin-1	 R1.302	 BioLegend,	San	Diego,	California,	US	
MICA	(159227)	
/	 R&D	 Systems,	 McKinley,	 Minneapolis,	
USA	
MICB	(236511)	
/	 R&D	 Systems,	 McKinley,	 Minneapolis,	
USA	
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3.1.2 Secondary	Antibodies	(Polyclonal)	
Name	(Clone)	 Conjugate	 Source	
Goat-anti	Mouse	IgG	
Cy3	 Jackson	ImmunoResearch,	West	Grove,	
Pennsylvania,	USA	
Goat-anti	Human	IgG	
PE	 Jackson	ImmunoResearch,	West	Grove,	
Pennsylvania,	USA	
	
	
3.1.3 IgG	Control	antibodies	
Name	(Clone)	 Conjugate	 Source	
IgG1	(MOPC21)	 PE	 BioLegend,	San	Diego,	California,	USA	
IgG1	(MOPC21)	 FITC	 BioLegend,	San	Diego,	California,	USA	
IgG1	(MOPC21)	 APC	 BioLegend,	San	Diego,	California,	USA	
	
3.1.4 Buffers	and	Media	
4	%	Paraformaldehyde	(PFA)	 PBS	
	 4	%	Paraformaldehyde	(PFA)	 	
	
FACS	Buffer	 PBS	
	 2	%	FCS	
	
LC-AA	Buffer	 PBS	
	 0.5	%	BSA	
	
CTL	Medium	 IMDM	
	 10	%	FCS	
	 1	%	Penicillin-Streptomycin	(10,000	U/mL)	(P/S)	
	
Ba/F3	Medium	 RPMI	1640	
	 10	%	FCS	
	 1	%	P/S	
	 50	µM	2-Mercaptoethanol	
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HEK293T/HeLa	Medium	 DMEM	
	 10	%	FCS	
	 1	%	P/S	
	
Calcium	washing	buffer	 IMDM	without	phenol	red	
	 2.5	mM	Probenecid	solution	(fresh,	in	NaOH)	
	 5	mM	HCl	
	 10%	FCS	
	 1%	P/S	
	
Calcium	assay	buffer	 IMDM	without	phenol	red	
	 2.5	mM	Probenecid	solution	
	 5	mM	HCl	
	 10	mM	Hepes	
	 2%	FCS	
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3.1.5 Cells	
	 Composition	of	Media	see	3.1.3	
Name	 Transfected	with	 Origin	 Medium	
Primary	NK	cells	 untransfected	 Whole	Blood	from	
healthy	humans	
CTL	or	vericyte	
HEK293T	 untransfected	 Human	embryonic	
kidney	
DMEM	
Phoenix	Ampho	 Constructs	for	
amphotrophic	virus	
gag-pol	&	envelope	
protein		
Human	embryonic	
kidney	
DMEM	
Ba/F3	 GFP	 Mouse	pro	B-Cells	 RPMI	
Ba/F3	 NTB-A	 Mouse	pro	B-Cells	 RPMI	
Ba/F3	 B7H6	 Mouse	pro	B-Cells	 RPMI	
Ba/F3	 ULBP2	 Mouse	pro	B-Cells	 RPMI	
Ba/F3	 CD48	 Mouse	pro	B-Cells	 RPMI	
K562	 untransfected	 CML	 CTL	
K562	 CD107a	 CML	 CTL	
K562	 SerpinB9	 CML	 CTL	
K562	 CD107a-SerpinB9	 CML	 CTL	
K562	 mbIL15-41BBL	 CML	 CTL	
One	Shot®	
TOP10	
Chemically	
Competent	E.	
coli	
Unknown	 E.coli	 LB	
	
3.1.6 	 Inhibitors	
Brefeldin	A	 Sigma-Aldrich,	St.	Louis,	Missouri,	USA	
Thapsigargin	 Abcam,	Cambridge,	UK	
Concanamycin	A	 Sigma-Aldrich,	St.	Louis,	Missouri,	USA	
Ionomycin		 Merck	Millipore,	Billerica,	Massachusetts,	USA	
N-Acetylcysteine	 Sigma-Aldrich,	St.	Louis,	Missouri,	USA	
3.1.7 	 Kits	
Dynabeads	untouched	human	NK	Kit	 Invitrogen/LifeTechnologies,	Darmstadt,	Germany	
ELISA	IFN-γ	 BioLegend,	San	Diego,	California,	USA	
ELISA	TNFα	 BioLegend,	San	Diego,	California,	USA	
Hi	Speed	Plasmid	Kit	 Qiagen,	Venlo,	Netherlands	
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3.1.8 	 Reagents	
PBS	 Thermo	Fisher	Scientific,	Rockford,	IL,	USA	
F(ab)2-Fragment		 Jackson	ImmunoResearch,	West	Grove,	
Pennsylvania,	USA	
Lipofectamine	2000	 Thermo	Fisher	Scientific,	Rockford,	IL,	USA	
Penicillin-Streptomycin	 Thermo	Fisher	Scientific,	Rockford,	IL,	USA	
Fetal	calf	serum		 Thermo	Fisher	Scientific,	Rockford,	IL,	USA	
Puromycin	 Calbiochem/Merck	Millipore,	Billerica,	MA,	USA	
G418	/	Geneticin?	 Thermo	Fisher	Scientific,	Rockford,	IL,	USA	
Dimethyl	sulfoxide	(DMSO)	 Avantor	(J.T.Baker),	Center	Valley,	PA,	USA	
Lymphocyte	Separation	Medium	(LSM)	 PAN	Biotech,	Aidenbach,	Germany	
IL-2	 NIH	Cytokine	Repository,	Frederick	MD,	USA	
IL-21	 Miltenyi	Biotech,	Bergisch	Gladbach,	Germany	
IL-15	 Pan-Biotech,	Aidenbach,	Germany	
Paraformaldehyde	(PFA)	 Sigma-Aldrich,	St.	Louis,	Missouri,	USA	
Polybrene	 Sigma-Aldrich,	St.	Louis,	Missouri,	USA	
BD	FACS	Permeabilizing	Solution	2	 BD,	Franklin	Lakes,	New	Jersey,	USA	
Cell	tracker	orange	 Thermo	Fisher	Scientific,	Rockford,	IL,	US	
Cell	tracker	violet	 Thermo	Fisher	Scientific,	Rockford,	IL,	US	
CFSE	 Thermo	Fisher	Scientific,	Rockford,	IL,	US	
ICAM-1-Fc	 R&D	Systems,	McKinley,	Minneapolis,	USA	
MgCl2	 AppliChem,	Darmstadt,	Germany	
EGTA	 Sigma-Aldrich,	St.	Louis,	Missouri,	USA	
Fluo-8	 Thermo	Fisher	Scientific,	Rockford,	IL,	US	
Probenecid	 Sigma-Aldrich,	St.	Louis,	Missouri,	USA	
IMDM	 Thermo	Fisher	Scientific,	Rockford,	IL,	US	
RPMI1640	 Thermo	Fisher	Scientific,	Rockford,	IL,	US	
IMDM	without	phenol	red	 Thermo	Fisher	Scientific,	Rockford,	IL,	US	
Hepes	 Thermo	Fisher	Scientific,	Rockford,	IL,	US	
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Chromium-51	 Hartmann	Analytic,	Braunschweig,	Germany	
Triton-X-100	 Carl	Roth,	Karlsruhe,	Germany	
Hydrogen	Peroxide	(H2O2)	 AppliChem,	Darmstadt,	Germany	
MFG-E8	 R&D	Systems,	McKinley,	Minneapolis,	USA	
Zombie-aqua	 BioLegend,	San	Diego,	California,	USA	
Vericyte	medium	 Medicyte,	Heidelberg,	Germany	
3.1.9 	 Software	
FlowJo	v.8.8.7		 FlowJo,	LLC,	Ashland	,USA	
GraphPad	PRISM	v.	5.0f	 GraphPad,	La	Jolla	,USA	
BD	FACSDiva	 BD,	Franklin	Lakes,	New	Jersey,	USA	
BD	CellQuest	 BD,	Franklin	Lakes,	New	Jersey,	USA	
3.1.10 	 Plasmids	
SerpinB9-pIRES-puro		 (Liesche,	2014)	
pBABE-SerpinB9	
pBABE-CD107a	
3.1.11 Equipment	
BD	FACSCalibur	 BD,	Franklin	Lakes,	New	Jersey,	USA	
BD	LSRFortessa	 BD,	Franklin	Lakes,	New	Jersey,	USA	
Tecan	M200	pro	 Tecan,	Männedorf,	Switzerland	
BD	FACSJazz	 BD,	Franklin	Lakes,	New	Jersey,	USA	 	
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3.2 Methods	
3.2.1 Cell	biology		
3.2.1.1 Cell	culture	
Cell	 lines	and	primary	NK	cells	were	incubated	in	a	humidified	incubator	at	37°C	and	5	%	CO2.	Cells	
were	maintained	 in	 appropriate	medium	 (see	 cell	 lines)	 and	 stably	 transfected	 cells	were	 selected	
with	puromycin	(0.5-1	µg/ml).	Cell	lines	were	split	all	2-3	days	and	grown	in	cell	culture	flasks,	which	
were	 exchanged	 every	 2-3	weeks.	 Cells	were	 slowly	 frozen	 in	 freeze-medium	 (FCS	 +	 10	%	DMSO)	
at	 -80°C	 and	 long-term	 stored	 at	 -170°C	 in	 liquid	 nitrogen.	 FCS	 and	 human	 serum	 were	 heat	
inactivated	(56°C,	30	minutes)	before	use.		
3.2.1.2 Isolation	of	primary	NK	cells	
Blood	 was	 received	 from	 healthy	 donors	 and	 peripheral	 blood	 mononuclear	 cells	 (PBMCs)	 were	
obtained	via	density	centrifugation	over	Lymphocyte	Separation	Medium	(LSM).	LSM	was	overlayed	
with	 blood	 and	 centrifuged	 at	 1025xg	 for	 25	 minutes.	 NK	 cells	 were	 isolated	 from	 PBMCs	 with	
Dynabeads®	Untouched™	Human	NK	Cells	Kit	(Thermo	Fischer)	via	negative	isolation	according	to	the	
manufacturer’s	instructions.	NK	cells	were	defined	as	CD3-CD56+	lymphocytes	and	had	a	purity	of	90-
99%.	 Purified	 NK	 cells	 were	 either	 used	 fresh	 or	 pre-activated.	 For	 pre-activation,	 NK	 cells	 were	
treated	over	night	with	200	IU/mL	recombinant	human	IL-2	or	cultivated	for	2-3	weeks	with	feeder	
cells	(see	3.2.1.3)	or	in	vericyte	NK	Cell	Growth	Medium	from	Medicyte	GmbH	(see	3.2.1.4).		
3.2.1.3 Expansion	of	NK	cells	with	feeder	cells	
After	isolation	purified	NK	cells	were	maintained	in	CTL	medium	(IMDM	+	10	%	FCS	+	1	%	P/S	see	0)	
supplemented	with	 200	 IU/mL	 recombinant	 human	 IL-2	 and	 100	ng/ml	 recombinant	 human	 IL-21.	
The	 cells	 were	 then	mixed	with	 30	 Gy	 irradiated	 K562mbIL15-41BBL	 feeder	 cells	 at	 a	 ratio	 of	 2:1	
(NK:K562mb15)	 and	 plated	 in	 96-U	 wells	 at	 a	 density	 of	 1x106	 -	 2x106	 cells/ml.	 NK	 cells	 were	
restimulated	after	7	days	with	the	same	amount	of	IL-2	and	feeder	cells	and	incubated	for	additional	
7	 days	 prior	 to	 first	 use.	 The	medium	was	 exchanged	 all	 3	 –	 4	 days	 and	 cells	 were	 splitted	 after	
reaching	a	density	of	3x106	cells	/	ml.		
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3.2.1.4 Cultivation	of	NK	cells	in	vericyte	medium		
As	an	alternative	to	feeder	cells,	NK	cells	were	maintained	in	vericyte	NK	Cell	Growth	Medium	from	
Medicyte	 GmbH	 (see	 2.1.4)	 containing	 10	 %	 FCS,	 1000	 IU/ml	 recombinant	 human	 IL-2,	 10	 ng/ml	
recombinant	human	IL-15	and	a	so	called	vericyte	factor	115.	After	isolation	NK	cells	were	cultured	in	
vericyte	medium	at	a	density	of	1x106	and	 split	1:2	 if	 they	 reached	2x106	 cells/ml.	Cells	were	used	
after	a	minimum	of	two	weeks.	
3.2.1.5 Retroviral	transfection	of	K562	cells	
K562	cells	were	stably	transfected	using	retroviruses	produced	by	Phoenix-AMPHO	cells.	The	genes	
of	 interest	were	subcloned	 in	pBABE	vector	and	purified	using	Hi	speed	Plasmid	Maxi	Kit	 (Qiagen).	
1x106	 Phoenix-AMPHO	 cells	were	 plated	 in	 a	 small	 tissue	 culture	 flask	 (T25)	 and	 transfected	with	
Lipofectamine	2000	according	to	the	manufacturer’s	instructions.	After	24	h	medium	was	exchanged	
with	 CTL	 medium	 and	 after	 an	 additional	 day,	 retrovirus-containing	 supernatant	 was	 harvested.	
0.5x106	K562	were	resuspended	in	the	virus	supernatant	and	5	µg/ml	Polybrene	was	added	prior	to	
centrifugation	(1.5	h	at	1350	g,	37	°C).	After	24	h	incubation,	medium	was	exchanged	with	fresh	CTL	
medium	and	0.5	µg/ml	Puromycin	was	added	for	selection.	
3.2.1.6 Fluorescence	activated	cell	sorting	
After	transfection	with	two	different	plasmids	containing	the	same	resistance,	K562	were	sorted	to	
enrich	 double	 positive	 cells.	 Cells	 were	 stained	 with	 Alexa	 Fluor	 488-labeled	 mAb	 against	 the	
transfected	 protein,	 which	 was	 expressed	 by	 fewer	 cells	 (see	 3.2.2.1)	 and	 sorted	 with	 a	 BD	
FACSJazz™.	 To	 obtain	 highly	 purified	 double	 positive	 cells	 FACS	 was	 adjusted	 to	 Sort	 objective	
“Purify”	and	Sort	mode	“2.0	Drops	Pure”.	After	sorting,	cells	were	~	97%	positive	for	both	proteins.	
3.2.2 Flow	cytometry	staining	and	functional	assays	
3.2.2.1 Cell	staining	for	flow	cytometry		
For	flow	cytometry	analysis,	cells	were	stained	in	96-V	plates	or	microtubes.	For	intracellular	staining	
cells	were	 fixed	with	2	%	PFA,	permeabilized	with	BD	FACS	Permeabilizing	Solution	2	buffer	 for	10	
minutes	at	RT	prior	staining.	A	minimum	of	0.2x106	cells	was	resuspended	in	50	µl	cold	FACS	buffer	
(PBS	+	2%	FCS)	containing	a	respective	amount	of	antibody.	The	antibody	was	either	unconjugated	or	
directly	conjugated	with	a	fluorophore.	After	20	minutes	incubation	on	ice,	cells	were	washed	and	if	
necessary	 stained	 with	 a	 secondary	 antibody.	 After	 staining	 the	 cells	 were	 resuspended	 in	 FACS	
buffer	and	analyzed	on	a	BD	LSR	FortessaTM.		
3.2.2.2 Cell	labeling	for	conjugate	and	detachment	assay	
Staining	NK	cells	and	target	cells	with	different	fluorescent	cell	dyes	permits	distinction	of	free	cells	
and	 conjugates.	 Cells	 were	 stained	 with	 Cell	 tracker	 orange	 or	 violet	 or	 with	 Carboxyfluorescein	
	 	 	 27	
succinimidyl	ester	(CFSE)	(all	from	Thermo	Fisher).	1x106	NK	cells	were	stained	with	10	µM	cell	tracker	
orange,	1x106	K562,	HeLa-CD48	or	Ba/F3	cells	were	stained	with	25	µM	cell	tracker	violet,	10	µM	cell	
tracker	 orange	 or	 5	 µM	 CFSE	 in	 PBS	 (depending	 on	 the	 experiment)	 for	 30	 minutes	 at	 37°C.	
Afterwards	 1	ml	 heat	 inactivated	 FCS	was	 added	 for	 10	minutes	 at	 room	 temperature	 to	 stop	 the	
reaction	by	binding	of	free	dye.	The	cells	were	washed	with	CTL	medium	and	incubated	for	at	least	
30	minutes	to	allow	unbound	dye	to	leak	out.	After	a	last	washing	step,	cells	were	resuspended	in	a	
concentration	 of	 1x106	 NK	 cells	 or	 2x106	 target	 cells	 per	 mL	 and	 used	 for	 functional	 assays	 (see	
below).	
3.2.2.3 Degranulation	assay	
NK	cells	and	target	cells	(K562	or	Ba/F3)	were	stained	with	cell	dyes	in	different	colors	(see	3.2.2.2).	
Cells	were	coincubated	at	a	ratio	of	1:2	(NK:Target	cell)	for	2	h	in	the	presence	of	α-CD107a	antibody.	
If	mentioned,	 inhibitor	was	added	directly	before	coincubation.	 In	the	end	cells	were	fixed	with	2%	
paraformaldehyde	 for	 10	minutes	 at	 room	 temperature,	washed	 and	 resuspended	 in	 FACS-buffer.	
Cells	were	directly	analyzed	in	a	flow	cytometer	and	the	amount	of	CD107a+	cells	in	all	NK	cells	was	
evaluated	using	FlowJo	software.		
3.2.2.4 Plate	bound	detachment	LC-AA	Assay	
To	 compare	 the	 LFA-1	 activation	 from	 untouched	 and	 freshly	 detached	 NK	 cells	 with	 NK	 cells	 in	
conjugates,	a	modified	Ligand-complex-based	adhesion	assay	(LC-AA)	was	performed.	0.8x105	HeLa-
CD48	 were	 plated	 in	 48-well	 plates	 one	 day	 before	 the	 experiment	 and	 stained	 with	 CFSE	 (see	
3.2.2.2).	 ICAM-1-Fc	chimera	 (50µg/ml)	and	PE-labeled	goat	anti-human	F(ab)2	 fragments	 (40µg/ml)	
were	mixed	in	LC-AA	buffer	(PBS	+	0.5%	BSA)	for	30	minutes	at	room	temperature	to	prepare	ICAM-
1-Fc	 complexes.	 0.7x106	 fresh,	 unstimulated	 NK	 cells	 were	 resuspended	 in	 ICAM-1-Fc	 complexes	
containing	 buffer	 and	 added	 to	 the	 HeLa-CD48.	 After	 30	 minutes	 the	 unbound	 NK	 cells	 were	
removed	 and	 the	 plate	 was	 washed	 two	 times	 with	 PBS.	 100	 µl	 new	 ICAM-1-Fc	 complexes	 were	
added	to	the	remaining	cells	and	incubated	for	additionally	30	minutes.	The	freshly	detached	NK	cells	
were	 removed	and	 the	 remaining	NK:HeLa-conjugates	were	detached	using	a	 cell	 scraper.	All	 cells	
were	 fixed	with	2%	PFA	after	 removal	and	directly	analyzed	with	a	BD	LSRFortessa.	The	binding	of	
ICAM-1-Fc	to	the	NK	cells	was	defined	as	positive	for	active	LFA-1,	quantified	using	FlowJo	software	
and	 illustrated	using	GraphPad	PRISM.	NK	cells	were	treated	with	10	mM	Mg2+	and	1	mM	EGTA	as	
positive	control.	
3.2.2.5 Conjugate	Assay	
NK	 cells	 and	 target	 cells	 were	 stained	 with	 fluorescent	 cell	 dyes	 in	 different	 colors	 (see	 3.2.2.2).	
0.5x105	fresh,	IL-2	activated	or	cultivated	NK	cells	were	mixed	with	1x106	target	cells	in	a	volume	of	
100	µl	and	centrifuged	for	one	minute	at	20xg	to	get	cells	in	close	proximity.	Cells	were	coincubated	
	28	
at	 37°C	 for	 0,	 5,	 10,	 20,	 40,	 60	 and	 90	minutes.	 If	mentioned	 in	 the	 experiment,	 an	 inhibitor	was	
added	directly	at	the	beginning	of	coincubation.	The	reaction	was	stopped	by	vortexing	the	cells	and	
fixing	 them	with	 2%	 PFA	 on	 ice.	 Cells	were	 directly	 analyzed	with	 a	BD	 LSRFortessa	 and	 data	was	
analyzed	with	FlowJo	software.	Conjugates	were	determined	as	double	positive	events	within	all	NK	
cells	and	illustrated	using	GraphPad	PRISM	software.	
3.2.2.6 Detachment	assay	(after	Culley	et	al.	2011)	
NK	cells	 and	 target	 cells	were	 stained	with	 fluorescent	 cell	 dyes	 in	different	 colors	 as	described	 in	
3.2.2.2	to	distinguish	free	cells	and	conjugates.	0.5x106	NK	cells	and	1x106	target	cells	were	mixed	in	
650	µl	medium,	centrifuged	for	one	minute	at	20xg	and	coincubated	for	30	minutes	at	37°C	to	allow	
formation	 of	 conjugates	 (pre-coincubation).	 Cells	 were	 diluted	 1:25	 with	 CTL	 medium	 and	 if	
mentioned	an	 inhibitor	was	added.	The	cell	mix	was	aliquoted	 in	 six	equal	 samples	and	 rotated	at	
37°C,	 which	 allows	 detachment	 of	 NK	 cells	 but	 prevents	 the	 formation	 of	 new	 conjugates.	 The	
reaction	was	stopped	after	0,	10,	20,	40,	60	and	90	minutes	by	vortexing	and	fixation	with	2%	PFA	on	
ice.	 As	 controls,	 NK	 cells	 and	 K562	 were	 mixed	 and	 diluted	 with	 medium	 without	 prior	 pre-
coincubation.	 The	 cells	were	 directly	 analyzed	with	 a	BD	 LSRFortessa	 and	 data	was	 analyzed	with	
FlowJo	 software.	 Conjugates	 were	 determined	 as	 double	 positive	 events	 within	 all	 NK	 cells.	 The	
decay	and	half-life	of	conjugates	was	determined	using	GraphPad	PRISM	and	the	following	formula	
for	a	one-phase	exponential	decay:	
τ = ln (𝑌!" − 𝑃𝑙𝑎𝑡𝑒𝑎𝑢𝑆𝑝𝑎𝑛 )−𝐾 	
	
τ		 -		 Half-life	[min]	
ln		 -		 Natural	logarithm	
Y		 -		 %	of	remaining	conjugates	[%]	
Span		 -		 Span	between	the	exponentially	determined	maximum	and		
	 	 minimal	amount	of	remaining	conjugates	
Plateau		 -		 Exponentially	determined	minimal	amount	of	remaining	conjugates	[%]	
K		 -		 Rate	constant	[min-1]	
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3.2.2.7 Calcium	Assay	
Cells	were	stained	with	fluorescent	cell	dyes	(see	3.2.2.2)	to	distinguish	free	NK	cells	and	NK	cells	in	
conjugates.	 To	 measure	 intracellular	 calcium	 signal,	 NK	 cells	 were	 then	 additionally	 stained	 with	
fluorescent	calcium	binding	dye	fluo-8.	1x106	cells	were	loaded	with	4.8	µM	fluo-8	in	wash	medium	
(IMDM	 without	 phenol	 red,	 2.5	 mM	 Probenecid	 solution,	 5	 mM	 HCl,	 10	 %	 FCS,	 1	 %	 P/S)	 for	 30	
minutes	at	37°C.	Cells	were	washed	twice	and	incubated	for	additional	30	minutes	to	allow	unbound	
fluo-8	to	leak	out.	After	a	last	washing	step,	NK	cells	were	resuspended	in	a	concentration	of	1x106	
cells/ml	in	assay	medium	(IMDM	without	phenol	red,	2,5	%	Probenecid	solution,	5	mM	HCl,	10	mM	
Hepes,	2	%	FCS).	A	Kinetik	of	the	calcium	signal	was	measured	for	NK	cells	alone	or	after	coincubation	
with	 K562	 in	 a	 BD	 FACSCalibur.	 The	 data	 was	 analyzed	 with	 FlowJo	 software.	 Conjugates	 were	
determined	as	double	positive	events	within	all	NK	cells.		
3.2.2.8 Calcium	Detachment	Assay	
To	measure	the	calcium	signal	during	NK	cell	detachment,	K562	were	stained	with	Cell	tracker	orange	
to	distinguish	between	free	K562	and	NK:K562	conjugates	 (see	3.2.2.2).	NK	cells	were	stained	with	
fluorescent	 calcium	 binding	 dye	 fluo-8	 (see	 0)	 and	 the	 NK	 cells	 were	 preincubated	 either	 with	
concanamycin	A	(50	nM)	or	DMSO	for	2	h.	0.5x106	NK	cells	and	1x106	target	cells	were	mixed	in	650	
µl	of	assay	medium	(IMDM	without	phenol	red,	2,5	%	Probenecid	solution,	5	mM	HCl,	10	mM	Hepes,	
2	 %	 FCS),	 centrifuged	 for	 one	 minute	 at	 20xg	 and	 coincubated	 for	 30	 minutes	 at	 37°C	 to	 allow	
formation	of	conjugates	(pre-coincubation).	Cells	were	diluted	1:25	in	assay	medium,	aliquoted	in	22	
equal	samples	and	rotated	at	37°C	to	facilitate	NK	cell	detachment	but	prevent	the	formation	of	new	
conjugates.	All	22	samples	were	measured	successively	over	a	time	period	of	88	minutes	and	every	
four	minutes	the	current	sample	was	exchanged	with	a	new	one.	Using	FlowJo	software,	NK	cells	and	
K562	were	plotted	against	each	other	and	conjugates	were	defined	as	double	positive	events.	The	
calcium	signal	for	free	NK	cells	and	NK	cells	in	conjugates	were	analyzed	over	time.	A	regression	line	
was	 calculated	 for	 the	 measured	 calcium	 data	 and	 the	 slope	 over	 time	 was	 calculated	 using	
GraphPad	PRISM	software.		
3.2.3 Further	Methods	
3.2.3.1 Chromium-51	release	assay	
Chromium-51	release	assay	was	performed	with	K562	or	Ba/F3	cells	as	target	cells.	5x106	cells	were	
harvested	and	resuspended	in	CTL	medium	(IMDM	+	10%	FCS	+	1%	P/S).	Cells	were	labeled	with	100	
µCi	 51Cr	 (3.7	 MBq)	 for	 1	 h	 at	 37°C,	 washed	 two	 times	 with	 fresh	 medium	 and	 resuspended	 at	 a	
concentration	 of	 5x104	 cells/ml.	 NK	 cells	 were	 harvested	 and	 plated	 in	 a	 96-U-well	 plate	 in	 serial	
dilutions	 from	10:1	 to	1,25:1	 (NK:target	 cell)	 in	 triplicate.	 5x103	 target	 cells	were	 added	 to	 the	NK	
cells	in	a	final	volume	of	200	µl	per	well	and	incubated	for	4	h	at	37°C.	For	a	serial	killing	Chromium-
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51	release	assay,	the	NK	cells	were	diluted	from	1:1	to	0,125:1	(NK:target	cell)	and	incubated	for	16	h	
at	 37°C	with	 5x103	 target	 cells/well.	 If	mentioned,	 inhibitors	were	 added	during	 coincubation.	 The	
maximum	release	was	determined	by	lysis	of	target	cells	with	1%	TritonX-100,	spontaneous	release	
was	determined	by	 incubating	target	cells	without	NK	cells	and	the	percentage	of	specific	 lysis	was	
calculated	as:	
% 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑙𝑦𝑠𝑖𝑠 =  experimental release− 𝑠𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠 𝑟𝑒𝑙𝑒𝑎𝑠𝑒maximum release− 𝑠𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠 𝑟𝑒𝑙𝑒𝑎𝑠𝑒  𝑥 100	
3.2.3.2 ELISA	assay	
NK	cells	were	either	preincubated	with	concanamycin	A	 (50	nM)	or	DMSO	 for	2h	and	coincubated	
with	K562	wildtype	or	K562-Sb9-CD107a	for	16	h.	The	cell	mix	was	centrifuged	and	the	supernatant	
frozen	 at	 -80°C.	 The	 supernatants	 of	 three	 independent	 experiments	 were	 thawed	 and	 analyzed	
using	 IFN-γ	 or	 TNF-α	 ELISA	 Kit	 according	 to	 the	 manufacturer’s	 instructions.	 The	 samples	 were	
analyzed	by	a	tecan	M200	pro	microplate	reader	and	the	data	was	analyzed	with	GraphPad	PRISM	
software.		
3.2.3.3 Preparation	of	dead	cell	supernatant	
Dead	 cell	 supernatant	 (DCS)	 was	 prepared	 by	 slowly	 killing	 K562	 or	 HEK293T	 cells	 by	 heat	 shock.	
2-3x106	 cells/ml	 K562	 or	 HEK293T	 cells	 were	 resuspended	 in	 fresh	 medium	 and	 incubated	 for	 7	
minutes	 (K562)	 or	 10	minutes	 (HEK293T)	 at	 56°C.	 Cells	were	 then	 incubated	 for	 2	 days	 at	 37°C	 to	
allow	cells	to	die	slowly.	At	the	day	of	the	experiment,	cells	were	centrifuged	and	supernatant	was	
used	 in	 Chromium-51	 release	 assays	 (see	 3.2.3.1)	 or	 detachment	 assays	 (see	 3.2.2.6).	 As	 controls,	
0.6x106	 cells/ml	were	 incubated	without	 heat	 shock	 for	 2	 days	 (Living	 cells	 supernatant	 –	 LCS)	 or	
fresh	medium	was	used.	
3.2.3.4 Statistical	analysis	
Statistical	 analyses	 were	 performed	 using	 GraphPad	 Prism	 v.5.0f	 (GraphPad	 Software,	 Inc.,	 San	
Diego,	 CA,	 USA).	 Two	 data	 groups	 were	 analyzed	 using	 paired,	 two-tailed	 student’s	 t-test.	 Other	
statistics	 methods	 are	 indicated.	 P-values	 <	 0.05	 were	 considered	 significant	 differences	 and	 are	
marked:	*	<	0.05;	**	<	0.01;	***	<	0.001;	ns	=	not	significant.	
	 	 	 31	
4 Results	
4.1 A	 flow	 cytometry-based	 assay	 system	 to	determine	 the	NK:target	 cell	
conjugate	half-life	
The	process	of	NK	cell	killing	can	be	divided	in	multiple	steps.	After	a	firm	adhesion	and	activation	of	
the	 NK	 cell,	 the	 delivery	 of	 cytotoxic	 proteins	 induces	 target	 cell	 apoptosis.	 The	 last	 step	 is	 the	
termination	of	the	immunological	synapse	and	detachment	of	the	NK	cell.	Although	much	is	known	
about	NK	 cell-mediated	 killing	of	 transformed	or	 infected	 cells,	 the	process	of	NK	 cell	 detachment	
remains	relatively	unclear.		
	
Figure	3.	The	procedure	of	a	detachment	assay	as	a	schematic	illustration.	Primary	NK	and	target	cells	were	stained	with	
membrane	dyes	in	different	colors	and	coincubated	in	a	small	volume	to	form	conjugates	(E:T=1:2).	After	30	minutes	pre-
coincubation,	cells	were	diluted	with	medium	and	inhibitor	was	added	if	indicated.	Cells	were	rotated	for	90	minutes	and	
samples	fixed	after	0,	10,	20,	40,	60	and	90	minutes	with	4%	PFA.	
In	order	to	further	analyze	the	process	of	NK	cell	detachment	this	study	focused	on	the	question	how	
NK	cells	 recognize	 the	 target	 cell	death	and	how	NK	cell	detachment	 is	 initiated	and	 regulated.	To	
investigate	 the	 NK	 cell	 detachment,	 a	 modified	 conjugate	 assay	 described	 by	 Culley	 et	 al.	 and	
modified	 by	 Netter	 (Culley	 et	 al.,	 2009;	 Netter,	 2014)	 was	 used.	 The	 detachment	 assay	 can	 be	
differentiated	 into	 two	 phases.	 If	 not	mentioned	 otherwise,	 primary	 NK	 cells	 were	 used	 after	 2-4	
weeks	cultivation	in	IL-2/IL-21/IL-15	and	feeder	cells	containing	medium,	when	they	show	the	highest	
activation	 (Granzin	et	al.,	 2016).	 To	distinguish	between	 single	 cells	 and	conjugates,	NK	and	 target	
cells	were	stained	with	intracellular	fluorescence	dyes	in	different	colors	and	afterwards	coincubated	
for	30	minutes	in	a	small	volume	(Figure	3).	In	this	precoincubation	phase,	NK	cells	form	a	significant	
amount	 of	 conjugates	 but	 remain	 in	 the	 exponential	 phase	 of	 conjugate	 formation,	 when	 more	
conjugates	are	formed	than	decayed.	Importantly,	minor	changes	in	the	effector	to	target	ratio	(E:T)	
or	pre-coincubation	duration	had	no	 significant	 effect	 on	 the	 conjugate	half-life	 (Netter,	 2014).	 To	
stop	 the	 continuing	 formation	 of	 conjugates,	 the	 cells	 were	 diluted	 25-fold	 and	 subdivided	 into	
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precoincubation 
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multiple	samples.	Each	sample	was	rotated	 for	different	 time-periods	 from	0	to	90	minutes.	 In	 the	
end,	the	samples	were	vortexed	briefly	to	separate	loosely	adherent	cells,	which	did	not	form	a	firm	
conjugate	 and	were	 fixed	with	paraformaldehyde	 (Figure	3).	NK	and	 target	 cells,	which	have	been	
incubated	separately	and	were	mixed	at	the	point	of	dilution,	did	not	 form	new	conjugates	(Figure	
4C).	
	
Figure	4.	Cultured	NK	cells	detach	after	approximately	50	minutes.	Gating	strategy	of	the	detachment	assay:	NK	cells	are	
plotted	on	the	Y-axis	and	target	cells	(here	K562)	are	plotted	on	the	X-axis.	First	a	gate	including	all	NK	cells	was	drawn	and	
within	 these	 cells	 on	 the	 double-positive	 events,	 which	 display	 the	 NK	 cells	 in	 conjugates,	 was	 gated.	 Plots	 are	 shown	
exemplarily	for	0	and	90	minutes	after	dilution	(A).	The	percentage	of	NK	cells	in	conjugates	was	determined	for	all	time-
points	(0,	10,	20,	40,	60	and	90	minutes),	normalized	to	time	point	0	minutes	after	pre-coincubation	and	plotted	against	the	
time.	Using	 the	 formula	 for	one-phase	exponential	decay	 the	half-life	 for	 the	NK	cell	detachment	was	 calculated	 (B,	 left	
panel)	 and	 is	 quantified	 for	 NK	 cells	 from	 8	 different	 healthy	 donors	 (B,	 right	 panel).	 The	 percentage	 of	 remaining	
conjugates	after	90	minutes	without	pre-coincubation	of	NK	and	K562	cells	(C).	
Directly	after	fixation,	the	samples	were	analyzed	by	flow	cytometry.	The	staining	with	two	different	
membrane	dyes	makes	 it	possible	 to	 separate	 three	cell	populations.	Free	NK	cells	and	 free	 target	
cells	appear	as	single	positive	events,	conjugates	between	an	NK	and	a	target	cell	appear	as	double	
positive	 events.	 To	 determine	 the	 percentage	 of	 NK	 cells	 in	 conjugates	 after	 each	 time-point,	 the	
fraction	of	NK	cells	engaged	in	conjugates	of	all	NK	cells	was	calculated	(Figure	4A).	The	number	of	
NK	cells	in	conjugates	after	0	minutes	of	dilution	was	set	to	100%	and	the	following	time	points	were	
normalized	to	this	sample	and	plotted	against	the	time.	To	calculate	the	half-life	of	the	conjugates,	a	
non-linear	 regression	 curve	 for	 one-phase	 decay	 was	 used	 to	 analyze	 the	 data.	 The	 half-life	
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determines	 the	 time-point	 when	 50%	 of	 the	 initial	 conjugates	 have	 been	 decayed	 (Figure	 4B).	
Cultured	NK	 cells	 detach	after	48.43	±	16.16	minutes.	 To	exclude	 the	possibility,	 that	NK	 cells	 and	
target	 cells	 form	 new	 conjugates	 after	 dilution,	 they	 were	 mixed	 in	 a	 large	 volume	 of	 medium	
without	prior	pre-coincubation.	After	the	following	90	minutes	coincubation,	only	2-3	%	of	these	NK	
and	target	cells	were	in	conjugates	(Figure	4C).	The	data	show,	that	this	assay	is	capable	to	study	NK	
cell	detachment.	
4.2 Influence	 of	 cytokine-induced	 pre-activation	 on	 NK	 cell	 effector	
functions	
The	ability	of	NK	cells	to	kill	a	target	cell	is	independent	of	a	pre-activation.	Nevertheless,	the	activity	
of	NK	 cells	 can	be	 increased	by	 a	broad	 range	of	 cytokines	 secreted	by	other	 cells	 of	 the	 immune	
system.	The	main	cytokines	with	activating	properties	are	IL-2,	IL-15	and	IL-21.		
To	 analyze	 the	 effects	 of	 NK	 cell	 activation	 on	 the	 cytotoxicity,	 degranulation	 and	 formation	 of	
conjugates	as	well	as	detachment,	differentially	activated	NK	cells	were	compared.	After	isolation,	NK	
cells	were	subdivided	in	three	groups.	The	first	group	was	rested	over	night	in	medium	without	the	
addition	of	any	cytokines.	The	second	group	was	treated	for	16	h	with	200	IU/ml	IL-2	to	initiate	NK	
cell	activation.	The	third	group	was	cultured	for	2-3	weeks	in	vericyte	NK	cell	medium,	which	contains	
high	levels	of	IL-2	(1000	IU/ml),	IL-15	(10	ng/ml)	and	a	not	otherwise	specified	factor	115.	This	group	
was	 supposed	 to	 have	 the	maximum	activity.	 The	 fresh	 and	 IL-2	 activated	NK	 cells	were	 tested	 in	
functional	assays	one	day	after	isolation,	the	cultured	NK	cells	after	2-3	weeks.		
	34	
	
In	a	standard	Chromium-51	release	assay	the	ability	of	NK	cells	to	lyse	K562	target	cells	in	relation	to	
the	ratio	between	both	cell	types	was	analyzed.	The	fresh,	rested	NK	cells	were	able	to	kill	K562	in	a	
dose	dependent	manner.	The	average	percentage	of	lysed	cells	at	a	ratio	of	2.5:1	(NK	cells:K562	cells)	
was	31.91%	±	9.8.	The	cytotoxicity	increased	after	activation	of	NK	cells	with	IL-2	over	night	and	the	
percentage	of	 lysed	cells	was	significantly	higher	compared	to	the	resting	cells	 (46.19%	±	16.67	%).	
The	 cultivation	 in	 vericyte	 medium	 for	 2-3	 weeks	 boosted	 this	 effect	 even	 more.	 The	 killing	 was	
significantly	increased	(61.08%	±	13.90%)	and	reached	a	plateau	at	a	ratio	of	5:1	(Figure	5A).	
The	 degranulation	 of	 the	 differentially	 activated	 NK	 cells	 showed	 a	 similar	 pattern.	 During	 2	 h	
coincubation	with	K562,	NK	cells	were	stained	with	anti-CD107a	as	a	marker	for	degranulation.	Fresh,	
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Figure	5.	Degranulation	and	killing	of	K562	target	cells	is	dependent	on	NK	cell	pre-activation.	After	 isolation	NK	cells	
were	rested	over	night	in	CTL	medium,	incubated	for	16	h	with	IL-2	(200	IU/ml)	or	cultured	for	2-3	weeks	in	vericyte	NK	
cell	medium.	Cytotoxicity	was	tested	in	a	standard	Chromium-51	release	assay	against	K562	cells.	Left	panel	shows	one	
representative	 donor,	 right	 panel	 quantification	 of	 10	 different	 donors.	 (A).	 Degranulation	 was	 analyzed	 after	 2	 h	
coincubation	with	K562	cells	 (E:T=1:2)	and	staining	 for	CD107a.	Left	panel	shows	one	representative	donor,	right	panel	
quantification	of	four	different	donors	(B).	Values	are	shown	as	mean	±	SD	(*p<	0.05;	**p<	0.01;	***p<	0.001).	
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rested	 NK	 cells	 were	 able	 to	 degranulate	 after	 coincubation	 with	 K562	 (20.78%	 ±	 3.65).	 The	
degranulation	was	 slightly	 but	 significantly	 increased	 if	 NK	 cells	 were	 pre-activated	with	 IL-2	 over	
night	(26.90%	±	5.24).	This	was	considerably	and	significantly	increased,	if	the	NK	cells	were	cultured	
in	vericyte	medium	for	2-3	weeks	(70.48%	±	9.89)	(Figure	5B).		
	
To	further	investigate	the	effect	of	NK	cell	activation,	the	ability	of	NK	cells	to	form	conjugates	with	
K562	target	cells	was	assessed.	Again,	fresh	NK	cells	were	able	to	bind	a	target	cell	and	form	a	stable	
immunological	synapse.	But	the	number	of	NK	cells	in	conjugates	after	40	minutes	coincubation	was	
the	 lowest	 (20.66%	 ±	 5.87)	 and	 could	 be	 significantly	 increased	 by	 activation	with	 IL-2	 over	 night	
(25.36%	±	6.47)	or	even	more	after	cultivation	 in	vericyte	medium	(28.87%	±	7.50)	(Figure	6A).	The	
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Figure	6.	Formation	of	conjugates	and	detachment	from	a	target	cell	 is	dependent	on	NK	cell	pre-activation.	After	
isolation,	NK	cells	were	rested	over	night	in	CTL	medium,	incubated	for	12	h	with	IL-2	(200	IU/mL)	or	cultured	for	2-3	
weeks	in	vericyte	NK	cell	medium.	Formation	of	conjugates	with	K562	target	cells	was	determined	in	a	conjugate	assay	
(A).	Detachment	was	tested	in	a	detachment	assay	against	K562	cells	(B).	Left	panels	show	one	representative	donor,	
right	 panels	 the	 quantification	 of	 10	 different	 donors.	 Values	 are	 shown	 as	 mean	 ±	 SD	 (*p<0.05;	 **p<0.01;	
***p<0.001).	
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relationship	between	NK	cell	activation	and	detachment	has	not	been	assessed	so	far.	Interestingly,	
the	results	differ	somewhat	from	the	other	functional	assays.	The	half-life	of	NK:K562	conjugates	was	
very	similar	for	fresh	and	IL-2	activated	NK	cells	(120.9	±	47.27	min	and	109.5	±	31.31	min).	Only	the	
cultivation	 in	 vericyte	 medium	 led	 to	 an	 acceleration	 of	 the	 NK	 cell	 detachment	 and	 significant	
decrease	of	the	conjugate	half-life	(62.60	±	17.08	min).	
These	results	show,	that	NK	cell	effector	functions	are	highly	dependent	on	the	activation	status	of	
the	NK	cell.	Not	pre-activated	NK	cells	formed	the	fewest	number	of	conjugates,	degranulate	less	and	
killed	 the	 least	 amount	 of	 target	 cells.	 The	 pre-activation	 with	 cytokines	 increases	 all	 of	 these	
effector	functions.	Here,	the	long-term	activation	with	high	concentrations	of	cytokines	IL-2	and	IL-15	
(vericyte	 medium)	 boosts	 these	 effects	 more	 than	 short-term	 activation	 with	 IL-2	 over	 night.	
Surprisingly,	even	though	IL-2	activated	NK	cells	lysed	target	cells	more	effectively	than	fresh	NK	cells	
the	 detachment	 kinetic	 was	 similar	 and	 was	 only	 accelerated,	 when	 NK	 cells	 were	 activated	 in	
vericyte	medium	(Figure	6B).	
In	 addition	 to	 the	 activation	 of	 NK	 cells	 by	 cytokines,	 it	 was	 investigated	 how	 the	 availability	 of	
ligands	for	activating	NK	cell	receptors	influences	the	effector	functions	of	NK	cells.	For	this,	mouse	
Ba/F3	cells,	 transfected	with	different	human	NK	cell	 ligands	were	used.	Cultured	primary	NK	cells	
were	coincubated	with	these	target	cells	and	the	formation	of	conjugates,	detachment,	cytotoxicity	
and	degranulation	was	analyzed	with	the	respective	functional	assays.		
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Figure	 7.	Different	 receptor-ligand	 interactions	 change	 the	 ability	 of	NK	 cells	 to	 form	 conjugates	 and	 the	 detachment	
kinetic	from	a	target	cell.	Cultured	primary	NK	cells	were	coincubated	with	Ba/F3	cells,	which	have	been	stably	transfected	
with	 NK	 cell	 ligands	 CD48,	 ULBP2,	 B7H6,	 NTB-A	 or	 GFP	 as	 a	 control.	 The	 cytotoxicity	 was	 analyzed	 using	 a	 standard	
Chromium-51	release	assay	(A).	Degranulation	was	analyzed	after	2	h	coincubation	(E:T=1:2)	and	staining	for	CD107a	on	NK	
cells	(B).	Formation	of	conjugates	was	determined	in	a	conjugate	assay.	Left	panel	shows	one	representative	experiment,	
right	panel	shows	the	quantification	of	3	different	NK	cell	donors	(C).	The	detachment	was	analyzed	in	a	detachment	assay.	
Left	panel	shows	the	detachment	of	one	representative	experiment	between	GFP	and	CD48	transfected	Ba/F3	cells.	Right	
panel	shows	the	quantification	of	3-4	NK	cell	donors	(D).	Values	are	shown	as	mean	±	SD	(*p<0.05).	
The	availability	of	different	NK	cell	ligands	on	the	target	cell	surface	had	a	large	impact	on	the	ability	
to	 kill	 the	 target	 cell.	 Cultured	primary	NK	 cells	 lysed	only	 few	Ba/F3	 cells	 transfected	with	a	GFP-
containing	control	vector.	The	expression	of	CD48,	the	natural	ligand	of	SLAM-related	receptor	2B4,	
slightly	 increased	 the	 number	 of	 killed	 target	 cells.	 This	 effect	 was	 enhanced,	 if	 the	 cells	 were	
transfected	with	NTB-A,	a	homophilic	NK	cell	receptor.	The	NCR	NKp30	is	known	to	deliver	a	strong	
activating	 signal.	 The	availability	of	 its	 ligand	B7H6	on	 the	 target	 cells	 facilitated	 the	NK	 cell	 to	 kill	
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even	more	 target	 cells.	 Expression	of	ULBP2,	 the	 ligand	 for	C-type	 lectin-like	 receptor	NKG2D,	had	
the	biggest	effect	on	the	pre-activated	NK	cells	and	led	to	the	lysis	of	most	of	the	target	cells	(Figure	
7A).	 Next,	 I	wanted	 to	 examine	 if	 NK	 cells	 degranulate	 differently	 after	 contact	with	 the	 different	
ligands.	 I	 coincubated	 the	 Ba/F3-transfectants	with	 cultured	 primary	 NK	 cells	 and	 determined	 the	
degranulation	by	staining	with	anti-CD107a	antibody.	The	results	show,	that	degranulation	and	the	
ability	to	kill	the	target	cells	are	strongly	associated.	Only	very	few	NK	cells	degranulate	after	contact	
to	GFP	 control	 transfected	Ba/F3	 cells.	 Ba/F3-CD48	 and	Ba/F3-NTB-A	 cells,	which	 have	 been	 killed	
only	 to	 a	 small	 extent,	 also	 stimulated	 the	NK	 cells	 the	 least.	 In	 contrast,	 triggering	 of	NKp30	 and	
NKG2D	with	their	ligands	B7H6	and	ULBP2	clearly	enhanced	the	NK	cell	degranulation	(Figure	7B).	To	
figure	out,	which	ligands	are	necessary	for	the	formation	of	conjugates,	I	performed	conjugate	assays	
and	quantified	the	number	of	conjugates	after	40	minutes.	Although	Ba/F3	cells	are	mouse	cells,	its	
ICAM-1	is	recognized	by	human	LFA-1	and	enables	adhesion	of	human	NK	cells.	Cultured	primary	NK	
cells	 were	 able	 to	 form	 conjugates	 with	 GFP	 control	 transfected	 Ba/F3	 cells	 to	 a	 small	 but	
measureable	extent.	After	40	minutes,	12.02	±	3.39	%	of	the	NK	cells	were	in	a	conjugate.	Again,	the	
presence	of	NTB-A	has	the	smallest	effect	on	NK	cell	effector	functions.	Only	16.46	±	5.28	%	of	the	NK	
cells	 formed	conjugates	with	Ba/F3-NTB-A	cells.	The	number	of	conjugates	was	clearly	 increased,	 if	
NKp30	was	triggered	by	Ba/F3	cells	that	were	transfected	with	B7H6	(19.17	±	1.71	%).	Interestingly,	
NK	cells	form	conjugates	to	the	same	extent	(19.07	±	3.29	%)	with	Ba/F3-CD48	cells,	which	showed	
only	 a	 slight	 effect	 in	 the	 previously	 shown	 cytotoxicity	 assays.	 Again,	 the	 triggering	 of	 NKG2D	 by	
ULBP2	 had	 the	 strongest	 effect	 on	 NK	 cells	 and	 led	 to	 the	 highest	 percentage	 of	 NK	 cells	 in	
conjugates	 after	 40	minutes	 (20.80	 ±	 7.39	%)	 (Figure	 7C).	 Finally	 I	was	 interested	 in	 the	 influence	
these	 ligands	 have	 on	 NK	 cell	 detachment.	 Importantly,	 as	 shown	 in	 Figure	 5C,	 the	 number	 of	
preformed	 conjugates	 differs	 between	 the	 Ba/F3-transfectants	 after	 30	minutes	 pre-coincubation.	
Nevertheless,	 I	 could	 perform	 detachment	 assays	 and	 saw	 differences	 in	 the	 conjugate	 decay	
between	 NK	 cells	 and	 the	 differentially	 transfected	 target	 cells	 (Figure	 7D,	 left	 panel).	 The	
quantification	 shows,	 that	 similar	 to	 the	 results	 of	 conjugate	 formation,	 CD48	 and	ULBP2	 had	 the	
biggest	 effect	on	NK	 cell	 detachment.	 Transfection	with	 these	 two	 ligands	 increases	 the	 conjugate	
half-life.	The	effect	of	B7H6	was	clearly	smaller	and	NTB-A	showed	no	differences	compared	to	the	
GFP	 control	 cells.	 These	 results	 show,	 that	 the	 interaction	 of	 different	NK	 cell	 receptors	 and	 their	
ligands	 has	 an	 effect	 on	 NK	 cell	 effector	 functions.	 While	 the	 effect	 of	 NTB-A	 was	 small,	 the	
NKG2D:ULBP2	interaction	showed	a	strong	effect	on	all	NK	cell	functions.	In	contrast,	the	interaction	
of	2B4	with	CD48	did	hardly	increase	the	cytotoxicity	but	influenced	the	adhesion	of	NK	cells.	 	
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4.3 Reduction	of	NK	cell	cytotoxicity	leads	to	slower	detachment	
NK	cell	killing	is	largely	mediated	by	the	exocytosis	of	lytic	granules.	In	a	former	study	in	our	lab,	we	
wanted	to	 investigate	 if	NK	cell	detachment	 is	depending	on	intrinsic	or	extrinsic	signals.	Therefore	
we	inhibited	the	target	cell	killing	by	depleting	mature	perforin.	The	NK	cells	were	treated	with	the	
drug	 concanamycin	 A,	 an	 inhibitor	 for	 vacuolar	 H+-ATPases.	 Concanamycin	 A	 inhibits	 the	 vacuolar	
type	H+-ATPase	and	thereby	acidifies	the	lytic	granules.	The	acidification	inhibits	cathepsin	L,	which	is	
needed	for	cleavage	of	 immature	perforin	 into	 its	active	 form	(Kataoka	et	al.,	1996;	Kataoka	et	al.,	
1994).	 Thus,	 treatment	with	 concanamycin	A	prevents	 the	maturation	of	perforin.	We	 could	 show	
that	 concanamycin	 A	 effectively	 decreases	 the	 amount	 of	 mature	 perforin	 in	 NK	 cells,	 which	
completely	abolished	the	killing	of	K562	cells.	This	had	no	effect	on	the	formation	of	conjugates	but	
strongly	decelerated	the	NK	cell	detachment	(Netter,	2014).	
	
	
In	a	first	step,	I	wanted	to	replicate	and	confirm	these	results.	I	cultured	primary	NK	cells	with	50	nM	
concanamycin	A	 for	2	h	or	DMSO	as	a	control	 to	prevent	 the	maturation	of	 functional	perforin.	As	
expected,	 intracellular	 staining	 with	 α-perforin	 antibody	 shows,	 that	 the	 treatment	 with	
concanamycin	 A	 depleted	 mature	 perforin	 nearly	 completely	 (Figure	 8A,	 brown	 histogram).	 In	
contrast,	NK	cells	 treated	with	DMSO	as	a	control	were	able	 to	normally	maturate	perforin	 (Figure	
8A,	 yellow	 histogram).	 Next,	 I	 could	 confirm	 that	 the	 absence	 of	 mature	 perforin	 due	 to	
concanamycin	 A	 treatment	 clearly	 decelerates	 the	 NK	 cell	 detachment	 from	 K562	 target	 cells	
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Figure	 8.	 Concanamycin	 A	 treated	
primary	 NK	 cells	 express	 less	 perforin	
and	 have	 a	 prolonged	 contact	 time	
with	K562	target	cells.	Cultured	primary	
NK	 cells	 were	 treated	 with	 50	 nM	
concanamycin	 A	 or	 DMSO	 as	 a	 control	
for	 2	h.	 Cells	were	 fixed	with	4	%	PFA,	
permeabilized	 and	 DMSO	 (yellow	
histogram)	and	concanamycin	A	(brown	
histogram)	 treated	 cells	 were	 stained	
with	α-perforin	 antibody	or	 IgG-control	
(grey	 histogram)	 (A).	 Concanamycin	 A	
(open	 circles)	 and	 DMSO	 (closed	
squares)	 treated	 NK	 cells	 were	
coincubated	in	a	detachment	assay	with	
K562	target	cells	(B).	
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compared	to	cells	treated	with	DMSO	(Figure	8B).	The	half-life	in	a	detachment	assay	increased	from	
∼	29	minutes	to	∼	550	minutes.	These	findings	confirm	the	results	from	Netter	and	allow	me	to	use	
concanamycin	 A	 in	my	 experiments	 to	 further	 investigate	 the	 effect	 of	 perforin	 depleted	NK	 cells	
with	a	decelerated	detachment.	
Another	approach	to	reduce	the	cytotoxicity	of	NK	cells	was	the	treatment	with	the	lactone	antibiotic	
Brefeldin	 A.	 Brefeldin	 A	 interrupts	 the	 vesicle	 transport	 from	 ER	 to	 Golgi	 and	 therefore	 prevents	
exocytosis	of	vesicles	(Fujiwara	et	al.,	1988;	Klausner	et	al.,	1992).	Exocytosis	of	cytotoxic	granules	is	
the	main	strategy	to	kill	a	target	cell	and	I	tried	to	block	this	process	and	analyze	the	effects	on	NK	
cell	detachment.	To	analyze	the	effect	of	Brefeldin	A	on	NK	cell	effector	functions,	I	treated	NK	cells	
with	5	µg/ml	Brefeldin	A	or	ethanol	as	solvent	control	and	coincubated	them	with	K562	target	cells.	
Performing	 the	 respective	 functional	 assays,	 I	 analyzed	 the	 formation	 of	 conjugates,	 cytotoxicity,	
degranulation	and	detachment.		
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Figure	 9.	 Treatment	 of	 NK	 cells	 with	
Brefeldin	 A	 has	 no	 influence	 on	 the	
formation	of	conjugates	but	accelerates	the	
detachment.	 NK	 cells	 were	 treated	 with	 5	
µg/ml	 Brefeldin	 A	 directly	 before	
coincubation	 with	 K562	 target	 cells.	 The	
formation	 of	 conjugates	 was	 analyzed	 in	 a	
conjugate	 assay.	 Left	 panel	 shows	 one	
representative	 experiment,	 right	 panel	
shows	 the	 number	 of	 conjugates	 after	 40	
min.	from	four	independent	experiment	(A).	
The	 cytotoxicity	was	 assessed	 in	 a	 standard	
Chromium-51	 release	 assay	 (B).	 The	
degranulation	 was	 measured	 using	 an	 α-
CD107a	 antibody	 after	 2	 h	 coincubation	 of	
Brefeldin	 A	 treated	 NK	 and	 K562	 cells	 (C).	
The	 detachment	 of	 preformed	 NK:K562	
conjugates	 was	 assessed	 in	 a	 detachment	
assay.	 Left	 panel	 shows	 one	 representative	
experiment	 and	 the	 right	 panel	 the	
quantification	of	NK	cells	from	four	different	
donors	 (D).	 Values	are	 shown	as	mean	±	SD	
(*p<0.05).	
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The	treatment	of	cultured	primary	NK	cells	with	5	µg/ml	Brefeldin	A	had	no	significant	effect	on	the	
formation	of	conjugates	(Figure	9A).	After	40	minutes,	28.88	±	5.79	%	of	the	Brefeldin	A	treated	and	
26.78	±	8.12	%	of	the	ethanol	treated	NK	cells	were	in	conjugates.	Analyzing	the	cytotoxicity	I	could	
show,	 that	Brefeldin	A	 reduces	 the	 specific	 lysis	 of	 K562	 in	 a	 standard	Chromium-51	 release	assay	
(Figure	 9B).	 This	 was	 probably	 due	 to	 a	 decreased	 ability	 to	 degranulate,	 as	 I	 could	 detect	 less	
CD107a	 on	 the	 cell	 surface	 of	 Brefeldin	 A	 treated	 NK	 cells	 after	 coincubation	 with	 K562	 cells	
compared	to	ethanol	treated	control	cells	(Figure	9C).	Surprisingly,	Brefeldin	A	treatment	accelerated	
the	 detachment	 of	 NK	 cells.	 The	 average	 half-life	 for	 Brefeldin	 A	 treated	 cells	 was	 40.89	 ±	 15.88	
minutes	 and	 therefore	 slightly	 but	 significantly	 shorter	 then	 for	 the	 control	 treated	 cells	 (50.44	 ±	
15.20	 minutes).	 These	 results	 show,	 that	 Brefeldin	 A	 treatment	 can	 decrease	 the	 NK	 cell	
degranulation	and	killing	of	K562	cells.	But	in	contrast	to	concanamycin	A,	the	Brefeldin	A	treatment	
did	not	decelerate	but	accelerate	the	conjugate	decay.		
In	 the	 next	 step	 I	 wanted	 to	 exclude	 the	 possibility,	 that	 the	 decelerated	 detachment	 of	
concanamycin	A	treated	NK	cells	was	a	side	effect	of	the	drug.	I	genetically	modified	the	target	cell	
line	 K562	 to	make	 them	more	 resistant	 against	 NK	 cell-mediated	 killing.	 For	 this,	 I	 overexpressed	
Serine	 protease	 inhibitor	 9	 (SerpinB9)	 and	 CD107a.	 This	 gave	me	 the	 opportunity	 to	 leave	 the	NK	
cells	completely	untouched.	
Cancer	cells	have	evolved	multiple	ways	to	escape	from	NK	cell-mediated	immunosurveillance.	One	
strategy	 is	 the	 overexpression	 of	 SerpinB9	 (Bladergroen	 et	 al.,	 2002),	 which	was	 shown	 to	 inhibit	
Granzyme	 B	 and	 therefore	 prevent	 the	 killing	 by	 cytotoxic	 immune	 cells	 (Bird	 et	 al.,	 1998).	 The	
lysosome-associated	 membrane	 protein	 CD107a/LAMP-1	 was	 recently	 shown	 to	 prevent	 the	
insertion	of	perforin	and	the	formation	of	pores	in	the	cell	membrane,	which	hinders	Granzyme	B	to	
enter	 the	 cell	 to	 induce	 apoptosis.	 Cytotoxic	 immune	 cells	 express	 CD107a	 to	 protect	 themselves	
against	their	own	perforin	(Cohnen	et	al.,	2013).		
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I	used	a	retroviral	 transfection	system	to	transfect	K562	cells	with	SerpinB9	and	CD107a.	Two	days	
after	transduction	with	the	viruses	containing	the	constructs,	the	transfected	cells	were	treated	with	
Puromycin	 for	 selection.	 Resistant	 cells	 were	 checked	 for	 the	 overexpression	 of	 the	 transfected	
protein	after	1-2	weeks.	After	intracellular	staining	with	α-SerpinB9	antibody,	endogenous	SerpinB9	
could	 be	 detected	 in	 the	 K562	wildtype	 cells.	 However,	 the	 K562-SerpinB9	 cells	 showed	 a	 clearly	
increased	 SerpinB9	 expression	 (Figure	 10A).	 In	 contrast,	 the	 K562	 wildtype	 cells	 showed	 no	 cell	
surface	expression	of	CD107a.	Only	the	K562-CD107a	cells	could	be	stained	by	α-CD107a	antibody.	
(Figure	10B)	
In	the	next	step	I	wanted	to	check,	if	the	stable	overexpression	of	SerpinB9	and	CD107a	in	K562	cells	
reduces	the	NK	cell-mediated	killing.	 In	a	standard	Chromium-51	release	assay	cultured	primary	NK	
cells	 from	the	same	donor	killed	 less	K562-SerpinB9	and	 less	K562-CD107a	cells	compared	to	K562	
wildtype	 cells	 (Figure	 11A).	 Of	 note,	 the	 overexpression	 of	 CD107a	 on	 the	 cell	 surface	 of	 K562-
CD107a	cells	did	not	influence	the	ability	of	NK	cells	to	form	conjugates	(Figure	11B).	Remarkably,	the	
detachment	 of	 NK	 cells	 from	 K562-SerpinB9	 or	 K562-CD107a	 conjugates	 was	 clearly	 decelerated	
compared	 to	 K562	wildtype	 conjugates.	NK	 cells	 detached	 after	 60.07	 ±	 18.44	minutes	 from	K562	
wildtype	 cells.	 The	overexpression	of	 SerpinB9	 significantly	 increased	 the	half-life	 to	115.8	±	22.59	
minutes	and	 the	overexpression	of	CD107a	 to	85.03	±	22.43	minutes.	 These	 results	 confirmed	 the	
experiments	with	concanamycin	A	treated	NK	cells.	Reduction	of	the	NK	cell	cytotoxicity	or	increasing	
of	the	target	cell	resistance	both	clearly	decelerates	the	NK	cell	detachment. 
K562	
SerpinB9 CD107a 
A B 
K562	
K562-SerpinB9	 K562-CD107a	
Figure	 10.	 K562	 cells	 could	 be	
stably	 transfected	 with	 SerpinB9	
and	 CD107a.	 K562	 cells	 were	
retrovirally	 transfected	 with	
SerpinB9	 and	 CD107a.	 K562	
wildtype	 cells	 (upper	 panels)	 and	
stably	 transfected	 cells	 (lower	
panels)	 were	 stained	 with	 α-
SerpinB9	(A)	or	α-CD107a	antibody	
(B).	Grey	histograms	show	staining	
of	 the	 respective	 cells	 with	 IgG	
antibody	as	a	control.	
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Figure	11.	The	overexpression	of	SerpinB9	and	CD107a	reduces	NK	cell-mediated	killing	and	decelerates	the	detachment	
from	target	cells.	NK	cells	were	coincubated	with	K562-SerpinB9	and	K562-CD107a.	The	cytotoxicity	of	NK	cells	against	the	
transfectants	was	assessed	in	a	standard	Chromium-51	release	assay	(A)	and	the	ability	to	form	conjugates	in	a	conjugate	
assay	(B).	One	representative	experiment	of	3	 is	shown.	The	detachment	from	target	cells	was	analyzed	in	a	detachment	
assay	(C).	Left	panel	shows	one	representative	experiment,	right	panel	shows	the	quantification	of	the	half-life	(n	=	4-11).	
Values	are	shown	as	mean	±	SD	(*p<0.05;	***p<0.001).	
	
After	 I	could	show,	that	NK	cells	detach	 later	 if	 their	ability	 for	killing	the	target	cell	 is	decreased,	 I	
wanted	to	investigate	the	opposite	situation.	I	induced	apoptosis	in	target	cells	while	they	were	in	a	
conjugate	with	an	NK	cell.	So	I	could	study	if	NK	cells	recognize	the	target	cell	death	and	initiate	the	
detachment,	 even	 if	 the	 target	 cell	 dies	 for	 an	 NK	 cell	 independent	 reason.	 For	 this	 I	 induced	
apoptosis	in	K562	cells	by	the	treatment	with	H2O2,	coincubated	them	with	cultured	primary	NK	cells	
and	studied	the	ability	to	form	conjugates	and	detach	with	the	respective	assays.	
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K562	 cells	 were	 treated	 with	 25	 mM	 H2O2	 for	 15	 minutes,	 then	 washed	 thoroughly	 and	 used	 in	
conjugate	 and	 detachment	 assays.	 Staining	 with	 a	 live/dead	 marker	 allowed	 me	 to	 illustrate	 the	
kinetics	 of	 apoptosis	 in	 the	 H2O2	 treated	 cells.	 About	 50	%	 of	 the	 K562	 cells	 died	 in	 the	 first	 120	
minutes,	which	represents	the	duration	of	a	detachment	assay.	During	the	first	30	minutes,	the	time-
period	I	use	to	let	the	NK	cells	form	conjugates,	only	∼	17	%	of	the	K562	cells	died	(Figure	12A).	I	did	
not	find	differences	in	the	formation	of	conjugates	when	I	coincubated	cultured	primary	NK	cells	with	
H2O2	treated	or	untreated	K562	target	cells	(Figure	12B,	left	panel).	After	40	minutes,	the	numbers	of	
conjugates	were	comparable	(Figure	12B,	right	panel).	This	gave	me	the	opportunity,	to	use	the	cells	
in	our	detachment	 assay	 and	analyze	 the	effect	of	NK	 cell	 independent	 apoptosis	 on	 the	decay	of	
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Figure	 12.	 NK	 cell	 detachment	
accelerates	when	the	target	cell	is	
apoptotic.	K562	cells	were	treated	
with	 25	 mM	 H2O2	 for	 15	 minutes	
and	 then	 washed.	 Samples	 were	
taken	 all	 30	 minutes	 and	 stained	
with	 life/dead-dye	 zombie-aqua.	
Percentage	 of	 dead	 cells	 is	 shown	
for	 H2O2	 treated	 cells	 (white	 bars)	
and	 untreated	 cells	 (black	 bars)	
(A).	 The	 formation	 of	 conjugates	
was	 assessed	 in	 a	 conjugate	 assay	
(B)	and	the	detachment	from	K562	
target	 cells	 was	 analyzed	 in	 a	
detachment	 assay	 (C).	 Left	 panels	
show	 one	 representative	
experiment,	 right	 panels	 show	 the	
quantification	 of	 three	
independent	 experiments	with	 NK	
cells	 from	 three	 different	 donors	
(**p<0.01).	
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NK:K562	conjugates.	NK	cells	detached	clearly	 faster	 if	coincubated	with	H2O2	 treated	K562	 (Figure	
12C,	 left	 panel).	 The	 half-life	was	 significantly	 decreased	 and	 dropped	 from	 44.19	 ±	 9.77	minutes	
without	H2O2	to	24.86	±	8.52	minutes	with	H2O2	(Figure	12C,	right	panel).	These	results	show	that	NK	
cell	detachment	is	dependent	on	extrinsic	signals	from	the	target	cell.	NK	cell	independent	apoptosis	
of	 the	 target	 cell	 leads	 to	 alterations	 of	 the	 target	 cell,	 which	 are	 recognized	 by	 the	 NK	 cell	 and	
induce	detachment.		
The	immune	disorder	familial	hemophagocytic	 lymphohistiocytosis	2	(FHL-2)	is	characterized	by	the	
absence	of	perforin	 in	 cytotoxic	 lymphocytes	 (Janka,	 2012;	 Stepp	et	 al.,	 1999a).	 This	 results	 in	 the	
overproduction	of	inflammatory	cytokines	TNF-α	and	IFN-γ	and	a	prolonged	conjugation	time	of	the	
NK	 cells	 (Jenkins	 et	 al.,	 2015).	 I	 wanted	 to	 investigate,	 if	 NK	 cells	 show	 the	 same	 cytokine	
overproduction	if	they	are	treated	with	concanamycin	A	or	coincubated	with	NK	cell	resistant	K562	
transfectants.	 To	 boost	 the	 protective	 effect	 of	 SerpinB9	 and	 CD107a,	 I	 cotransfected	 K562	 with	
vectors	 for	 both	 proteins	 and	 sorted	 the	 cells	 to	 increase	 the	 amount	 of	 cells	 coexpressing	 both	
proteins.	 The	 newly	 transfected	 K562-SerpinB9-CD107a	 cells	 expressed	 clearly	more	 SerpinB9	 and	
CD107a	compared	to	K562	wildtype	cells	(Figure	13A).		
	
	
I	treated	cultured	primary	NK	cells	with	5	nM	concanamycin	A	to	prevent	the	maturation	of	perforin	
and	 reduce	 the	 cytotoxicity.	 I	 coincubated	 the	 NK	 cells	 with	 K562	 wildtype	 cells	 for	 16	 h	 and	
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Figure	13.	NK	cells	produce	more	of	
the	 cytokines	 TNF-α	 and	 IFN-γ	 if	
treated	 with	 concanamycin	 A	 or	
coincubated	 with	 K562-SerpinB9-
CD107a.	K562	 cells	were	 retrovirally	
transfected	 with	 SerpinB9	 and	
CD107a.	 K562	 wildtype	 cells	 (upper	
panels)	 and	 stably	 transfected	 cells	
(lower	 panels)	 were	 stained	with	 α-
SerpinB9	 or	 α-CD107a	 antibody.	
Grey	histograms	show	staining	of	the	
respective	cells	with	 IgG	antibody	as	
a	 control	 (A).	 Cultured	 primary	 NK	
cells	 were	 coincubated	 with	 K562	
cells	 over	 night	 and	 production	 of	
TNF-α	 (left	 panel)	 or	 IFN-γ	 (right	
panel)	 was	 assessed	 by	 ELISA.	 NK	
cells	 were	 either	 treated	 with	
concanamycin	A	(50	nM)	for	2	h	and	
coincubated	with	K562	wildtype	(wt,	
grey	 bar).	 Or	 untreated	 cultured	
primary	 NK	 cells	 were	 coincubated	
with	 K562-SerpinB9-CD107a	 cells	
(white	 bar).	 As	 a	 control,	 cultured	
primary	 NK	 cells	 were	 coincubated	
with	 K562	 wildtype	 cells	 (black	 bar)	
(B).	 Values	are	shown	as	mean	±	SD	
(*p<0.05).	
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measured	the	concentration	of	secreted	TNF-α	and	IFN-γ	in	the	supernatant.	I	found	the	secretion	of	
TNF-α	 to	 be	∼	 3.4	 fold	 increased	 if	 the	 NK	 cells	 were	 treated	 with	 concanamycin	 A	 compared	 to	
untreated	NK	cells.	Additionally,	the	amount	of	secreted	INFγ	was	more	than	4.5	fold	higher.	
In	a	second	approach	I	coincubated	untouched	cultured	primary	NK	cells	with	K562-SerpinB9-CD107a	
cells.	Notably,	the	cotransfection	with	SerpinB9	and	CD107a	reduced	the	NK	cell-mediated	killing	and	
delayed	the	detachment	similar	as	 I	 saw	with	K562	cells	overexpressing	only	one	of	 these	proteins	
(data	 not	 shown).	 But	 this	 effect	 was	 not	 boosted	 by	 the	 overexpression	 of	 both	 proteins.	 The	
coincubation	of	cultured	primary	NK	cells	with	K562-SerpinB9-CD107a	also	resulted	in	a	significantly	
higher	 production	 of	 TNF-α	 and	 IFN-γ.	 The	 secretion	 of	 TNF-α	 was	 increased	 by	 1.5	 fold	 and	 the	
secretion	 of	 IFN-γ	 by	∼	 2	 fold.	 These	 results	 show,	 that	 delayed	NK	 cell	 detachment	 increases	 the	
secretion	of	proinflammatory	cytokines	TNF-α	and	IFN-γ	(Figure	13B).	
4.4 Calcium	and	redox	signaling	are	important	second	messengers	for	NK	
cell	detachment	
Calcium	 is	 an	 important	 second	 messenger	 in	 all	 eukaryotic	 cells.	 In	 lymphocytes,	 calcium	 is	
responsible	for	many	cell	functions	like	proliferation	and	cytotoxicity.	NK	cells	get	stimulating	signals	
over	the	whole	period	of	conjugation.	I	wanted	to	analyze,	how	the	calcium	signal	changes	over	time.		
	
Figure	14.	The	calcium	signal	of	NK	cells	in	conjugates	is	increased	compared	to	free	NK	cells.	Cultured	primary	NK	cells	
were	coincubated	with	K562	target	cells	for	30	minutes	(E:T	=	1:2).	NK	cells	were	stained	with	calcium	binding	dye	fluo-8	
and	K562	cells	with	cell	tracker	orange	to	distinguish	between	free	NK	cells	and	K562	as	well	as	conjugates	(left	panel).	The	
calcium	signal	of	free	NK	cells	(red	line)	and	NK	cells	in	conjugates	(blue	line)	was	analyzed	over	10	minutes	(right	panel).	
NK	cells	were	stained	with	calcium	binding	dye	fluo-8	and	K562	with	cell	tracker	orange.	This	allowed	
me	to	distinguish	between	free	NK	cells,	free	K562	cells	and	conjugates	consisting	of	both	cell	types	
(Figure	 14,	 left	 panel).	 Similar	 to	 a	 detachment	 assay,	NK	 and	 K562	 cells	were	 coincubated	 for	 30	
minutes	to	form	conjugates	and	then	diluted	1:25.	Cells	were	divided	in	multiple	samples	and	rotated	
to	allow	NK	cells	to	detach.	All	samples	were	measured	in	succession,	each	for	4	minutes.	Using	this	
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approach,	 I	 can	analyze	 the	calcium	signal	 in	NK	cells,	which	have	been	 in	 conjugates	 for	different	
time	periods	and	combine	these	data	to	one	continuous	kinetic.		
Free	NK	cells,	stained	with	fluo-8,	showed	a	low	calcium	signal	(Figure	14,	red	line).	This	intracellular	
calcium	signal	was	constant	and	did	not	change	over	time.	In	contrast,	NK	cells	in	conjugates	showed	
a	 clearly	 increased	 calcium	 signal	 (Figure	 14,	 blue	 line).	 The	 calcium	 signal	was	 at	 any	 time	higher	
than	the	calcium	signal	from	free	NK	cells,	but	the	signal	decreased	over	time.	
In	the	next	step	I	wanted	to	analyze	the	effect	of	calcium	signaling	on	NK	cell	detachment,	which	has	
not	been	investigated	before.	In	our	flow	cytometry	system	it	is	not	possible	to	measure	the	calcium	
signal	of	a	 single	NK	cell	over	 the	 time	of	 conjugation	and	detachment.	Therefore,	 I	measured	 the	
calcium	level	of	the	whole	population	of	NK	cells	in	conjugates	over	time	as	described	for	Figure	14.		
	
Figure	 15.	 Decrement	 of	 the	 calcium	 signal	 of	 NK	 cells	 in	 conjugates	 is	 decelerated	 if	 NK	 cells	 are	 pretreated	 with	
concanamycin	A.	NK	 cells	were	pretreated	 for	 2	 h	with	 50	nM	 concanamycin	A	or	DMSO	as	 a	 control	 and	 stained	with	
calcium	binding	dye	fluo-8.	After	30	min	pre-coincubation,	detachment	was	analyzed	over	90	minutes.	Calcium	signal	of	NK	
cells	in	conjugates	was	plotted	against	the	time	and	regression	line	was	calculated	(top	panels).	Slope	of	calcium	signal	over	
time	for	DMSO	and	concanamycin	A	treated	NK	cells	is	illustrated	for	3	different	donors	(lower	panel)	(*p<0.05).	
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I	wanted	to	investigate	how	the	calcium	signal	in	NK	cells	changes	if	the	cells	were	unable	to	detach	
from	target	cells.	For	this,	I	treated	cultured	primary	NK	cells	for	2	h	with	50	nM	concanamycin	A	to	
prevent	 the	 maturation	 of	 perforin	 and	 thereby	 reduce	 the	 detachment	 (see	 Figure	 8).	 NK	 cells	
treated	with	DMSO	as	a	control,	showed	a	strong	calcium	signal	in	the	beginning	of	the	experiment.	
The	NK	 cells	measured	 later	during	 the	detachment	assay,	 showed	 lower	 calcium	 levels.	 I	 saw	 the	
same	effect	in	NK	cells	treated	with	concanamycin	A	(Figure	15,	upper	panels).	However,	the	calcium	
signal	 decreased	 less	 over	 time.	 Importantly,	 the	 curve	 shows	 changes	 of	 the	 mean	 fluorescence	
intensity	of	the	calcium	signal	from	the	NK	cell	population	in	conjugates	over	time.	From	these	data,	I	
could	calculate	a	regression	 line	and	estimate	the	slope	of	the	calcium	signal	 in	NK	cells	over	time.	
The	slope	of	the	calcium	signal	in	DMSO	treated	NK	cells	was	significantly	decreased	compared	to	NK	
cells	treated	with	concanamcin	A	(Figure	15,	lower	panel).	These	results	show,	that	the	calcium	signal	
in	NK	cells	is	maintained	if	the	NK	cells	cannot	kill	and	detach	from	the	target	cell.	
An	 important	 step	 for	 the	 formation	 of	 the	 immunological	 synapse	 is	 the	 binding	 of	 adhesion	
receptor	 αLβ2	 integrin	 (LFA-1)	 to	 its	 ligands	 Intercellular	 Adhesion	 Molecules	 (ICAMs).	 The	
adhesiveness	of	LFA-1	depends	on	its	conformation	state	and	clustering	and	is	controlled	by	inside-
out	signaling.	Activation	of	the	NK	cell	leads	to	increased	affinity	and	avidity	of	LFA-1.		
The	 question	 has	 been	 raised,	 if	 NK	 cells	 downregulate	 the	 activity	 of	 LFA-1	 after	 recognizing	 the	
target	cell	death	to	decrease	adhesion	and	force	detachment.	 I	performed	a	LCAA-Assay	to	analyze	
the	 activity	 of	 LFA-1	 by	 staining	 with	 antibody	 labeled	 ICAM-1-complexes	 and	 compared	 fresh	
unstimulated	 NK	 cells	 1)	 before	 conjugation	 2)	 in	 conjugates	 with	 a	 target	 cell	 and	 3)	 freshly	
detached	(Figure	16A).	ICAM-1	complexes	bind	to	the	activated	high	affinity	and	high	avidity	forms	of	
LFA-1.	To	stimulate	the	binding,	I	used	HeLa-CD48	as	target	cells.		
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Figure	 16.	 LFA-1	 activity	 is	 increased	 in	 freshly	 detached	 NK	 cells	 compared	 to	 NK	 cells	 in	 conjugates.	NK	 cells	 were	
coincubated	with	adherent	HeLa-CD48	target	cells	for	30	minutes	in	the	presence	of	ICAM-1-Fc	complexes.	NK	cells,	which	
have	 not	 been	 attached	 in	 the	 next	 30	minutes,	 were	 fixed	 and	 the	 NK	 cells	 in	 conjugates	 incubated	 for	 additional	 30	
minutes.	In	the	end,	freshly	detached	NK	cells	and	NK	cells	in	conjugates	were	fixed	(A).	The	number	of	ICAM-1-Fc	positive	
NK	cells	and	the	MFI	is	quantified	for	2	independent	experiments.	Values	are	shown	as	mean	±	SD	(B).	
NK	cells,	which	had	not	formed	a	conjugate	in	the	first	30	minutes	of	coincubation	with	HeLa-CD48	
cells,	had	 the	 lowest	 LFA-1	activity.	The	 ICAM-1	complexes	bound	only	 to	2.32	±	0.34	%	of	 the	NK	
cells.	But	I	can’t	exclude,	that	those	NK	cells	have	been	in	contact	with	a	target	cell	in	the	30	minutes	
before	 and	 detached	 really	 fast.	 NK	 cells,	 which	 were	 in	 a	 conjugate	 showed	 an	 increased	 LFA-1	
activity.	3.48	±	2.47	%	of	the	NK	cells	bound	the	ICAM-1	complexes.	The	mean	fluorescence	intensity	
(MFI)	 can	 be	 used	 to	 compare	 the	 overall	 amount	 of	 ICAM-1	 complexes	 bound	 to	 the	 cells.	 I	
measured	 the	MFI	of	 all	NK	 cells	 in	 the	 three	 samples.	 This	 value	was	moderately	 increased	 in	NK	
cells	 in	conjugates	(79.57	±	24.33)	compared	to	free	NK	cells	(48.97	±	28.36).	 Interestingly,	NK	cells	
which	 have	 been	 in	 a	 conjugate	 after	 30	minutes	 coincubation	 and	 detached	 in	 the	 following	 30	
minutes,	showed	the	highest	LFA-1	activity.	5.82	±	1.88	%	of	the	cells	bound	ICAM-1	complexes.	The	
MFI	was	5-fold	higher	compared	with	free	NK	cells.	The	results	show	that	NK	cells	increase	the	LFA-1	
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affinity	 and	 avidity	 after	 activation	 and	 binding	 to	 a	 target	 cell.	 But	 differently	 than	 expected,	 the	
freshly	detached	NK	cells	displayed	a	higher	LFA-1	activity	than	NK	cells	in	conjugates	(Figure	16B).	
In	 the	 next	 step,	 I	 wanted	 to	 further	 investigate	 the	 effect	 of	 calcium	 signaling	 on	 NK	 cell	
detachment.	I	used	the	drug	Thapsigargin	to	manipulate	intracellular	calcium	levels	and	analyzed	the	
effect	 on	 conjugate	 formation,	 cytotoxicity,	 degranulation	 and	 the	 detachment	 from	 K562	 target	
cells.	Thapsigargin	interrupts	calcium	homeostasis	by	inhibition	of	the	Sarco-Endoplasmic	Reticulum	
Ca2+	ATPase	(SERCA)	(Thastrup	et	al.,	1990).	This	blocks	the	transport	from	cytosolic	calcium	into	the	
ER	and	therefore	quickly	increases	the	cytosolic	calcium	concentration.	
	
Examining	the	effect	of	artificially	induced	high	cytosolic	calcium	level,	I	treated	cultured	primary	NK	
cells	directly	before	coincubation	with	K562	target	cells	with	10	µM	Thapsigargin	and	analyzed	the	
impact	on	the	formation	of	conjugates.	I	could	not	observe	any	changes	in	the	adhesion	of	NK	cells	to	
K562	cells	after	Thapsigargin	treatment	compared	to	DMSO	treated	NK	cells	(Figure	17A).	In	contrast,	
the	rise	of	cytosolic	calcium	levels	by	Thapsigargin	abolished	the	cytotoxicity	completely.	After	a	4	h	
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Figure	 17.	 NK	 cell	 detachment	 is	 accelerated	
and	 killing	 is	 abolished	 after	 treatment	 with	
Thapsigargin.	NK	cells	were	treated	with	10	µM	
Thapsigargin	directly	 before	 coincubation	with	
K562	 target	 cells	 and	 the	 formation	 of	
conjugates	was	 analyzed	 in	 a	 conjugate	 assay.	
Left	 panel	 shows	 one	 representative	
experiment	 and	 the	 right	 panel	 the	
quantification	 of	 NK	 cells	 from	 three	 different	
donors	 (A).	 The	 cytotoxicity	was	 analyzed	 in	 a	
standard	 Chromium-51	 release	 assay	 (One	
representative	 experiment	 from	 three	
independent	 experiments)	 (B).	 The	
degranulation	 was	 measured	 in	 a	 CD107a-
Assay	 after	 2	 h	 coincubation	 (mean	 ±	 SD	 of	
three	 independent	 experiments)	 (C).	 The	
detachment	of	 preformed	NK:K562	 conjugates	
was	 assessed	 in	 a	 detachment	 assay.	
Thapsigargin	was	 added	 directly	 after	 dilution	
of	 conjugates.	 Left	 panel	 shows	 one	
representative	 experiment	 and	 the	 right	 panel	
the	 quantification	 of	 NK	 cells	 from	 three	
different	donors	(*p<0.05)	(D).		
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Chromium-51	release	assay,	hardly	any	target	cells	have	been	lysed	(Figure	17B).	Notably,	this	was	a	
long-term	effect.	I	used	a	16	h	Chromium-51	release	assay	with	very	low	NK	to	K562	ratios	to	monitor	
serial	 killing.	 Even	 in	 this	 16	 h	 assay,	 NK	 cells	 totally	 lost	 the	 ability	 to	 lyse	 target	 cells	 (data	 not	
shown).	 In	 order	 to	 find	 the	 reason	 for	 this	 defect	 in	 cytotoxic	 capability,	 I	 tested	 if	 the	 cells	
degranulate	after	binding	a	 target	 cell,	 but	 I	 could	not	 find	any	difference	 in	NK	 cells	 treated	with	
Thapsigargin	 or	 with	 DMSO	 as	 a	 control	 (Figure	 17C).	 Finally,	 analyzing	 the	 NK	 cell	 detachment,	 I	
found	 NK	 cells	 to	 detach	 significantly	 earlier	 after	 treatment	 with	 Thapsigargin.	 The	 half-life	 was	
reduced	from	64.24	±	21.48	minutes	to	24.09	±	11.47	minutes	(Figure	17D).	These	results	show,	that	
NK	cells	need	calcium	homeostasis	for	conjugate	maintenance.	Disruption	of	this	homeostasis	leads	
to	decay	of	the	conjugate	and	abolishes	the	NK	cell	cytotoxicity.	
Another	possibility	to	raise	intracellular	calcium	concentration	is	the	use	of	the	ionophore	Ionomycin.	
Ionomycin	can	transport	calcium	ions	freely	across	the	cell	membrane,	which	allows	ions	to	diffuse	
into	 the	 cytosol.	 I	 tested	 the	 effect	 of	 Ionomycin	 on	 NK	 cell	 effector	 functions	 as	 described	 for	
Thapsigargin	in	Figure	18.	
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Similar	to	the	treatment	with	Thapsigargin,	the	addition	of	1.3	mM	Ionomycin	did	not	have	any	effect	
on	 the	 formation	 of	 conjugates.	 After	 40	 minutes	 ∼	 20	 %	 of	 both	 Ionomycin	 but	 also	 the	 DMSO	
treated	NK	cells	formed	conjugates	with	K562	target	cells	(Figure	18A).	The	specific	lysis	of	K562	cells	
in	a	4	h	Chromium-51	release	assay	was	slightly	reduced	in	the	presence	of	Ionomycin	(Figure	18B).	
But	 this	 effect	was	 less	 stable	 compared	with	 the	 Thapsigargin	 treatment.	 In	 a	 16	h	Chromium-51	
release	assay,	I	found	no	difference	in	the	specific	lysis	of	K562	cells	between	Ionomycin	treated	and	
untreated	NK	cells	(data	not	shown).	Romera-Cardenas	et	al.	reported,	that	after	16	h	treatment	with	
Ionomycin,	 NK	 cells	 became	 hyporesponsive	 and	 showed	 a	 clear	 reduction	 in	 the	 ability	 to	
degranulate.	Nevertheless,	after	2	h	I	found	NK	cells	to	degranulate	more	in	response	to	K562	cells	if	
they	 had	 been	 treated	 with	 Ionomycin	 compared	 to	 DMSO	 control	 (Figure	 18C).	 It	 has	 to	 be	
investigated,	if	the	secretion	of	lytic	granules	was	directed	towards	the	target	cell	or	if	Ionomycin	just	
stimulated	 the	 undirected	 secretion	 of	 lytic	 granules.	 An	 explanation	 for	 the	 reduced	 cytotoxicity	
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Figure	 18.	 Treatment	 with	 calcium	
ionophore	 Ionomycin	 accelerates	
detachment	 but	 reduces	 cytotoxicity.	 NK	
cells	 were	 treated	 with	 1.3	 mM	 Ionomycin	
directly	 before	 coincubation	 with	 K562	
target	 cells	and	the	 formation	of	conjugates	
was	 analyzed	 in	 a	 conjugate	 assay.	 Left	
panels	 show	one	 representative	 experiment	
and	 right	 panels	 the	 quantification	 of	 NK	
cells	 from	 three	 different	 donors	 (A).	 The	
cytotoxicity	 was	 analyzed	 in	 a	 standard	
Chromium-51	 release	 assay	 (One	
representative	experiment	out	of	 three)	 (B).	
The	 degranulation	 was	 measured	 in	 a	
CD107a-Assay	 after	 2	 h	 coincubation.	 Three	
independent	 experiments	 are	 quantified.	
Values	 are	 shown	 as	 mean	 ±	 SD	 (*p<0.05)	
(C).	 The	 detachment	 of	 preformed	NK:K562	
conjugates	 was	 assessed	 in	 a	 detachment	
assay.	 Ionomycin	 was	 added	 directly	 after	
dilution	of	 the	 conjugates.	 Left	 panel	shows	
one	representative	experiment	and	the	right	
panel	 the	 quantification	 of	 NK	 cells	 from	
three	different	donors	(*p<0.05)	(D).		
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could	 be	 a	 strong	 acceleration	 in	 the	NK	 cell	 detachment.	 If	 Ionomycin	was	 added	 at	 the	 point	 of	
dilution,	NK:K562	conjugates	decayed	very	fast	compared	to	DMSO	treated	control	samples	(Figure	
18D).	 Ionomycin	 significantly	 reduced	 the	 half-life	 from	 40.58	 ±	 9.37	 minutes	 to	 20.44	 ±	 10.11	
minutes.	 These	 results	 demonstrate,	 that	 calcium	 is	 an	 important	 signaling	 molecule	 for	 NK	 cell	
effector	functions.	Manipulating	the	calcium	levels	by	treatment	with	calcium	ionophore	Ionomycin	
has	a	large	impact	on	the	maintenance	of	NK	conjugates	and	reduces	the	stability	clearly.		
Besides	 calcium	 signaling,	 many	 intracellular	 proteins	 are	 regulated	 by	 redox	 signaling.	 Mainly	
NADPH	oxidases	produce	ROS,	which	oxidize	and	thereby	activate	or	inhibit	other	molecules	(Ushio-
Fukai,	2006).	NK	cell	effector	functions	are	known	to	be	influenced	by	redox	signaling.	For	example,	
the	 activity	 of	 transcription	 factor	NFκB	 is	 among	 others	 dependent	 on	 ROS	 (Stottmeier	 and	Dick,	
2016).	 I	 wanted	 to	 investigate	 if	 redox	 signaling	 is	 also	 important	 for	 NK	 cell	 detachment	 and	
maintenance	of	NK:K562	 conjugates	 and	NK	 cell	 cytotoxicity.	 Therefore	 I	 treated	NK	 cells	with	 the	
antioxidant	 N-acetylcysteine,	 which	 reduces	 ROS	 and	 thereby	 manipulates	 intracellular	 redox	
signaling.	
	 	
	54	
	
The	addition	of	5	mM	N-Acetylcysteine	at	the	point	of	coincubation	did	not	lead	to	differences	in	the	
formation	of	conjugates	(Figure	19A,	left	panel).	Quantification	of	the	percentage	of	conjugates	after	
40	minutes	 showed,	 that	 the	 treatment	 with	 N-Acetylcysteine	 has	 no	 significant	 influence	 on	 the	
formation	of	conjugates	(Figure	19A,	right	panel).	But	I	could	reveal,	that	N-Acetylcysteine	had	a	little	
effect	on	NK	cell	cytotoxicity.	The	killing	of	K562	target	cells	was	slightly	decreased	 in	a	4	h	(Figure	
19B)	 and	 a	 16	 h	 Chromium-51	 release	 assay	 (data	 not	 shown).	 I	 also	 saw	 the	 trend	 that	 N-
Acetylcysteine	 reduces	 the	 ability	 of	NK	 cells	 to	 degranulate	 after	 contact	with	 target	 cells	 (Figure	
19C).	 Applied	 in	 a	 detachment	 assay,	 N-Acetylcysteine	 clearly	 accelerated	 the	NK	 cell	 detachment	
(Figure	19D).	This	led	to	a	significantly	reduced	half-life	of	NK:K562	conjugates	in	the	presence	of	N-
Acetylcysteine	and	could	explain	the	decreased	cytotoxicity.	These	results	show,	that	redox	signaling	
is	also	involved	in	the	maintenance	of	NK	cell	conjugates	and	manipulation	of	the	intracellular	redox	
milieu	can	decrease	NK	cell	effector	functions.	 	
Un
tre
ate
d
N-
Ac
etl
yc
ys
tei
ne
 5 
mM
0
20
40
60
t 1
/2
 [m
in
]
**
Detachment from Conjugates
0 20 40 60 80 100
0
25
50
75
100
125
Time [min]
%
 R
em
ai
ni
ng
 C
on
ju
ga
te
s
Formation of Conjugates
0 20 40 60 80 100
0
5
10
15
20
25
30
Time [min]
%
 N
K
 C
el
ls
 in
 C
on
ju
ga
te
s
Un
tre
ate
d
N-
Ac
etl
yc
ys
tei
ne
 5 
mM
0
5
10
15
20
25
30
%
 N
K
 C
el
ls
 in
 C
on
ju
ga
te
s
 [a
fte
r 4
0 
m
in
]
A
B C
D
Cytotoxicity 
1,25:1 2,5:1 5:1 10:1
50
60
70
80
90
100
%
 s
pe
c.
 L
ys
is
E:T
DMSO
N-Acetlycysteine 5 mM
Degranulation
Ct
rl
N-
Ac
etl
yc
ys
tei
ne
 5 
mM
0
10
20
30
40
50
C
D
10
7a
+ 
N
K
 C
el
ls
Figure	 19.	 Treatment	 with	 antioxidant	 N-
Acetylcysteine	has	a	slight	effect	on	killing	and	
decreases	 NK:K562	 conjugate	 stability.	 NK	
cells	were	treated	with	5	mM	N-Acetylcysteine	
directly	 before	 coincubation	 with	 K562	 target	
cells	 and	 the	 formation	 of	 conjugates	 was	
analyzed	in	a	conjugate	assay.	Left	panel	shows	
one	 representative	 experiment	 and	 the	 right	
panel	the	quantification	of	NK	cells	 from	three	
different	 donors	 (A).	 The	 cytotoxicity	 was	
analyzed	 in	 a	 standard	 Chromium-51	 release	
assay	 (One	 representative	 experiment	 from	
three	 independent	 experiments)	 (B).	 The	
degranulation	 was	 measured	 in	 a	 CD107a-
Assay	 after	 2	 h	 coincubation.	 Three	
independent	 experiments	 are	 quantified	 (C).	
The	 detachment	 of	 preformed	 NK:K562	
conjugates	 was	 assessed	 in	 a	 detachment	
assay.	 N-Acetylcysteine	 was	 added	 directly	
after	 dilution	 of	 conjugates.	 Left	 panel	 shows	
one	 representative	 experiment	 and	 the	 right	
panel	the	quantification	of	NK	cells	 from	three	
different	donors	(**p<0.01)	(D)	
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4.5 Influence	of	the	inhibiting	receptor	CD300a	on	NK	cell	detachment	
So	far,	the	depicted	results	show	that	NK	cells	are	able	to	detect	the	target	cell	death	and	react	by	
immediate	 detachment.	 In	 order	 to	 find	 the	mechanism	 how	NK	 cells	 recognize	 the	 death	 of	 the	
target	cell,	several	possibilities	have	to	be	considered.	The	existence	of	a	special	NK	cell	receptor	that	
can	 identify	 and	 bind	 damage	 associated	 molecular	 patterns	 (DAMPs)	 and	 inhibit	 the	 NK	 cell	
functions	 is	 one	 possible	mechanism.	 Cantoni	 et	 al.	 reported,	 that	 the	NK	 cell	 receptor	 CD300a	 is	
expressed	on	all	NK	cells	and	has	inhibitory	functions	through	intracellular	ITIM	motifs	(Cantoni	et	al.,	
1999).	This	receptor	can	bind	to	phosphatidylserine	(Nakahashi-Oda	et	al.,	2012),	a	lipid	that	is	only	
present	on	the	cell	surface	of	apoptotic	cells.	The	 ligation	of	CD300a	with	PS	 leads	to	an	 inhibitory	
signal	and	reduces	NK	cell	cytotoxicity	(Lankry	et	al.,	2013).	
	
	
	
I	 tested	 if	 the	 interaction	 of	 CD300a	 and	 its	 ligand	 phosphatidylserine	 has	 any	 effect	 on	 NK	 cell	
detachment	 and	 cytotoxicity	 by	 blocking	 with	 MFG-E8.	 MFG-E8	 binds	 to	 phosphatidylserine	 and	
prevents	 the	 ligation	 with	 CD300a	 (Lankry	 et	 al.,	 2013).	 To	 investigate	 the	 effect	 on	 NK	 cell	
detachment,	 I	diluted	preformed	NK:K562	conjugates	with	medium	and	added	1	µg/ml	MFG-E8	or	
BSA	as	a	control.	I	analyzed	the	amount	of	NK	cells	in	conjugates	after	0	and	40	minutes.	The	result	
for	0	minutes	sample	was	set	to	100	%	and	the	40	minutes	time-point	was	normalized.	 I	could	not	
find	 any	 significant	 differences	 in	 the	 detachment	 after	 treatment	 with	 MFG-E8	 (Figure	 20,	 left	
panel).	Also	I	could	not	find	a	reduced	ability	to	kill	K562	target	cells,	if	1	µg/ml	MFG-E8	was	added	in	
a	standard	4	h	Chromium-51	release	assay	(Figure	20,	right	panel).	This	indicates,	that	the	interaction	
of	inhibitory	receptor	CD300a	and	phosphatidylserine	has	no	effect	on	NK	cell	detachment.	
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Figure	 20.	 Blocking	 of	 CD300a-
phosphatidylserine	 interaction	 has	 no	
effect	 on	 the	 cytotoxicity	 or	
detachment	 of	 NK	 cells.	 Cultured	
primary	NK	cells	were	coincubated	with	
K562	 target	 cells	 for	 30	 minutes.	
Directly	after	dilution	10	µg/ml	MFG-E8	
was	 added	 to	 the	 cells	 and	 the	
detachment	 was	 analyzed	 after	 40	
minutes	 (left	 panel).	 The	 cytotoxicity	
was	analyzed	after	addition	of	10	µg/ml	
MFG-E8	 in	 a	 standard	 Chromium-51	
release	 assay	 (right	 panel,	 n=1)	 ns=not	
significant.	
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4.6 The	effect	of	soluble	factors	on	NK	cell	effector	functions	
Another	possibility	I	considered	was	the	influence	of	soluble	factors,	which	are	secreted	by	the	dying	
target	cell	and	 influence	the	NK	cell	 functions.	 It	 is	well	known	that	cells	shed	surface	proteins	and	
secrete	apoptotic	vesicles	in	the	process	of	apoptosis.	I	wanted	to	investigate,	if	NK	cells	sense	these	
proteins	 or	 vesicles	 and	 use	 them	 as	 an	 indicator	 of	 target	 cell	 death	 to	 initiate	 the	 process	 of	
detachment.	
	
Figure	21.	Dead	cell	supernatant	decreases	the	cytotoxicity	of	NK	cells	in	a	16	h	serial	killing	assay.	Dead	cell	supernatant	
was	created	by	killing	of	3x106	HEK293T	/	ml	by	heat	shock	over	two	days	and	discarding	the	dead	cells	by	centrifugation.	
NK	 cells	 and	 K562	 target	 cells	were	 coincubated	 in	 the	 dead	 cell	 supernatant	 in	 a	 standard	 4	 h	 and	 a	 16	 h	 serial	 killing	
Chromium-51	 release	 assay	 (A).	 The	 cytotoxicity	 at	 the	 E:T	 1.25:1	 (	 4	 h	 assay)	 and	 1:1	 (16	 h	 assay)	 for	 four	 different	
experiments	with	different	NK	cell	donors	was	quantified	and	normalized	to	100	%	to	control.	Values	are	shown	as	mean	±	
SD	(ns=not	significant;	***p<0.001)	(B).	
To	 investigate	 the	 influence	 of	 soluble	 proteins,	 vesicles	 or	 other	 molecules	 on	 NK	 cell	 effector	
functions,	I	produced	so-called	dead	cell	supernatant	(DCS).	I	induced	apoptosis	in	K562	or	HEK293T	
cells	by	a	short	heat	shock,	let	them	die	slowly	over	2	days	and	collected	the	supernatant.	In	this	DCS	
NK	cells	were	coincubated	with	new	K562	target	cells	and	their	effector	functions	were	tested	in	the	
respective	assays.	
At	first,	 I	performed	Chromium-51	release	assays	to	test	the	cytotoxicity	of	NK	cells	 in	DCS	or	fresh	
medium	as	a	control.	After	4	h	coincubation	with	K562	cells,	cultured	primary	NK	cells	killed	slightly	
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less	 target	 cells	 if	 coincubated	 in	 DCS	 than	 in	 fresh	 medium	 (Figure	 21A,	 left	 panel).	 But	 these	
variations	were	small	and	did	not	reach	significance	(Figure	21B).	 In	contrast,	 in	a	16	h	serial	killing	
assay	 NK	 cells	 killed	 clearly	 fewer	 target	 cells	 if	 coincubated	 in	 DCS	 compared	 to	 fresh	 medium	
(Figure	 21A,	 right	 panel).	 The	 combination	 of	 4	 individual	 experiments	 showed,	 that	 those	
differences	were	significant	and	the	cytotoxicity	was	reduced	to	56.77	±	26.90	%	of	the	fresh	medium	
control	(Figure	21B).	These	data	indicate,	that	cells	secrete	or	lose	proteins,	molecules	or	vesicles	in	
the	process	of	dying.	They	seem	to	influence	NK	cells	and	reduce	the	ability	to	kill	multiple	targets	in	
a	row.	
	
To	further	analyze	the	effect	of	dead	cell	supernatant	on	NK	cells,	I	investigated	the	ability	of	NK	cells	
to	form	conjugates,	degranulate	or	detach	 in	the	presence	of	DCS	compared	to	fresh	medium.	The	
coincubation	of	cultured	primary	NK	cells	and	K562	target	cells	in	DCS	had	no	effect	on	the	formation	
of	conjugates	in	the	first	60	minutes	(Figure	22A).	The	percentage	of	conjugates	was	comparable	to	
NK	cells,	which	have	been	coincubated	with	K562	in	fresh	medium.	The	degranulation	of	NK	cells	was	
also	not	 influenced	by	DCS.	NK	cells,	which	have	been	coincubated	with	K562	cells	and	afterwards	
stained	for	the	degranulation	marker	CD107a,	showed	a	similar	percentage	of	CD107a	positive	cells.	
The	mean	for	CD107a+	NK	cells	was	29.19	±	29.53	%	for	dead	cell	supernatant	and	25.10	±	22.86	%	
for	 fresh	medium	 (Figure	 22B).	 Finally,	 I	 investigated	 if	DCS	 influences	 the	NK	 cell	 detachment.	As	
additional	control,	I	collected	the	supernatant	from	target	cells	incubated	for	2	days	in	fresh	medium	
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Detachment C 
B Figure	 22.	 Dead	 cell	 supernatant	 has	 no	
effect	on	 the	 formation	of	 conjugates	or	
degranulation	 but	 accelerates	 the	
detachment	of	NK	cells.	NK	cells	and	K562	
target	 cells	were	coincubated	 in	dead	cell	
supernatant	 and	 the	 formation	 of	
conjugates	 was	 analyzed	 in	 a	 conjugate	
assay.	One	representative	experiment	out	
of	 three	 independent	 experiments	 is	
shown	 (A).	 After	 2	 h	 coincubation,	 the	
degranulation	 was	 assessed	 by	 staining	
with	 α-CD107a.	 Results	 from	 three	
independent	 experiments	 are	 quantified.	
Values	 are	 shown	 as	 mean	 ±	 SD	 (B).	
Preformed	 NK:K562	 conjugates	 were	
diluted	 in	 dead	 cell	 supernatant	 in	 a	
detachment	 assay.	 Left	 panel	 shows	 one	
representative	experiment,	right	panel	the	
quantification	 of	 5	 independent	
experiments	 with	 NK	 cells	 from	 different	
donors.	 Values	 are	 shown	 as	 mean	 ±	 SD	
(*p<0.05)	(C).		
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without	a	prior	heat	shock	(living	cell	supernatant	=	LCS).	After	2	days	incubation	the	viability	of	the	
K562	cells	was	below	20%	for	DCS	and	above	80%	for	LCS	(data	not	shown).	In	a	detachment	assay	I	
coincubated	NK	and	K562	cells	 in	 fresh	medium	to	 form	conjugates	under	 identical	 conditions	and	
afterwards	used	the	DCS,	LCS	or	fresh	medium	to	dilute	the	cells.	The	detachment	of	NK	cells,	which	
have	been	diluted	in	DCS	was	slightly	accelerated	compared	to	LCS	or	fresh	medium	(Figure	22C,	left	
panel).	 Also	 the	 half-life	 was	 significantly	 reduced.	 The	 coincubation	 in	 fresh	 medium	 led	 to	 a	
conjugate	half-life	of	41.51	±	8.43	minutes	and	was	reduced	to	35.65	±	3.65	minutes	if	the	cells	were	
diluted	in	LCS.	The	use	of	DCS	significantly	decreased	the	half-life	even	more	to	32.17	±	5.83	minutes.	
These	 data	 indicate,	 that	 proteins,	molecules	 or	 vesicles,	which	 have	 been	 secreted	 by	 dying	 cells	
also	influence	the	detachment	of	NK	cells.		
I	tried	to	identify	the	proteins,	molecules	or	vesicles	that	are	responsible	for	this	effect.	To	analyze	if	
apoptotic	bodies	caused	the	observed	accelerated	detachment,	 I	 isolated	all	vesicles	of	 the	DCS	by	
centrifugation	(16,000	xg,	30	minutes).	NK	cells	were	treated	with	isolated	apoptotic	bodies	in	fresh	
media	 or	 with	 the	 vesicle	 free	 supernatant.	 But	 I	 could	 not	 find	 any	 differences	 in	 the	 NK	 cell	
detachment	if	coincubated	with	or	without	apoptotic	bodies	(data	not	shown).	Another	theory	was	
that	NK	cells	take	up	DNA	fragments,	which	have	been	released	by	the	target	cell	 in	the	process	of	
dying.	 Intracellular	NK	cell	 receptors	 could	bind	 the	 target	 cell	DNA	and	 sense	an	 inhibitory	 signal,	
which	reduces	the	NK	cell	activity	and	forces	the	detachment.	To	investigate	this	possibility,	I	treated	
DCS	with	1	mg/ml	DNase	I	to	remove	any	free	DNA.	The	coincubation	in	medium	with	or	without	free	
DNA	 had	 also	 no	 effect	 on	 the	 NK	 cell	 detachment	 (data	 not	 shown).	 These	 data	 indicate,	 that	
neither	 apoptotic	 bodies	 nor	 free	 DNA	 are	 responsible	 for	 the	 observed	 reduced	 cytotoxicity	 and	
accelerated	detachment	of	NK	cells	in	DCS.	
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4.7 NK	cell-mediated	loss	of	target	cell	adhesion	molecules	and	ligands	for	
activating	NK	cell	receptors	during	target	cell	death	
An	 important	 factor	 to	maintain	 the	NK:target	 cell	 conjugate	 is	 the	binding	of	NK	cell	 receptors	 to	
their	 ligands	 on	 the	 target	 cell.	 The	 constant	 delivery	 of	 an	 activating	 signal	 leads	 to	 the	 ongoing	
secretion	of	cytotoxic	granules,	which	in	the	end	induces	apoptosis	in	the	target	cell.	I	examined	the	
possibility	that	apoptosis	of	the	target	cell	 leads	to	changes	in	the	protein	compisition	of	the	target	
cell	surface.	If	ligands	for	activating	NK	cell	receptors	are	lost,	this	could	decrease	the	NK	cell	activity	
and	accelerate	the	conjugate	decay.	
	
Figure	23.	K562	target	cells	lose	activating	NK	cell	ligand	B7H6	after	NK	cell-mediated	killing.	NK	cells	and	K562	target	cells	
were	coincubated	for	2	h	and	stained	with	 life/dead	marker	Zombie-aqua.	Afterwards,	cells	were	stained	with	antibodies	
against	ligands	for	activating	NK	cell	receptors	MICA,	MICB,	B7H6,	Nectin-2,	ULBP1	and	ULBP2.	Expression	of	the	indicated	
proteins	 on	 living	 and	 dead	 K562	 cells	 was	 analyzed.	 Histograms	 from	 one	 representative	 experiment	 are	 shown	 (A).	
Percent	positive	cells	 (B)	and	the	Mean	fluorescence	 intensity	 (MFI)	 (C)	 is	quantified	 for	 three	 independent	experiments.	
Values	are	shown	as	mean	±	SD	(*p<0.05;	***p<0.001).	
To	investigate	the	expression	profile	of	ligands	for	activating	NK	cell	receptors,	I	coincubated	NK	and	
K562	cells.	After	2	h	I	stained	the	cells	with	a	live/dead	marker	and	antibodies	against	ligands	for	the	
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activating	 NK	 cell	 receptors	 NKG2D	 (MICA,	 MICB,	 ULBP1,	 ULBP2),	 NKp30	 (B7H6)	 and	 DNAM-1	
(Nectin-2),	 which	 are	 known	 to	 be	 expressed	 by	 K562	 cells.	 Using	 this	 staining	 strategy,	 I	 could	
distinguish	 between	 K562	 cells	 that	 were	 alive	 or	 have	 been	 killed	 by	 NK	 cells	 and	 analyze	 the	
expression	of	the	indicated	proteins.	I	evaluated	the	percentage	of	positive	cells	(Figure	23B)	and	the	
mean	fluorescence	intensity	(MFI)	(Figure	23C),	which	gives	a	relative	value	for	the	expression	level	
of	the	antigens	on	the	cell.		
The	NKG2D	ligands	MICA,	MICB,	ULBP1	and	ULBP2	were	all	expressed	by	the	K562	cells	(Figure	23A).	
After	2	h	coincubation,	the	NKG2D	ligands	were	expressed	in	average	by	19.51	±	5.58	%	of	the	living	
K562	 cells	 (Figure	 23B).	 The	 killed	 K562	 cells	 showed	 no	 significant	 differences	 in	 the	 expression	
MICA,	MICB,	ULBP1	and	ULBP2	(in	average	16.08	±	9.91	%).	The	MFI	of	the	NKG2D	ligands	was	also	
unaltered,	which	showed	that	K562	did	not	lose	or	gain	NKG2D	ligands	after	cell	death	(Figure	23C).	
In	 contrast,	 Nectin-2	 was	 expressed	 by	 the	 majority	 of	 living	 K562	 cells	 and	 this	 number	 did	 not	
change	 if	 they	 have	 been	 killed	 by	 NK	 cells.	 Interestingly,	 the	MFI	 of	 Nectin-2	 increases	 after	 cell	
death	(Figure	23C).	The	NKp30	ligand	B7H6	was	also	expressed	by	a	majority	of	the	living	K562	cells.	
After	 the	cells	have	been	killed,	most	of	 them	 lost	B7H6.	The	 results	 indicate,	 that	 target	 cells	 can	
lose	ligands	for	activating	NK	cell	receptors	in	the	process	of	NK	cell-mediated	apoptosis.	
Besides	ligands	for	activating	and	inhibitory	receptors,	NK	cells	interact	with	adhesion	molecules	on	
the	 target	 cell.	 Adhesion	 receptors	 on	 the	 NK	 cell	 surface	 bind	 to	 their	 ligands	 on	 the	 target	 cell	
membrane,	which	 results	 in	 a	 firm	conjugate.	 This	 ligation	 is	maintained	during	 the	whole	 time	of	
conjugation.	 In	 order	 to	 investigate,	 if	 target	 cells	 lose	 adhesion	 molecules	 after	 NK	 cell	 induced	
apoptosis,	I	compared	the	adhesion	molecules	on	living	and	dead	K562	cells.	I	used	the	same	staining	
strategy	 like	 in	 Figure	 23.	 NK	 and	 K562	 cells	 were	 coincubated	 and	 afterwards	 stained	 with	 a	
live/dead	 marker	 and	 antibodies	 against	 several	 adhesion	 molecules:	 CD15	 (Lewis	 X.),	 CD54	
(Intercellular	Adhesion	Molecule	1,	 ICAM-1),	CD58	(Lymphocyte	function-associated	antigen	3,	LFA-
3),	CD59	(MAC-inhibitory	protein),	CD62E	(E-Selectin)	and	CD102	(ICAM-2).		
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Figure	24.	After	killing	by	NK	cells,	K562	target	cells	lose	a	broad	range	of	adhesion	molecules.	NK	cells	and	K562	target	
cells	 were	 coincubated	 for	 2	 h	 and	 stained	 with	 life/dead	 marker	 Zombie-aqua.	 Afterwards,	 cells	 were	 stained	 with	
antibodies	against	adhesion	molecules	CD15,	CD54,	CD58,	CD59,	CD62E	and	CD102.	Expression	of	the	indicated	proteins	on	
living	and	dead	K562	cells	was	analyzed.	Histograms	from	one	representative	experiment	are	shown	(A).	Percent	positive	
cells	(B)	and	the	MFI	(C)	are	quantified	for	three	independent	experiments.	Values	are	shown	as	mean	±	SD	(*p<0.05).	
All	 adhesion	 molecules	 were	 expressed	 to	 a	 similar	 level	 on	 the	 cell	 surface	 of	 living	 K562	 cells	
(Figure	24A).	But	after	2	h	coincubation	the	tested	adhesion	molecules	have	been	clearly	reduced	on	
the	cell	surface	of	killed	K562	cells.	On	average,	∼	60	%	of	the	living	K562	cells	were	positive	for	each	
of	 the	adhesion	molecules.	After	 the	NK	cells	have	killed	the	cells,	about	 two-third	of	 the	cells	 lost	
expression	of	the	tested	adhesion	proteins	(Figure	24B).	Analyzing	the	MFI	of	the	adhesion	proteins	
before	and	after	cell	death,	it	became	clear	that	also	the	average	expression	level	of	these	molecules	
is	 reduced	 on	 dead	 K562	 (Figure	 24C).	 These	 results	 show,	 that	 K562	 cells	 lose	 many	 of	 their	
adhesion	molecules	during	NK	cell-mediated	killing.	Thereby	the	adherence	between	NK	and	target	
cell	is	reduced,	the	detachment	is	accelerated.	
	
A 
B C 
K562 alive 
K562 dead 
IgG 
CD15 CD54
CD59 CD102
CD58
CD62E
M
FI
CD
15
CD
54
CD
58
CD
59
CD
62
E
CD
10
2
0
2000
4000
6000
*
* *
*
CD
15
CD
54
CD
58
CD
59
CD
62
E
CD
10
2
0
20
40
60
80
100
%
 p
os
itv
e 
ce
lls
* * **
	62	
	 	
	 	 	 63	
5 Discussion	
5.1 Influence	 of	 cytokine-induced	 pre-activation	 on	 NK	 cell	 effector	
functions	
NK	cells	deliver	cytotoxic	proteins	through	direct	contact	with	the	target	cells	and	the	formation	of	
an	 immunological	synapse.	The	efficiency	of	NK	cell	killing	depends	on	numerous	factors.	 It	 is	well-
understood	 how	 NK	 cells	 are	 activated	 by	 diseased	 cells	 and	 how	 the	 NK:target	 cell	 conjugate	 is	
formed	(Gasser	and	Raulet,	2006;	Mace	et	al.,	2014;	Watzl	and	Long,	2010).	Also	the	mechanism	NK	
cells	 use	 to	 release	 cytotoxic	 content	 and	 how	 apoptosis	 is	 induced	 in	 the	 target	 cells	 was	
investigated	in-depth	during	the	last	four	decades	(Caligiuri,	2008).	NK	cell	killing	is	most	effective	if	
one	single	NK	cell	 kills	multiple	 target	cells	 in	a	process	called	serial	killing.	Since	NK	cells	 can	only	
form	one	IS	at	once	they	first	have	to	break	the	contact	with	the	first	target	before	they	can	bind	and	
kill	another	one.	The	termination	of	the	NK:target	cell	conjugate	 is	an	active	and	regulated	process	
(Netter,	2014).	Otherwise	the	NK	cells	would	detach	too	early	and	the	target	cell	could	survive	or	the	
NK	 cell	 detaches	 too	 late	 and	 is	 ineffective.	 In	 this	 thesis	 I	 investigated	 the	 regulation	 of	 NK	 cell	
detachment	and	adressed	the	question	how	NK	cells	recognize	the	target	cell	death.		
To	 investigate	 the	 regulation	 of	 NK	 cell	 detachment	 I	 used	 a	 modified	 flow	 cytometry-based	
approach	 after	 Culley	 et	 al..	 I	 could	 confirm	 results	 from	 former	 studies	 in	 our	 lab	 that	 cultivated	
human	primary	NK	cells	detach	after	approximately	48	minutes	from	K562	target	cells	(Netter,	2014).	
However,	I	could	observe	variations	in	the	conjugate	half-life	between	NK	cells	from	different	donors.	
I	 assume	 that	besides	genetic	 factors,	 the	pre-activation	of	NK	cells	by	pro-inflammatory	cytokines	
influences	the	NK	cell	detachment.	Affected	by	stress,	age,	diseases	or	infections,	cells	of	the	immune	
system	 from	 different	 donors	 produce	 variable	 amounts	 of	 pro-inflammatory	 cytokines	 (Bernstein	
and	Murasko,	 1998;	 Claus	 et	 al.,	 2016a;	 Elenkov	 and	Chrousos,	 2002;	 Kleiner	 et	 al.,	 2013).	 I	 could	
show	that	 the	pre-activation	of	human	NK	cells	has	a	 large	effect	on	NK	cell	effector	 functions.	As	
described	 in	 the	 introduction	 in	 detail,	 the	 process	 of	 NK	 cell	 killing	 can	 be	 discriminated	 into	
different	 phases.	 Here	 I	 compared	 the	 ability	 of	 differently	 pre-activated	 NK	 cells	 to	 adhere,	
degranulate,	kill	and	detach	from	K562	target	cells	for	the	first	time.	Freshly	isolated	NK	cells,	which	
have	 not	 been	 pre-activated	 in	 vitro,	 are	 able	 to	 bind,	 degranulate	 and	 kill	 target	 cells.	 This	 is	
consistent	with	early	findings	that	NK	cells	are	cytotoxic	even	without	prior	sensitization	(Herberman	
et	al.,	1975;	Kiessling	et	al.,	1975).	IL-2	is	a	key	activator	of	NK	cells.	I	could	show	that	short	time	IL-2	
activated	NK	cells	form	more	conjugates	with	K562	cells	in	less	time.	IL-2	stimulates	the	high	affinity	
and	 high	 avidity	 conformation	 of	 LFA-1,	which	 results	 in	 an	 increased	 binding	 to	 ICAM	 expressing	
target	 cells	 (Barber	 and	 Long,	 2003;	 Suck	 et	 al.,	 2011).	 The	 activation	 of	 transcription	 factor	NFκB	
downstream	of	 the	 IL-2	 receptor	 induces	 the	production	of	perforin	 and	Granzymes	 (Huang	et	 al.,	
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2006;	Zhou	et	al.,	2002).	Thus,	the	IL-2	activated	NK	cells	are	able	to	secrete	more	cytotoxic	granules,	
which	increases	the	lysis	of	target	cells.	Cultured	NK	cells	are	able	to	produce	even	larger	amounts	of	
cytotoxic	granules.	This	results	 in	a	strongly	increased	degranulation	and	killing	of	the	target	cells.	 I	
show	that	target	cell	death	 is	sensed	by	the	NK	cell	and	initiates	the	IS	termination,	which	explains	
why	fast	killing	cultured	NK	cells	detach	clearly	earlier.	Surprisingly,	the	pre-activation	with	IL-2	was	
not	sufficient	to	accelerate	NK	cell	detachment	even	though	more	target	cells	were	killed.	Probably,	
the	 cytotoxicity	of	 fresh	and	 IL-2	 activated	NK	 cells	was	 too	 similar	 and	 the	detachment	 assay	not	
sensitive	enough	to	display	differences	in	the	half-life.	Hence,	the	recognition	of	target	cell	death	or	
the	initiation	of	NK	cell	detachment	can	be	sped	up	by	long-term	pre-activation	with	high	amounts	of	
cytokines.	
5.2 Triggering	 of	 single	 receptors	 differently	 stimulates	 NK	 cell	
detachment	
In	 the	 next	 step	 I	 investigated	 the	 influence	 of	 single	 NK	 cell	 receptors	 on	 the	 adhesion,	
degranulation,	killing	and	detachment	by	coincubation	of	NK	cells	with	Ba/F3	cells,	transfected	with	
the	associated	 ligand.	 Importantly,	 I	 used	cultured	NK	cells,	which	have	been	pre-activated	 for	2-3	
weeks.	It	is	known,	that	degranulation	is	positively	correlated	with	killing	of	target	cells	(Alter	et	al.,	
2004)	and	I	could	show	that	triggering	of	NKp30	and	NKG2D	led	to	the	strongest	degranulation	and	
thereby	highest	number	of	lysed	cells.	I	conclude	that	in	pre-activated	NK	cells	ligation	of	NKp30	or	
NKG2D	alone	is	sufficient	to	induce	target	cell	lysis.	In	contrast,	co-stimulatory	receptors	NTB-A	and	
2B4	are	less	sufficient	to	 induce	degranulation,	and	NK	cells	stimulated	via	these	receptors	thereby	
lyse	clearly	 less	target	cells.	Human	cultivated	NK	cells	are	able	to	bind	untransfected	mouse	Ba/F3	
cells	 through	 LFA-1:ICAM-1	 interaction	 (Johnston	 et	 al.,	 1990).	 I	 detected	 small	 differences	 in	 the	
adhesion	and	detachment	of	NK	cells	if	only	one	activating	receptor	was	triggered	by	the	target	cell.	
However,	the	presence	of	each	of	the	four	different	ligands	on	the	target	cells	clearly	increased	the	
adhesion	compared	to	untransfected	target	cells.	This	effect	was	most	likely	induced	through	inside-
out	signaling,	which	increases	the	affinity	and	avidity	of	LFA-1	(Beals	et	al.,	2001).	Although	binding	
to	 CD48-transfected	 target	 cells	 only	 slightly	 increases	 the	 cytotoxicity	 of	 NK	 cells,	 it	 has	 a	 large	
influence	on	the	formation	of	conjugates.	This	has	two	reasons:	On	the	one	hand	ligation	of	NK	cell	
receptor	 2B4	 to	 CD48	 increases	 LFA-1	 affinity	 to	 ICAM	 molecules	 through	 inside-out	 signaling	
(Hoffmann	et	al.,	2011;	Urlaub	et	al.,	2017).	On	the	other	hand	CD48	can	additionally	bind	to	NK	cell	
adhesion	receptor	CD2,	which	further	increases	the	adhesion	(Arulanandam	et	al.,	1993).	The	binding	
of	NKG2D	to	ULBP2	or	NKp30	to	B7H6	results	in	a	strong	adhesion	mainly	through	activation	of	LFA-1	
(Raemer	et	al.,	2009;	Segovis	et	al.,	2009).	NTB-A	only	 slightly	activates	 LFA-1	 (Urlaub	et	al.,	2017)	
and	 showed	 the	 smallest	 effect	 on	NK	 cell	 adhesion	 in	my	 experiments.	 However,	 the	 homophilic	
interaction	with	NTB-A	molecules	on	 target	cells	 increases	 the	adhesion	compared	 to	control	 cells.	
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Finally	I	could	show	that	the	dynamics	of	NK	cell	detachment	are	affected	by	the	triggered	activating	
receptor.	NK	cells	detach	quickly	from	control	or	NTB-A	transfected	cells,	which	promote	only	weak	
adhesion.	In	contrast,	triggering	of	the	receptors	2B4/CD2,	NKG2D	or	NKp30,	which	promote	strong	
adhesion,	 decelerated	 the	 NK	 cell	 detachment.	 This	 shows	 that	 termination	 of	 the	 NK:target	 cell	
contact	 needs	 loosing	 of	 NK	 cell	 adhesion	 molecules	 from	 their	 ligands	 on	 the	 target	 cell.	 The	
stronger	 an	 NK	 cell	 adheres	 to	 a	 target	 cell,	 the	 more	 effort	 it	 needs	 to	 release	 the	 cell-cell	
connection.	However,	this	conclusion	stands	in	contrast	to	the	observation	that	NK	cell	detachment	
is	 accelerated	 if	 the	 killing	 is	 increased.	 It	 would	 be	 possible	 that	 NK	 cells	 cannot	 form	 functional	
contacts	with	the	GFP-transfected	Ba/F3	cells,	which	causes	the	fast	detachment	and	short	half-life	
and	makes	them	inappropriate	as	a	control.	
5.3 Calcium	 and	 ROS	 are	 important	 second	 messengers	 for	 NK	 cell	
detachment	
Calcium	and	ROS	are	 important	 for	NK	cell	effector	 functions.	 It	 is	well	 investigated	 that	especially	
PLCγ-dependent	 calcium	mobilization	 is	needed	 for	granule	exocytosis	and	killing	of	 the	 target	 cell	
(Patterson	et	al.,	2005).	Importantly,	formation	of	a	NK:target	cell	conjugate	is	independent	of	raising	
cytosolic	calcium	level	as	I	did	not	find	any	differences	in	the	formation	of	conjugates	after	treatment	
with	Thapsigargin	or	 Ionomycin.	The	opening	of	calcium	channels	 is	a	very	fast	event.	The	calcium-
influx	 occurs	 directly	 after	 formation	 of	 the	 IS	 and	 triggering	 of	 activating	 receptors	 (Mace	 et	 al.,	
2014;	Oh-hora	and	Rao,	2008).	 I	could	show	that	 the	high	calcium	 level	 in	conjugated	NK	cells	was	
maintained	 during	 the	whole	 synapse	 time,	 probably	 due	 to	 ongoing	 activating	 signaling,	which	 is	
needed	for	the	IS	maintenance	(Huppa	et	al.,	2003;	Netter,	2014).	Reduction	of	the	target	cell	death	
with	concanamycin	A	decelerates	the	detachment	and	maintains	the	activating	signaling	and	thereby	
calcium	levels.	However,	the	correct	calcium	level	seems	to	be	 important	for	 IS	stability	as	NK	cells	
detach	immediately	after	treatment	of	pre-formed	conjugates	with	Thapsigargin	or	Ionomycin,	which	
both	 increase	 the	 cytosolic	 calcium	 levels.	 Calcium-influx	 is	 a	 local	 event	 and	 CRAC	 channels	 are	
recruited	to	the	IS	where	they	increase	the	calcium	level	directly	at	the	contact	site	with	the	target	
cell	 (Hartzell	et	al.,	2016;	Lioudyno	et	al.,	2008).	Calcium	 is	 important	 for	 the	reorganization	of	 the	
actin	cytoskeleton	at	the	IS	(Hartzell	et	al.,	2016)	and	in	T	cells	the	level	has	to	be	maintained	during	
the	 contact	 time	 to	 prevent	 detachment	 (Bunnell	 et	 al.,	 2001).	 Treatment	 with	 Thapsigargin	 or	
Ionomycin	 increases	 the	 calcium	 level	 in	 the	whole	 cell	 and	not	only	 in	 the	 region	adjacent	 to	 the	
target	 cell,	which	 could	mimic	 activation	 in	 distant	membrane	 regions.	 Activating	 signals	 could	 be	
withdrawn	from	the	IS,	which	then	destabilizes	the	synapse	and	forces	the	detachment.	This	would	
be	consistent	with	the	observations	of	Choi	and	colleagues	that	activating	signals	from	a	new	target	
can	 accelerate	 detachment	 from	 bound	 targets	 (Choi	 and	Mitchison,	 2013).	 After	 treatment	 with	
Thapsigargin	 or	 Ionomycin	 the	 degranulation	 of	 NK	 cells	 was	 not,	 or	 only	 slightly	 affected.	 The	
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decreased	lysis	of	target	cells	can	be	explained	by	the	rapid	detachment.	It	is	also	possible,	that	the	
calcium-induced	activation	of	distant	membrane	regions	leads	to	undirected	degranulation.	
I	could	also	show	that	redox	signaling	influences	NK	cell	effector	functions.	The	maintenance	of	the	IS	
needs	 energy	 in	 form	 of	 ATP	 (Netter,	 2014).	 The	 energy	 is	 provided	 by	 mitochondria,	 which	 are	
recruited	to	the	contact	site	after	formation	of	the	IS	(Abarca-Rojano	et	al.,	2009)	and	are	responsible	
for	 the	 production	 of	 ROS.	 Elimination	 of	 ROS	 with	 antioxidant	 N-Acetylcysteine	 accelerated	 the	
detachment	of	NK	cells	and	slightly	decreased	degranulation	and	lysis	of	the	target	cells.	Given	that	
ROS	are	associated	with	F-actin	dynamics	in	several	cell	types	(Munnamalai	and	Suter,	2009;	Sakai	et	
al.,	 2012;	 Taulet	 et	 al.,	 2012),	 the	mitochondrial	 ROS	 production	 at	 the	 IS	 participates	most	 likely	
directly	 in	 the	 stabilization	 of	 the	 actin-network	 and	 tightens	 the	 contact	with	 the	 target	 cell.	 The	
influence	of	ROS	on	F-actin	could	also	 increase	the	LFA-1	dependent	adhesion	of	the	NK	cell	to	the	
target.	Treatment	with	the	pro-oxidative	compound	WF-10	was	shown	to	enrich	LFA-1	at	the	IS.	This	
increases	the	adhesion	of	CTLs	to	their	targets	and	prevents	detachment	and	serial	killing	(Wabnitz	et	
al.,	2016).	The	clustering	of	high	affinity	LFA-1	at	the	IS	 is	dependent	on	F-actin	flow	(Comrie	et	al.,	
2015).	Thus,	it	is	mandatory	for	the	termination	of	the	IS	that	ROS	production	is	reduced	after	target	
cell	death.	
5.4 Reduction	of	NK	cell	cytotoxicity	leads	to	decelerated	detachment	
Former	studies	showed	that	NK	cells	detach	clearly	later	from	target	cells	if	NK	cells	were	unable	to	
kill	due	to	perforin	absence	(Jenkins	et	al.,	2015;	Netter,	2014).	To	prevent	maturation	of	perforin	I	
treated	 NK	 cells	 with	 concanamycin	 A,	 which	 is	 not	 a	 specific	 perforin	 inhibitor.	 Concanamycin	 A	
inhibits	 the	 vacuolar	 type	 H+-ATPase	 and	 thereby	 raises	 the	 pH	 of	 lytic	 granules.	 The	 acidification	
inhibits	cathepsin	L,	which	is	needed	for	cleavage	of	immature	perforin	into	its	active	form	(Kataoka	
et	 al.,	 1996;	 Kataoka	 et	 al.,	 1994).	 This	 raise	 the	 question	 if	 side	 effects	 of	 the	 concanamycin	 A	
treatment	prevents	termination	of	the	IS	directly.	The	delayed	detachment	would	be	caused	by	these	
side	 effects	 and	 not	 by	 the	 decreased	 NK	 cell	 cytotoxicity	 due	 to	 the	 loss	 of	 mature	 perforin.	
Therefore,	 I	 treated	NK	 cells	with	 Brefeldin	 A	 to	 confirm	 the	 concanamycin	 A	 results.	 The	 lactone	
antibiotic	 Brefeldin	 A	 interrupts	 the	 vesicle	 transport	 from	 ER	 to	 Golgi,	 which	 leads	 to	 an	
accumulation	 of	 proteins	 in	 the	 ER	 and	 prevents	 the	 exocytosis	 of	 vesicles	 (Fujiwara	 et	 al.,	 1988;	
Klausner	et	al.,	1992).	 I	used	Brefeldin	A	 in	order	to	abolish	the	secretion	of	cytotoxic	proteins	and	
could	detect	a	decrease	in	degranulation,	which	led	to	a	reduced	lysis	of	target	cells	although	these	
effects	were	less	dramatic	compared	to	concanamycin	A.	Surprisingly,	the	detachment	of	Brefeldin	A	
treated	 NK	 cells	 was	 slightly	 accelerated,	 which	 was	 the	 opposite	 effect	 to	 concanamycin	 A	
treatment.	 A	 side	 effect	 of	 Brefeldin	 A	 is	 the	 partial	 interruption	 of	 the	 microtubule	 and	 actin	
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cytoskeleton	(Alvarez	and	Sztul,	1999).	Both	are	fundamental	for	the	maintenance	of	the	IS	(Netter,	
2014),	which	explains	the	accelerated	detachment.		
I	could	show	that	the	NK	cell	detachment	can	be	decelerated	by	coincubation	with	resistant	target	
cells.	Importantly,	the	overexpression	of	SerpinB9	or	CD107a	decreases	the	killing	of	target	cells	only	
mildly	compared	to	the	treatment	with	concanamycin	A.	It	can	be	assumed	that	the	translocation	of	
CD107a	onto	the	outer	cell	membrane	is	not	the	only	mechanism	to	prevent	the	insertion	of	perforin	
(Cohnen	et	al.,	2013)	and	is	not	sufficient	to	protect	a	cell	completely	from	perforin-induced	killing.	
Additionally,	Granzyme	B	uses	further	mechanisms	to	induce	apoptosis	beside	activation	of	caspases	
(Rousalova	 and	Krepela,	 2010),	which	 explains	why	overexpression	of	 SerpinB9	did	not	 abolish	NK	
cell	killing	completely.	Nevertheless,	the	delayed	detachment	from	resistant	target	cells	compared	to	
untransfected	 controls	 shows	 that	 target	 cell	 death	 is	 one	 important	 step	 to	 initiate	 NK	 cell	
detachment.	 I	 hypothesize	 that	 apoptosis-induced	 alterations	 in	 the	 target	 cell	 membrane	 are	
recognized	by	the	NK	cell	and	induce	the	termination	of	the	IS.		
In	the	next	step	I	investigated	if	these	apoptosis-induced	alterations	are	necessarily	caused	by	the	NK	
cells.	 It	 is	 known	 that	 during	 the	 contact	 time,	membrane	 fragments	 and	 proteins	 are	 exchanged	
between	 both	 cells,	 which	 can	 reduce	 the	 NK	 cell	 cytotoxicity	 (Roda-Navarro	 et	 al.,	 2006).	
Additionally,	 Granzymes	 cleave	 specific	 pro-caspases	 and	 further	 proteins	 in	 the	 target	 cell	
(Voskoboinik	et	al.,	2015;	Waterhouse	et	al.,	2005).	 I	 induced	NK	cell	 independent	target	cell	death	
by	a	hydrogen	peroxide	pulse	and	determined	the	NK	cell	detachment.	Hydrogen	peroxide	 induces	
apoptosis	mainly	through	activation	of	caspase-3	and	-9	via	the	mitochondrial	pathway	(Saito	et	al.,	
2006;	Singh	et	al.,	2007).	In	contrast,	Granzyme	B	activates	caspase-3	and	-7	(Rousalova	and	Krepela,	
2010).	 I	observed	a	clearly	accelerated	NK	cell	detachment	from	target	cells,	that	died	for	a	NK	cell	
unrelated	reason.	This	demonstrates	that	termination	of	the	NK	cell	IS	is	initiated	by	apoptosis	of	the	
target	cell,	which	has	not	to	be	induced	by	the	NK	cell.	In	vivo,	different	immune	cells	fight	together	
against	 diseased	 and	 infected	 cells	 and	 induce	 apoptosis	 by	 different	 mechanisms.	 The	 ability	 to	
recognize	NK	cell	 independent	apoptosis	enables	NK	cells	to	detach	as	early	as	possible	from	target	
cells.	This	can	increase	serial	killing	and	thereby	the	efficiency	of	NK	cells.	
5.5 Loss	of	target	cell	adhesion	molecules	and	ligands	for	activating	NK	cell	
receptors	during	target	cell	death	
In	 order	 to	 detect	 the	 apoptosis-induced	 alterations	 after	 NK	 cell-mediated	 target	 cell	 death,	 I	
investigated	the	protein	composition	of	the	target	cell	membrane	before	and	after	cell	death.		
Upon	 ligation	 some	activating	NK	cell	 receptors	are	 internalized.	 Freshly	detached	NK	cells	 show	a	
decreased	expression	of	2B4,	DNAM-1	and	NKG2D	(Netter,	2014).	This	diminishes	activating	signaling	
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over	 the	period	of	 conjugation.	However,	 this	down-regulation	 is	not	dependent	on	 the	 target	 cell	
death	 and	 will	 probably	 just	 down-modulate	 the	 NK	 cell	 activation,	 which	 might	 facilitate	 the	
detachment	 and	 formation	 of	 a	 new	 IS	 with	 another	 target	 cell.	 I	 could	 show	 that	 another	
mechanism	to	diminish	the	NK	cell	activation	is	the	down-regulation	of	specific	ligands	on	the	target	
cell	membrane.	After	NK	cell-mediated	killing,	K562	 target	 cells	 lose	 the	NKp30	 ligand	B7H6.	 Since	
NKp30	 is	not	 internalized	after	 ligation	with	 its	 ligand,	this	could	be	a	mechanism	to	reduce	NKp30	
signaling	after	target	cell	death.	B7H6	was	shown	to	be	shed	by	metalloproteases	“a	disintegrin	and	
metalloproteinase”	 (ADAM)-10	 and	 ADAM-17	 from	 tumor	 cells	 (Schlecker	 et	 al.,	 2014).	 The	
expression	 of	 both	 metalloproteases	 is	 induced	 after	 apoptosis	 and	 ADAM-10	 was	 shown	 to	
colocalize	with	caspase-3,	a	main	target	of	Granzyme	B	(Lizama	et	al.,	2011;	Musumeci	et	al.,	2014;	
Rousalova	 and	 Krepela,	 2010).	 In	 contrast,	 ligands	 for	 NKG2D	 and	 DNAM-1,	 which	 are	 both	
internalized	after	ligation,	are	not	down-regulated	on	apoptotic	cells.		
I	hypothesize	that	ongoing	activating	signaling	is	important	to	keep	LFA-1	in	a	high	affinity	and	high	
avidity	state	during	conjugation	with	a	target	cell.	The	loss	of	activating	signals	could	cause	the	return	
of	LFA-1	to	its	low	affinity/avidity	state	and	promote	the	detachment	of	the	NK	cell.	I	could	show	that	
after	detachment	NK	cells	have	more	LFA-1	in	a	higher	adhesiveness	state	than	before	conjugation.	
Unfortunately	I	could	not	detect	high	affinity/avidity	LFA-1	on	NK	cells	in	conjugates.	This	may	have	
technical	reasons	because	after	target	cell	contact	LFA-1	is	recruited	to	the	IS	(Zheng	et	al.,	2009)	and	
it	 is	 not	 clear	 if	 ICAM-1-complexes	 can	 enter	 the	 IS.	 Hence	 I	 was	 not	 able	 to	 declare	 if	 the	
conformation	state	of	LFA-1	is	changed	to	its	less	affinity/avidity	state	prior	to	detachment.	However,	
the	 LFA-1	 ligands	 ICAM-1	 (CD54)	 and	 ICAM-2	 (CD102)	were	 clearly	 reduced	 on	 the	 cell	 surface	 of	
apoptotic	 target	 cells.	 ICAM-3	 (CD50)	 was	 earlier	 shown	 to	 be	 down-regulated	 on	 apoptotic	 cells	
(Hart	et	al.,	2000).	This	could	be	a	mechanism	to	decrease	the	LFA-1-mediated	adhesion	of	NK	cells	
to	dying	target	cells.	At	the	same	time	LFA-1	could	be	retained	in	an	activation	state,	which	is	higher	
compared	to	LFA-1	on	resting	NK	cells.	Thereby	the	freshly	detached	NK	cell	needs	less	time	to	bind	
and	kill	a	new	target	cell,	which	was	already	observed	by	Choi	et	al.	(Choi	and	Mitchison,	2013).		
Beside	ICAM-1	and	ICAM-2	I	found	several	other	adhesion	molecules	to	be	removed	from	the	target	
cell	membrane	 after	 induction	of	 apoptosis.	 CD15	was	 earlier	 shown	 to	 be	 removed	 from	 the	 cell	
surface	of	neutrophils	after	 induction	of	apoptosis	 (Hart	et	al.,	 2000).	 It	 can	bind	 to	CD62E,	CD62L	
and	CD62P	(E-,	L-	and	P-selectins)	on	the	NK	cell	surface	and	is	therefore	important	for	the	adhesion	
between	 both	 cells	 (Varki,	 1994).	 Blocking	 of	 CD15	 on	 cancer	 cells	 with	 antibodies	 was	 shown	 to	
decrease	the	adhesion	to	CD62E	expressing	cells	(Jassam	et	al.,	2016).	After	activation,	shedding	of	
CD62E	and	release	of	soluble	sCD62E	is	a	well	characterized	phenomenon	(Pigott	et	al.,	1992).	This	
can	 explain	 the	 observed	 reduction	 of	 CD62E	 on	 the	 cell	 surface	 of	 the	 target	 cell	 after	 NK	 cell	
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conjugation.	The	 reduction	of	CD15	and	CD62E	on	 the	 target	 cell	 after	NK	cell-mediated	apoptosis	
will	therefore	decrease	the	adhesion	of	NK	cells	and	contribute	to	the	detachment.		
CD58	 and	 CD59	 are	 both	 ligands	 for	 the	 NK	 cell	 adhesion	 receptor	 CD2,	 which	 not	 only	 provides	
adhesion	 to	 the	 target	 cell	 but	 also	 mediates	 ERK1/2	 phosphorylation	 (Zheng	 et	 al.,	 2009).	 The	
reduction	 of	 CD58	 and	 CD59	 on	 target	 cells	 after	 NK	 cell-mediated	 apoptosis	 decreases	 both,	 the	
CD2-mediated	 adhesion	 towards	 the	 target	 cell	 and	 activating	 signaling	 via	 ERK1/2.	 The	 latter	 is	
important	for	the	NK	cell	activity	as	blocking	of	CD2	with	antibodies	clearly	decreases	NK	cell	effector	
functions	(Zheng	et	al.,	2009).		
Beta-catenin	containing	cell-cell	contacts	are	cleaved	by	caspase-3	after	 induction	of	apoptosis	and	
decrease	adhesiveness	to	neighboring	cells	(Brancolini	et	al.,	1997).	The	reduction	of	CD62E	which	I	
saw	 after	 NK	 cell-mediated	 apoptosis	 is	 most	 likely	mediated	 by	 caspases,	 as	 the	 treatment	 with	
caspase	inhibitor	zVAD	reduces	the	shedding	of	CD62E	in	the	mouse	(Harrington	et	al.,	2006).	During	
the	execution	phase	of	apoptosis,	an	apoptotic	microtubule	network	 (AMN)	 is	 formed	beneath	the	
cell	membrane	and	forms	a	caspases	free	area.	The	cleavage	and	removal	of	adhesion	molecules	by	
proteases	 is	only	possible	after	caspases	have	depolymerized	 the	AMN	(Oropesa-Avila	et	al.,	2013;	
Sanchez-Alcazar	et	al.,	2007).	This	could	be	a	mechanism	to	prevent	the	premature	detachment	from	
the	NK	cell	before	the	target	cell	has	been	successfully	killed.	Additionally,	activated	Granzyme	B	was	
shown	to	cleave	adhesion	molecules	like	fibronectin	on	the	target	cell	membrane	before	entering	the	
cell	(Hendel	and	Granville,	2013).		However,	this	Granzyme	B-mediated	removal	of	adhesion	proteins	
is	not	related	to	apoptosis	and	could	only	serve	as	a	mechanism	to	reduce	the	overall	adhesion	and	
facilitate	 the	 detachment	 after	 target	 cell	 death.	 It	 could	 also	 explain	 the	 detachment	 of	NK	 cells,	
which	were	unable	to	kill	the	target	cell	after	some	time.		
5.6 Cytokine	hypersecretion	after	decelerated	NK	cell	detachment	
The	 disease	 familial	 hemophagocytic	 lymphohistiocytosis	 2	 (FHL-2)	 is	 characterized	 by	 cytokine	
storms	 with	 high	 serum	 concentrations	 of	 TNF-α	 and	 IFN-γ	 (Henter	 et	 al.,	 1991).	 Jenkins	 and	
colleagues	could	show,	that	the	absence	of	functional	perforin	in	NK	cells	and	CTLs	in	FHL-2	prolongs	
the	synapse	time	since	the	effector	cells	were	unable	to	kill	the	target	cell	(Jenkins	et	al.,	2015).	This	
is	 consistent	 with	my	 data.	 I	 analyzed	 the	 secretion	 of	 TNF-α	 and	 IFN-γ	 by	 NK	 cells	 in	 vitro	 after	
deleting	mature	perforin	or	during	co-incubation	with	resistant	target	cells.	Both	approaches	led	to	
the	 hypersecretion	 of	 TNF-α	 and	 IFN-γ.	 This	 reveals	 that	 cytokine	 hypersecretion	 is	 caused	 by	
prolonged	 contact	 time	 between	 NK	 cells	 and	 their	 targets	 and	 is	 not	 a	 side	 effect	 of	 perforin	
absence.	Ongoing	signaling	 is	 important	 for	 IS	maintenance	 (Huppa	et	al.,	2003;	Netter,	2014).	The	
inability	to	kill	the	target	cell	prevents	the	loss	of	ligands	for	activating	and	adhesion	receptors	on	the	
target	cell	membrane	and	the	prolonged	activating	signaling	maintains	the	high	calcium	levels.	The	
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persistent	calcium	influx	can	lead	to	the	continuous	production	of	pro-inflammatory	cytokines	(Maul-
Pavicic	et	al.,	2011).		
5.7 Influence	of	the	inhibitory	receptor	CD300a	on	NK	cell	detachment	
Another	 possible	 mechanism	 for	 NK	 cell	 detachment	 is	 the	 recognition	 of	 DAMPs	 by	 specialized	
inhibitory	receptors.	They	could	reduce	the	NK	cell	activity	and	force	the	decay	of	the	conjugate	after	
target	 cell	 death.	 Mace	 et	 al.	 propose	 that	 the	 interaction	 of	 CD300a	 with	 PS	 on	 the	 surface	 of	
apoptotic	 cells	 could	 induce	 the	NK	 cell	 detachment	 (Mace	 et	 al.,	 2014).	 In	 fact,	 NK	 cells	 have	 an	
increased	ability	to	 lyse	target	cells	 if	 the	CD300a-PS	 interaction	 is	blocked	with	MFG-E8	(Lankry	et	
al.,	 2013).	 However,	 blocking	 CD300a	 with	 MFG-E8	 in	 our	 detachment	 assay	 did	 not	 lead	 to	 an	
alteration	in	NK	cell	detachment.	MFG-E8	only	blocks	the	interaction	of	CD300a	with	PS	and	perhaps	
the	interaction	with	its	other	ligand	PE	is	more	important	for	NK	cell	detachment	or	CD300a	simply	
has	no	role	in	the	induction	of	the	NK	cell	detachment.	It	is	conceivable	that	CD300a	functions	more	
as	a	detector	for	apoptotic	cells	and	initiator	of	an	inhibitory	synapse.	The	triggering	of	CD300a	could	
prevent	the	firm	adhesion	to	dead	cells.	Notably,	 I	did	not	see	differences	 in	the	 lysis	of	K562	cells	
after	blocking	CD300a	with	MFG-E8.	It	is	possible	that	MFG-E8	can’t	enter	the	sealed	IS,	whereby	an	
investigation	 in	 our	 assay	 system	 would	 not	 be	 possible	 as	 I	 added	 MFG-E8	 after	 formation	 of	
conjugates.	
5.8 The	effect	of	soluble	factors	on	NK	cell	effector	functions	
Shedding	of	membrane	proteins	 and	 release	of	 apoptotic	 vesicles	 after	 induction	of	 apoptosis	 is	 a	
well-known	phenomenon	(Ilan	et	al.,	2001;	Kern	et	al.,	2000).	After	activation	of	caspases,	cleavage	
of	Rho	associated	kinase	ROCK1	promotes	membrane	blebbing	(Coleman	et	al.,	2001;	Sebbagh	et	al.,	
2001).	These	apoptotic	vesicles	seem	to	have	an	inhibitory	effect	on	NK	cells	in	my	experiments.		
The	effect	of	dead	cell	supernatant	on	NK	cell	functions	remains	ambiguous.	It	could	be	mediated	by	
secreted	or	shed	molecules	or	by	apoptotic	vesicles.	I	detected	a	long-lasting	inhibitory	effect	of	dead	
cell	 supernatant	 on	 NK	 cells.	 This	 indicates	 a	 systemic	 inhibition	 by	 the	 released	 soluble	 factors.	
Yufeng	Xie	et	al.	report	that	CTLs	are	 inhibited	by	membrane	bound	transforming	growth	factor-ß1	
(TGF-ß1)	on	apoptotic	bodies,	which	are	released	by	tumors	after	radiation-induced	apoptosis	in	the	
mouse	(Xie	et	al.,	2009).	TGF-ß1	can	decrease	NK	cell	function	by	down-regulation	of	receptors	like	
NKG2D	and	decrease	the	production	of	pro-inflammatory	cytokines	probably	through	repression	of	
the	mTOR	pathway	(Bellone	et	al.,	1995;	Dasgupta	et	al.,	2005;	Viel	et	al.,	2016).	Future	studies	have	
to	 examine,	 if	 K562/HEK293T-derived	 apoptotic	 bodies	 have	membrane	bound	 TGF-ß1	 and	 if	 they	
interact	 with	 and	 inhibit	 NK	 cells.	 Notably,	 I	 also	 saw	 a	 similar	 inhibitory	 effect	 of	 dead	 cell	
supernatant,	which	was	centrifuged	to	remove	apoptotic	bodies.	However,	apoptotic	bodies	are	very	
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heterogeneous	and	vary	 in	 size	 from	50-5000	nm	 (Akers	et	 al.,	 2013).	 It	 is	most	 likely,	 that	not	all	
vesicles	have	been	removed	and	I	cannot	clearly	link	the	inhibitory	effect	to	other	soluble	molecules.		
In	addition	to	the	inhibition	of	NK	cell	cytotoxicity,	I	saw	a	direct	effect	of	dead	cell	supernatant	on	
the	NK:target	cell	conjugate	stability.	As	mentioned	before,	Choi	et	al.	postulate	a	mechanism	called	
“kinetic	priming”	for	the	detachment	of	NK	cells.	Thus,	NK	cells	use	signals	from	new	targets	in	close	
proximity	to	 force	the	detachment	 from	the	old	target	 (Choi	and	Mitchison,	2013).	The	addition	of	
new	 targets	 in	 a	 detachment	 assay	 at	 the	 time-point	 of	 dilution	 clearly	 accelerates	 the	 NK	 cell	
detachment	 (Netter,	 2014).	 Apoptotic	 vesicles	 or	 shed	 ligands	 could	 bind	 receptors	 distant	 to	 the	
target	 cell	 contact	 site.	 This	 could	 subtract	 activating	 signals	 from	 the	 IS,	 decrease	 the	 conjugate	
stability	and	accelerate	the	NK	cell	detachment.	
5.9 Model	for	NK	cell	detachment	
On	basis	of	my	results,	I	propose	a	model	for	the	regulation	of	NK	cell	detachment.	This	depends	on	
the	recognition	of	target	cell	death	by	NK	cells,	which	initiates	the	termination	of	the	IS	by	reduction	
of	ongoing	activating	signaling.	
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Figure	25.	Schematic	Model	of	NK	cell	adhesion	(I)	and	detachment	(II	and	III).	
I. The	immunological	synapse	consists	of	activating	receptors,	which	bind	their	 ligands	on	
the	target	cell.	Via	inside-out	signaling,	adhesion	receptors	are	clustered	at	the	target	cell	
contact	 site	 and	 the	 adhesiveness	 of	 LFA-1	 increases	 by	 conformational	 changes.	 This	
leads	to	a	firm	adhesion	and	formation	as	well	as	maintenance	of	the	 IS.	The	emerging	
activating	signal	initiates	degranulation	and	killing	of	the	target	cell.	
II. The	 secreted	 cytotoxic	 proteins	 enter	 the	 target	 cell	 and	 induce	 apoptosis.	 The	 dying	
target	cell	loses	ligands	for	activating	NK	cell	receptors.	Additionally,	activating	receptors	
are	internalized	after	ligation,	which	diminishes	the	activating	signal.	Soluble	molecules,	
which	 are	 secreted	 by	 the	 apoptotic	 target	 cell	 may	 also	 inhibit	 the	 NK	 cell.	 The	
decreased	 inside-out	 signaling	 lowers	 the	 adhesiveness	 of	 adhesion	 receptors	 and	
together	with	the	loss	of	adhesion	molecules	on	the	target	cell,	this	reduces	the	adhesion	
towards	the	target	cell.	
III. The	NK	cell	detaches	from	the	target	cell,	and	is	able	to	bind	and	kill	another	cell.	
This	model	 explains	 the	 experimental	 findings	 that	 detachment	 is	 an	 important	 factor	 for	 NK	 cell	
effector	 functions.	The	regulation	 is	highly	dependent	on	extrinsic	signals	 from	the	target	cell	after	
induction	 of	 cell	 death.	 Loss	 of	 NK	 cell	 ligands	 and	 adhesion	 molecules	 on	 the	 target	 cell	 during	
apoptosis	 are	mainly	 responsible	 for	 the	 detachment	 of	 NK	 cells.	 A	 reduced	 ability	 to	 kill,	 due	 to	
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resistant	 target	 cells	 or	 absence	 of	 cytotoxic	 proteins,	 decelerates	 the	 NK	 cell	 detachment.	 This	
prolonged	 conjugation	 time	 has	 functional	 consequences,	 as	 ongoing	 activating	 signaling	 and	
sustained	 Ca2+	 flux	 leads	 to	 the	 production	 of	 more	 pro-inflammatory	 cytokines.	 These	 findings	
facilitate	an	important	insight	in	NK	cell	regulation	after	degranulation.	It	could	help	in	understanding	
diseases	like	FHL-2	with	impaired	NK	cell	functions	or	fighting	cancer	diseases	with	NK	cell	resistant	
tumors.		
In	the	end	some	questions	remain.	The	proposed	model	of	NK	cell	detachment	can	only	apply	to	lytic	
NK	cell	contacts,	which	are	important	for	the	clearance	of	diseased	cells.	However,	the	stimulation	of	
NK	cells	by	DCs	or	macrophages	requires	the	formation	of	a	non-lytic,	regulatory	IS	(Borg	et	al.,	2004;	
Lapaque	 et	 al.,	 2009).	 This	 regulatory	 IS	 is	 terminated	 without	 lysis	 of	 the	 target	 cell.	 Further	
investigations	have	to	reveal	how	NK	cells	detach	from	contacts	without	induction	of	apoptosis.	
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7 Abbreviations	ADAM	 A	disintegrin	and	metalloproteinase	AKT	 Protein	kinase	B	AMN	 Apoptotic	microtubule	network	Arl8b	 ADP-ribosylation	factor-like	protein	8B	BAT-3	 HLA-B-associated	transcript	3	CAR	 Chimeric	antigen	receptor	CCL5	 CC-chemokine	ligand	5	CD	 Cluster	of	differentiation	CDC	 Cholesterol-dependent	cytolysin	Cdc42	 Cell	division	control	protein	42	homolog	CLP	 Common	lymphoid	progenitor	CRAC	 Calcium-release-activated	calcium	CREB	 cAMP	response	element-binding	protein	CTL	 Cytotoxic	T-Lymphocyte	DAG	 Diacylglycerol	DAP10	 DNAX-activating	protein	of	10	kDa	DAP12	 DNAX-activating	protein	of	12	kDa	DC	 Dendritic	cell	DCS	 Dead	cell	supernatant	DMSO	 Dimethylsulfoxide	DNAM-1	 DNAX	accessory	molecule	EAT2	 Ewing's	sarcoma-associated	transcript	2	ER	 Endoplasmatic	reticulum	ERK	 extracellular	signal-regulated	kinase	FACS	 Fluorescence-activated	cell	sorting	FAK	 Focal	adhesion	kinase	FasL	 FAS	Ligand	Fc	 Fragment	crystallizable	FCS	 Fetal	calf	serum	FHL-2	 Familial	hemophagocytic	lymphohistiocytosis	2	GADS	 GRB2-related	adaptor	downstream	of	Shc	GEF	 Guanine	exchange	factor	GFP	 Green	fluorescent	protein	GM-CSF	 Granulocyte-macrophage	colony-stimulating	factor	Grb	 Growth	factor	receptor-bound	protein	GTP	 Guanosintriphosphat	HA	 Hemagglutinin	IFN	 Interferon	IL	 Interleukin	InsP3	 Inositol-1,4,5-trisphosphate	IS	 Immunological	synapse	ITAM	 Immunoreceptor	tyrosine-based	activation	motif	ITIM	 Immunoreceptor	tyrosine-based	inhibitory	motif	ITK	 Interleukin-2-inducible	T-cell	kinase	ITSM	 Immunoreceptor	tyrosine-based	switch	motif	JAK	 Janus	kinase	kDa	 Kilo	dalton	LAT	 Linker	of	activated	T	cells	LCAA	 Ligand	complex–based	adhesion	assay	LCS	 Live	cell	supernatant	LFA	 Lymphocyte	function-associated	antigen	LSM	 Lymphocyte	Separation	Medium	MACPF	 The	membrane	attack	complex/perforin	
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MAPK	 Mitogen-activated	protein	kinase	MFG-E8	 Milk	fat	globule-EGF	factor	8	protein	MHC	 Major	histocompatibility	complex	MICA/B	 MHC	class	I	polypeptide-related	sequence	A/B	MIP	 Macrophage	inflammatory	protein	MTOC	 Microtubule-organizing	center	mTOR	 Mechanistic	target	of	rapamycin	Munc13	 Mammalian	uncoordinated-13	NCR	 Natural	cytotoxicity	receptor	NFAT	 Nuclear	factor	of	activated	T-cells	NFκB	 Nuclear	factor	'kappa-light-chain-enhancer'	of	activated	B-cells	NK	cell	 Natural	killer	cell	NKG2D	 Natural	killer	group	2D	NKT	cells	 Natural	killer	T	cells	NOX	 NADPH	oxidase	ORAI1	 Calcium-release-activated	calcium	molecule	1	P/S	 Penicillin-streptomycin	PBL	 Peripheral	blood	lymphocytes	PBMC	 Peripheral	blood	mononuclear	cell	PCNA	 Proliferating	cell	nuclear	antigen	PDGF-D	 Platelet	derived	growth	factor	D	PE	 Phosphatidylethanolamine	PI3K	 P85α	subunit	of	phosphatidylinositol-3	kinase	PIPKIγ	 PtdIns(4)P	5-kinase	PLCγ1	 Phospholipase	C	γ1	PS	 Phosphatidylserine	PtdIns(4,5)P2	 Phosphatidylinositol-4,5-bisphosphate	PtdIns(4)P)	5-kinase	 Type	Iγ	phosphatidylinositol	4-phosphate	PTP	 Protein	tyrosine	phosphatase	PVR	 Poliovirus	receptor	ROCK	 Rho-kinase	ROS	 Reactive	oxygen	species	SAP	 SLAM-associated	protein	SERCA	 Sarcoplasmic/endoplasmic	reticulum	calcium	ATPase	SerpinB9	 Serine	protease	inhibitor	9	SHIP	 SH2-containing	inositol	polyphosphate	5-phosphatase	SHP	 Src	homology	region	2	domain-containing	phosphatase	SLAM	 Signaling	lymphocytic	activating	molecule	SLP76	 SH2	domain	containing	leukocyte	protein	of	76kDa	SNARE	 Soluble	NSF	attachment	protein	receptor	STAT	 Signal	transducers	and	activators	of	transcription	STIM1/2	 Stromal	interaction	molecule	1/2	SYK	 Spleen	tyrosine	kinase	TGF	 Transforming	growth	factor	TIGIT	 T	cell	immunoreceptor	with	Ig	and	ITIM	domains	TNF	 Tumor	necrosis	factor	TRAF2	 TNF	receptor-associated	factor	2	TRAIL	 TNF-related	apoptosis-inducing	ligand	ULBP	 UL16	binding	proteins	VAMP	 Vesicle-associated	membrane	protein	WASp	 Wiskott–Aldrich	Syndrome	protein	ZAP	 Zeta-chain-associated	protein	kinase	zVAD	 zVAD-fmk	
